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8 Chapter 1
INTRoDUCTIoN
The field of corneal and refractive surgery offers the patient the possibility of 
becoming independent of spectacles and/or contact lenses. The attainment of this 
treatment goal is of particular importance to individuals who are restricted in 
their professional and social life by their contact lens or spectacle intolerance.
The developments and outcome of refractive surgery have received increasing 
attention in the medical literature and public media, a phenomenon which is 
mainly related to the numerous success stories and the dramatic changes achieved 
by correction of the refractive error and the resultant independence of spectacles 
and contact lenses.
Numerous corneal and refractive surgery techniques have become available for 
the correction of the refractive error, with the majority of treatments consisting 
of myopic and myopic-astigmatic corrections. Since the start of excimer laser 
treatments and surgical implantations of phakic anterior chamber lenses, the 
field of corneal and refractive surgery has greatly evolved. Refractive surgery 
techniques have been refined and continually evolving to be more specifically 
geared towards the individual optical design, which can differ greatly between 
individuals and depends on various factors, such as the amount of the refractive 
error and the degree of optical aberrations. In addition, treatments are being 
refined to more adequately meet the specific aims of the individual patient 
seeking treatment. Laser ablation techniques have changed from the standard 
correction of the refractive error to personalized and optimized laser treatments 
and from broad-beam to scanning-spot or flying-spot devices. These days, the 
choice of anterior chamber intraocular lenses (IoL) include a range of various 
phakic lenses, including toric phakic IoLs and foldable phakic IoLs. The role of 
the appropriate optical zone size in laser ablation treatment, the relevance of pupil 
size and optical aberrations continue to play an important part in the selection of 
refractive surgery candidates.
Despite the instant success stories related to the dramatic changes in the refractive 
error, numerous studies on the initial outcome demonstrated a decreased quality 
of vision, which may be attributed to contrast sensitivity loss and subsequent 
optical side effects, such as night vision complaints, glare and halos. The evalu-
ation of patient satisfaction is of paramount importance in the full assessment 
of corneal and refractive surgery outcome and is gradually receiving a central 
role in relation to the pre- and postoperative evaluation of the refractive surgery 
patient. This trend can be seen from the growing amount of medical reports, 
starting some 25 years ago and vastly increasing throughout the last decade. The 
main questions related to patient satisfaction are: Is the patient happy with the 
outcome? Was the goal of treatment reached? Does the clinical outcome corre-
late with the subjective result? The necessity for a more precise assessment of 
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subjective quality of vision and patient satisfaction after refractive surgery has 
increased with the discovery of several optical side effects, namely night vision 
complaints, glare and halos. The exact nature of these optical side effects remains 
difficult and sometimes faces us with challenges and limitations concerning the 
full attainment of a satisfying refractive and patient outcome. However, optical 
side effects are also known to decrease within the first 6 months after treatment, 
which might be the result of a gradual (neural) adaptation to a new condition. 
This is confirmed by the finding that the majority of patients are very happy with 
their outcome and would choose the same surgical treatment again, if they had 
to do it all over again.
Patient questionnaires can assist in the evaluation of patient satisfaction and will 
continue to play a central role when selecting refractive surgery candidates. It is 
of vital importance that the eye surgeon adequately assesses the specific needs of 
the patient, makes a full objective evaluation of the patients’ eye and then decides 
whether or not this individual can be helped by the correction of their refractive 
error through a surgical intervention.
Various types of questionnaires may then assist in evaluating the outcome of 
treatment.
Aim and outline of the thesis
The aims of this thesis are to study the visual outcome and patient satisfaction 
of various refractive surgery techniques for the correction of the refractive error 
and to evaluate the significance of various clinical parameters on the selection of 
refractive surgery candidates.
Chapter 1 is a literature review which discusses the background of the various 
refractive surgery devices and techniques. It summarizes the available literature 
on patient satisfaction and questionnaires, including subjective and objective 
quality of vision. The clinical outcome and potential benefits and drawbacks of 
various laser refractive techniques, phakic IoL implantations and visual rehabili-
tation modalities after penetrating keratoplasty are also discussed.
Chapters 2 and 3 describe the role of specifically designed instruments to deter-
mine pupil size for refractive surgery and evaluate the effect of iris-fixated phakic 
IoLs on pupil dynamics and the potential consequences for decision taking in 
selecting patients for refractive surgery.
Chapter 4 discusses visual outcome and patient satisfaction after laser in situ 
keratomileusis for the correction of myopia.
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Chapters 5 and 6 discuss the results after Artisan phakic IoL implantation for 
the correction of myopia. Chapter 5 reports the functional outcome and patient 
satisfaction after 1 year and chapter 6 reports the results after 10 years.
Chapters 7 and 8 discuss the application of the Artisan toric IoL in patients 
with aberrations in the corneal shape after corneal transplantation surgery and 
corneal refractive surgery. Chapter 7 demonstrates a 3-year follow-up analysis of 
Artisan toric IoL implantation for the correction of post-keratoplasty ametropia 
in phakic and pseudophakic eyes. Chapter 8 describes 2 case reports of Artisan 
toric aphakic IoL lens implantation for the correction of severe astigmatism after 
radial keratotomy.
In chapter 9 a complication and the consequences for the individual patient of 
implantation of a foldable phakic IoL are described.
Chapters 10 compares in vitro and in vivo differences between a non-foldable 
polymethyl methacrylate phakic IoL and a recently developed foldable phakic 
IoL and analyses changes in optical aberrations for the correction of myopia.
PATIENT SATISFACTIoN
How can we measure subjective and objective quality of refractive surgery?
With the increasing amounts of new and improved keratorefractive surgery 
treatments for the correction of the refractive error, the importance of systematic 
evaluation of the treatment outcome has grown. Until recently, the evaluation 
and comparison of refractive surgery techniques were mainly focused on the 
objective, clinical outcome such as the subjective and objective refraction, uncor-
rected and best-corrected visual acuity (UCVA and BCVA; efficacy), refraction 
within 1 diopter (D) of the targeted correction (predictability) and the number 
of Snellen acuity lines lost or gained after the procedure (safety). Formats for 
reporting these parameters have been suggested in the literature.1, 2
Patient satisfaction after refractive surgery, however, entails the greater area of 
quality of life and functional status as self-perceived by the patient. The area 
of measuring patient satisfaction is complex and multidimensional, since it is 
influenced by the combination of subjective quality of vision, personal expecta-
tions and personality type.3, 4 It is important that refractive surgeons understand 
patient motivations for seeking surgery, since this can influence their postopera-
tive satisfaction. 
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In order to predict the unhappy patient it is important to:
1. Identify what the expectations and motivations of patients are before 
undergoing refractive surgery;
2. Describe the population of satisfied and dissatisfied patients;
3. Identify parameters responsible for patient dissatisfaction.
Patient satisfaction can be defined by the difference between the patient’s expec-
tation before surgery and the outcome after surgery. An example is the ‘discon-
formation-of-expectations’ model (Fig. 1), which explains that if perceived 
performance is evaluated as worse than the expectation, negative disconfirmation 
results in dissatisfaction.5, 6 This model closely adheres to the current theory of 
“undersell and overdeliver” to achieve satisfied patients in corneal and lenticular 
refractive surgery.
The importance of consumer satisfaction can also be found in the world of 
marketing, where firms are advised to develop specified definitions of consumer 
satisfaction, which will guide the assessment of satisfaction. This measurement 
process seems to be necessary to move closer to truly understanding customers 
and to make better managerial decisions.7
Patient satisfaction questionnaires
one of the most effective and efficient ways to study patient expectations and 
motivations is by using validated questionnaires, which systematically ask patients 
about their experiences.4, 8-22 Self-administered questionnaires, rather than 
physician-administered questionnaires, enable a more objective view of patient 
satisfaction and quality of vision. When a test is administered by a physician, 
results may be biased and patients might feel compelled to always answer in the 
Figure 1. The ‘disconformation-of-expectations’ model
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affirmative. Several studies have used questionnaires for the assessment of patient 
expectations and satisfaction. Realistic preoperative patient expectations seem 
to correlate well with postoperative patient satisfaction, meaning that a good 
understanding of patient motivation for seeking refractive surgery is important.12 
Primary reasons for seeking refractive surgery such as laser in situ keratomileusis 
(LASIK) are a desire for freedom from spectacles or contact lenses (32.1%) and 
spectacle or contact lens intolerance (30.4%).23, 24
The questionnaire which we used in our studies is a psychometric instrument 
that was developed and validated by Brunette et al. and has been previously used 
for the evaluation of patient satisfaction after photorefractive keratectomy (PRK) 
and to assess postoperative visual symptoms.9, 10 The questionnaire was translated 
into the Dutch language from the original English. For analysis purposes, the 66 
items of the questionnaire were grouped in seven distinct scales which were self-
administered by patients. Scale scores increased with satisfaction, ranging from 1 
(very dissatisfied) to 5 (very satisfied). Each of the seven scales covered a specific 
aspect of quality of vision, including global satisfaction, quality of uncorrected 
and corrected vision, quality of night vision, glare, daytime driving and night 
driving.
Several other patient satisfaction questionnaires have been developed in order to 
assess subjective visual disability and self-rated quality of vision in patients with 
ocular disease:
The QUoTE Cataract Questionnaire was developed at our institution to measure 
quality of care from the perspective of cataract patients. The acronym QUoTE 
stands for “quality of care through the patients’ eyes”. The questionnaire was 
developed as a self-administered measure using both qualitative and quantitative 
research methods. QUoTE questionnaires can be used in quality-assessment 
studies to evaluate the quality of health care services from the patients’ perspec-
tive in a very general way. They can also be used in studies whose aim is quality 
improvement at the level of specific quality aspects.18
The Refractive Status and Vision Profile (RSVP) is a questionnaire that consists 
of eight scales, designed to measure self-reported functioning, symptoms, health 
perceptions, and expectations in individuals with refractive error.19
The VF-14 questionnaire, developed by the Cataract PoRT group, has proven 
test–retest reliability, responsiveness, and international validity in cataract patients 
specifically. The questionnaire evaluates functional status related to vision and 
can detect clinically meaningful changes following cataract surgery and provide 
information related to the outcome of surgery.4, 20-22
The National Eye Institute-Refractive Error Quality of Life survey (NEI-RQL) 
includes 13 scales which are designed to assess the impact of refractive error 
and its correction on daily life. The scales are clarity of vision, expectations, 
near vision, far vision, diurnal fluctuations, activity limitations, glare, symptoms, 
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dependence on correction, worry, suboptimal correction, appearance, and satis-
faction with correction. The NEI-RQL questionnaire appears to be useful for 
comparisons of various surgical and non-surgical methods for the correction of 
the refractive error.11, 16, 17
oUTCoMES oF CoRNEAL REFRACTIVE SURGERY
over the years, surgical procedures for the correction of moderate to severe 
myopia have been developed. These procedures can either involve the cornea 
(corneal refractive surgery) or the lens (lenticular refractive surgery).
Corneal refractive surgery procedures for treatment of myopia
Radial keratotomy (RK)
Before the popularity of excimer photoablative refractive surgery, the technique 
of RK (popularized by Fyodorov)25 was among the most widely used surgical 
techniques for the correction of myopia, being a popular procedure during the 
eighties and early nineties, especially in Russia and the United States and to a 
lesser extent in Europe.26-28 The method of RK consists of making deep radial 
incisions in the paracentral and peripheral anterior cornea using a diamond blade 
knife. The technique results in flattening of the central corneal curvature and 
steepening of the peripheral area, which reduces the degree of myopia.
The number of RK incisions, diameter of the optic zone and patient age deter-
mine the refractive outcome after RK. Incision direction was shown to be another 
predictor, with the centripetal (versus the centrifugal) incision decreasing myopia 
to a higher degree.
Although the treatment by RK initially resulted in satisfactory refractive results, 
it appeared not to be as predictable as current refractive surgery techniques. one 
common and challenging side effect of RK was the development of secondary 
and continuing hyperopia. Clinical studies have shown that hyperopic shift after 
RK occurred with a frequency of 17% to 43%, with an additional incidence of 
1% to 2% each year.29-31 The Prospective Evaluation of Radial Keratotomy study 
was a 9-center clinical trial which analyzed the long-term (10-year) effects and 
stability of myopic RK (with a range of -2.00 to -8.75 D).29 They showed that 
53% of eyes achieved an UCVA ≥ 20/20, and 85% ≥ 20/40. They also showed that 
38% of eyes achieved a refraction ± 0.50 D and 60% ± 1.0 D. Most importantly, 
they observed a progressive hyperopic shift up to 10 years after RK. This was also 
shown in another 10-year report, but they suggested that the refractive and acuity 
changes were mainly normal physiologic changes.32 Finally, a different retrospec-
tive 10-year RK study did not observe any significant refractive changes.33
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A less common side effect after RK is the development of irregular astigmatism, 
which can be induced by the intersection of the incisions with the visual axis or 
by the eccentricity of the optical zone.34 Some other side effects are fluctuating 
vision and glare.29, 35, 36
Aside from treating myopia, RK has also been used for the correction of astig-
matism (also known as arcuate keratotomy), although the predictability of this 
technique is known to be slightly less than that for correction of myopia. The 
procedure has been shown to be an effective and safe method for correcting 
moderate to severe naturally occurring astigmatism.37-40
The popularity of RK declined since the approval of the excimer laser in 1995, 
due to the superior outcomes of PRK and LASIK.
Photorefractive keratectomy (PRK)
In the late 1980s, the technique of laser and tissue interaction was first described 
by Trokel and Srinivasan and one of the first clinical results were demonstrated 
by Seiler et al.41, 42 They proved that the far-ultraviolet (193-nm) argon fluoride 
excimer laser could be used for the permanent removal of corneal stromal tissue 
in a precise manner, with minimal damage to the adjacent corneal tissue. PRK 
became widely available for the correction of myopia in the early 1990s.
In the early days, PRK was the main treatment for low to moderate myopia. The 
technique underwent various developments, varying from laser systems, treat-
ment algorithms to the choice of transition and ablation zones. In PRK, before 
the laser ablation occurs, the corneal epithelium is removed, either manually 
with a blade or a rotating brush or after alcohol administration.
Short-term problems after PRK are discomfort in the first 24 hours; a delay in 
visual recovery lasting 3 to 5 days during epithelial healing; and haze lasting 
weeks to months after the procedure. Previous studies with 1.5 to 6-year follow-
up demonstrated that PRK ablations often show an immediate postoperative 
hyperopic shift, due to a thinner epithelium.43-46 The hyperopic shift is often 
compensated by a period of regression that stabilizes between 1 and 6 months. 
Refractive stability after PRK is generally achieved after 6 months to 1 year and 
maintained for up to a period of 5 years.
Long-term studies on the outcome of PRK found no evidence of progressive 
time-dependent hyperopic shift or late regression, with trace haze in 0% to 17.2% 
after 12 years. They concluded that corneal haze was transient and generally 
resolved by 1 year. Finally, they suggested that chronic stromal remodeling and 
corneal ectasia are unlikely events after PRK.47, 48
In summary, for treatment of patients with low-to-moderate myopia, PRK has 
shown to produce stable and predictable results with an excellent safety profile.
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Laser in situ keratomileusis (LASIK)
Barraquer was one of the leaders in the development of the use of lamellar refractive 
surgery to correct refractive errors by myopic keratomileusis, in which a lenticule 
was excised from the cornea with a microkeratome and its refractive power was 
altered by cutting in a cryolathe using freezing techniques. He first described the 
technique in 1965 and presented the initial clinical results in 1981.49, 50
In 1991, Pallikaris first reported on the results of LASIK, which meant a major 
change in the field of refractive surgery.51 The side effects associated with PRK 
made LASIK treatment to be the leading procedure in refractive surgery.52 The 
popularity of LASIK is probably related to the relatively fast visual recovery time, 
minimal discomfort immediately after treatment and the minimal incidence 
of haze. For low to moderate myopia, LASIK has proven to be very effective, 
predictable and safe, achieving an UCVA of 20/40 or more in 82%-100% of 
eyes and an UCVA of 20/20 in 54%-93.9% of eyes. The technique has shown to 
achieve a very accurate correction, with 72%-96.1% of eyes achieving a refractive 
error within ±0.50 D of the intended correction and 87.9%-100% of eyes within 
±1.00 D of the intended correction.12, 52-70 For moderate to high myopia (>-6.0 
D), the results show more variation.53, 59, 68, 70-77 (Tables 1 and 2)
PRK and LASIK candidates typically have healthy eyes; thus, achieving and 
maintaining high levels of (subjective) satisfaction after surgery are important. 
Reports show that patient satisfaction after LASIK seems to range between 
82% and 98%.8, 12, 72, 78 Patients are generally very satisfied with their uncor-
rected vision, visual recovery and quality of life after LASIK treatment, with 
the majority of patients reporting that they would have the surgery again 
(up to 98%) and/or recommend the procedure to a friend up to (97%).8, 12, 14, 71, 
74, 79
Myopic regression is a condition that can occur after LASIK. The risk of myopic 
regression increases with the degree of preoperative myopia and patient age. 
Long-term studies on LASIK for treatment of moderate and extreme myopia 
showed a trend towards myopic regression, changing from 52%-96% of eyes 
within ±1.0 D of the attempted correction after 1 year to 46%-91% after 5 to 6 
years follow-up.57, 71, 80 In contrast, LASIK studies with lower degrees of preopera-
tive myopia (<-6.0 D) have reported refractive stability achieved at 3 to 6 months 
and sustained to 2 years.55, 81
Benefits of LASIK as opposed to PRK are diminished discomfort and haze, thus 
leading to a more rapid visual rehabilitation.52, 55
Tahzib_Boek_06.indb   15 11-8-2008   11:32:17
16 Chapter 1
T
ab
le
 1
-A
. 
o
ve
rv
ie
w
 o
f c
om
pa
ra
ti
ve
 s
tu
di
es
 fo
r 
la
se
r 
in
 s
it
u 
ke
ra
to
m
ile
us
is
 fo
r 
co
rr
ec
ti
on
 o
f l
ow
 t
o 
m
od
er
at
e 
m
yo
pi
a.
A
ut
ho
r,
 y
ea
r
N
um
be
r 
of
 e
ye
s 
Fo
llo
w
-u
p 
(m
os
)
M
ea
n 
or
 r
an
ge
 
pr
eo
p 
SE
 (
D
)
M
ea
n 
po
st
op
 
SE
 (
D
)
M
ea
n 
SE
 ±
 
1.
0 
D
 (
%
)
M
ea
n 
SE
 ±
 
0.
5 
D
 (
%
)
U
C
V
A
 ≥
 
20
/4
0 
(%
)
U
C
V
A
 ≥
 
20
/2
0 
(%
)
L
os
s 
≥ 
2 
li
ne
s 
B
C
V
A
Ja
bb
ur
, 2
00
5*
27
7
6
-3
.2
±
1.
3
0.
00
±
0.
26
99
.3
90
.3
99
.6
93
.9
0
K
oh
ne
n,
 2
00
4*
97
12
-5
.2
2±
2.
07
-0
.2
5±
0.
43
95
.0
77
.0
98
.0
83
.0
0
K
an
ja
ni
, 2
00
4*
15
0
6
-5
.2
5±
1.
68
-0
.3
6±
0.
93
87
.9
79
.9
83
.9
69
.9
1
N
ui
jt
s,
 2
00
2
12
6
-4
.3
5±
2.
11
-0
.0
6±
0.
41
10
0
92
.0
10
0
83
.0
0
N
ui
jt
s,
 2
00
2*
12
6
-3
.8
8±
1.
92
0.
00
±
0.
21
10
0
92
.0
10
0
67
.0
0
Sh
ai
kh
, 2
00
2
11
0
3
-4
.8
7±
2.
5
-0
.2
3±
0.
4
N
/A
90
.0
10
0
83
.0
0
B
al
az
si
, 2
00
1
12
5
6
-4
.0
1±
1.
59
0.
02
±
0.
64
91
.2
73
.0
94
.6
81
.9
0
M
ro
ch
en
, 2
00
1*
35
3
-4
.8
±
2.
3
-0
.2
2±
0.
59
93
.5
67
.7
10
0
93
.5
0
T
ol
e,
 2
00
1
31
4
6
-0
.5
0 
to
 -
6.
0
N
/A
N
/A
78
.0
N
/A
80
.0
1.
4
K
no
rz
, 2
00
0
11
4
3
-3
.8
3±
1.
67
N
/A
10
0
96
.1
10
0
82
.4
3.
9
R
ev
ig
lio
, 2
00
0
13
6
6
-1
.0
0 
to
 -
5.
99
0 
to
 –
0.
50
96
.3
90
.4
82
.0
54
.0
0
E
l D
an
as
ou
ry
, 1
99
9
26
12
-3
.4
4±
0.
72
-0
.0
3±
0.
44
10
0
87
.5
10
0
79
.2
0
E
l M
ag
hr
ab
y,
 1
99
9
33
24
-4
.8
0±
1.
60
0.
00
±
0.
60
90
.0
72
.0
10
0
61
.0
6.
0
SE
 =
 s
ph
er
ic
al
 e
qu
iv
al
en
t;
 D
 =
 d
io
pt
er
s;
 U
C
V
A
 =
 u
nc
or
re
ct
ed
 v
is
ua
l a
cu
it
y;
 B
C
V
A
=
 b
es
t-
co
rr
ec
te
d 
vi
su
al
 a
cu
it
y;
 N
/A
 =
 n
ot
 a
va
il
ab
le
 i
n 
th
e 
ar
ti
cl
e
* 
W
av
ef
ro
nt
-g
ui
de
d 
la
se
r 
ab
la
ti
on
s
Tahzib_Boek_06.indb   16 11-8-2008   11:32:17
17Introduction
T
ab
le
 1
-B
. 
o
ve
rv
ie
w
 o
f c
om
pa
ra
ti
ve
 s
tu
di
es
 fo
r 
la
se
r 
in
 s
it
u 
ke
ra
to
m
ile
us
is
 fo
r 
co
rr
ec
ti
on
 o
f m
od
er
at
e 
to
 h
ig
h 
m
yo
pi
a.
A
ut
ho
r,
 y
ea
r
N
um
be
r 
of
 e
ye
s 
Fo
llo
w
-u
p 
(m
os
)
M
ea
n 
pr
eo
p 
SE
 (
D
)
M
ea
n 
po
st
op
 
SE
 (
D
)
M
ea
n 
SE
 ±
 
1.
0 
D
 (
%
)
M
ea
n 
SE
 ±
 
0.
5 
D
 (
%
)
U
C
V
A
 ≥
 
20
/4
0 
(%
)
U
C
V
A
 ≥
 
20
/2
0 
(%
)
L
os
s 
≥ 
2 
li
ne
s 
B
C
V
A
K
ym
io
ni
s,
 2
00
7
11
14
0
-1
2.
96
±
3.
17
-1
.1
4±
1.
67
55
.0
N
/A
46
.0
N
/A
27
.0
H
jo
rt
da
l, 
20
05
25
12
-6
.0
 t
o 
-8
.0
-2
.4
N
/A
N
/A
44
.0
N
/A
N
/A
A
iz
aw
a,
 2
00
3*
22
6
-7
.3
0±
2.
72
-0
.1
4±
0.
75
86
.4
77
.3
95
.5
77
.3
0
Se
ku
nd
o,
 2
00
3
33
76
-1
3.
65
-0
.8
8
46
.0
N
/A
33
.0
N
/A
15
.2
M
al
ec
az
e,
 2
00
2
25
12
-9
.3
9±
14
.7
-0
.7
4±
0.
67
64
.0
N
/A
80
.0
N
/A
12
.0
E
l D
an
as
ou
ry
, 2
00
2
45
12
-1
3.
24
±
2.
3
-0
.8
7±
0.
8
58
.5
24
.4
58
.5
12
.2
12
.2
Ly
le
, 2
00
1
33
2
12
-1
1.
69
±
1.
46
-0
.3
7±
0.
80
84
.0
N
/A
89
.5
45
.8
1.
8
M
cD
on
al
d,
 2
00
1
17
7
6
U
pt
o 
-1
1.
0
-0
.2
9±
0.
45
94
.4
75
.2
93
.9
60
.5
0.
6
M
ag
al
la
ne
s,
 2
00
1
24
24
-1
0.
9±
2.
6
–0
.0
±
0.
5
N
/A
N
/A
N
/A
N
/A
N
/A
K
no
rz
, 2
00
0
89
3
-7
.8
3±
1.
38
N
/A
90
.0
75
.0
95
.0
62
.5
2.
5
R
ev
ig
lio
, 2
00
0
13
6
6
-1
.0
0 
to
 -
5.
99
0 
to
 –
0.
50
96
.3
90
.4
82
.0
54
.0
0
M
cG
he
e,
 2
00
0
76
24
-1
0.
7±
4.
4
–0
.6
±
1.
3
N
/A
N
/A
76
.5
32
.4
1.
3
Po
p,
 2
00
0
10
7
12
-6
.1
1±
2.
17
N
/A
98
.7
77
.9
10
0
83
.1
0
H
er
sh
, 1
99
8
22
0
6
-9
.3
0
-1
.2
9
40
.7
27
.1
55
.7
26
.2
3.
2
SE
 =
 s
ph
er
ic
al
 e
qu
iv
al
en
t;
 D
 =
 d
io
pt
er
s;
 U
C
V
A
 =
 u
nc
or
re
ct
ed
 v
is
ua
l a
cu
it
y;
 B
C
V
A
=
 b
es
t-
co
rr
ec
te
d 
vi
su
al
 a
cu
it
y;
 N
/A
 =
 n
ot
 a
va
il
ab
le
 i
n 
th
e 
ar
ti
cl
e 
* 
W
av
ef
ro
nt
-g
ui
de
d 
la
se
r 
ab
la
ti
on
s
Tahzib_Boek_06.indb   17 11-8-2008   11:32:18
18 Chapter 1
Risks of LASIK
Although the risks associated with LASIK are considered to be low, intra-oper-
ative and postoperative flap-related complications are sight-threatening and have 
resulted in a permanent loss of BCVA. The overall incidence of intra-operative 
LASIK flap complications (such as incomplete flaps, buttonholes, free caps, torn 
flaps) ranges from 0.3% to 5.7%.82-100
Ectasia post-LASIK
Another rare, but important complication that can occur after LASIK is postopera-
tive corneal ectasia. The occurrence of iatrogenic keratectasia was first described 
by Seiler et al, who recommended a residual corneal thickness of the stromal bed 
of at least 250 microns, based on biochemical considerations.101 The ectasia seems 
to be related to biomechanical changes in the cornea after treatment. Previous 
reports on post-LASIK ectasia show an incidence between 0.12% and 0.66%.92, 93, 
102 Risk factors that might contribute to the development of ectasia after LASIK 
have been suggested to be: high intraocular pressure, irregular topography, thin 
corneas, thin remaining corneal beds, forme fruste keratoconus, thick corneal 
flaps, large optical zones, and possible high myopia. 77, 92, 94-97, 101-115 
In summary, LASIK has shown to be effective, predictable and safe, with the 
advantages of rapid visual recovery and minimal discomfort. Since its advent, 
LASIK has become the most widely performed refractive surgery technique, 
with high patient satisfaction.
Table 2. Reported factors leading to vision disturbances.8, 14, 150, 156, 157
Factors RK PRK/LASEK LASIK
Large scotopic pupil size X X X
Small optical clear zone X X X
Haze X 
Flap complications X
Variable corneal steepening X
Ectasia X X
Epithelial ingrowth X X
Extensive scarring X X
Irregular astigmatism X X X
Small ablation diameter X X
Decentration of ablation zone X X
RK=Radial keratotomy; PRK=Photorefractive keratectomy; LASEK=Laser-assisted sub -
epithelial keratectomy; LASIK=Laser in situ keratomileusis.
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Laser-assisted subepithelial keratectomy (LASEK)
LASEK was introduced independently in 1999,116, 117 and described by several 
investigators after that.118-122 The aim of LASEK is to preserve the original 
anatomy of the cornea and to avoid potential risks posed by the creation of a 
LASIK flap. The treatment is in fact a blend of PRK and LASIK, aiming to 
decrease the potential complications of the two treatments. It avoids the flap-
related complications and reduces the risk of keratectasia associated with LASIK. 
LASEK does not use a microkeratome to create a stromal flap. In LASEK treat-
ment, diluted ethanol solution is applied to loosen the corneal epithelium, after 
which the epithelium is partially removed from Bowman’s layer, connected only 
at a hinge. Laser treatment is applied directly to Bowman’s layer, and the epithe-
lium is replaced and covered by a bandage contact lens.
one of the main therapeutic advantages of LASEK is that it can be performed 
in cases in which LASIK may be contraindicated. These include eyes with thin, 
steep, and flat corneas; epithelial basement membrane dystrophy; large pupils 
(requiring wider and therefore deeper ablations); higher myopia; deep-set eyes 
or tight orbits.
Reports have shown that LASEK is a safe, effective and predictable treatment, 
which can be seen as a good alternative to LASIK for the surgical correction of 
myopia. These studies showed that 91%-94% of eyes achieved an UCVA ≥ 20/40 
and 73%-91% an UCVA of ≥ 20/20. After 2 years follow-up, 62%-65.9% of eyes 
achieved a refraction within ±0.5 D of the desired refraction and 92%-100% of 
eyes ±1.0 D. Loss of 1 or more lines of BCVA was demonstrated in 14.4%-16.3% 
of eyes after 1 year follow-up.123-137 Comparing LASEK with PRK and LASIK, 
it has been indicated that the recovery period after LASEK is shorter than after 
PRK 128, but might be somewhat slower than after LASIK. Discomfort after 
LASEK seems to be less than after PRK, which is probably related to the fact 
that the epithelial flap acts as a biological therapeutic lens that protects the ablated 
stroma.131
Previous reports have shown various incidences of corneal haze after LASEK.124, 
125, 132, 133, 138, 139 LASEK can be combined with the use of mitomycin-C (MMC), 
a cytostatic drug known to inhibit proliferating cells and can be used to prevent 
post-ablation corneal haze in high risk cases.140, 141 Various studies have shown the 
clinical use of MMC in other refractive surgery procedures.142-145
Epithelial laser in situ keratomileusis (epi-LASIK)
Epi-LASIK uses a modified microkeratome (epikeratome) to create a thin corneal 
epithelium flap before surface ablation. The difference between epi-LASIK and 
LASEK is that the separation of the epithelium is obtained mechanically without 
alcohol. Epi-LASIK has been proposed as a safe alternative to LASIK and is espe-
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cially suitable for patients with low to moderate myopia and myopic astigmatism, 
thin corneas, and in individuals with steeper or flatter corneas, where the cutting 
of a LASIK flap could potentially impose flap-related complications. The healing 
period and visual recovery tends to be slower than traditional LASIK.146-148 Post-
operative discomfort usually occurs within the first 48 hours after surgery. A 
recent study by Pallikaris et al presented the preliminary results of epi-LASIK 
and stated that this technique is a safe and efficient method for the correction of 
low myopia, demonstrating that after 3 months follow-up, more than 96% of 44 
treated eyes reach an UCVA of 20/40 or better and 92% an UCVA of 20/25 or 
better. All the treated eyes were within ±0.50 D between 1 and 3 months after 
the procedure.147
In comparison with LASEK, it has been suggested that the incidence of haze 
after ablation of the cornea is less with epi-LASIK. Pallikaris showed that after 3 
months follow-up, 56% of eyes had clear corneas, 41% had trace haze and 3% had 
mild amounts of corneal haze.147
Longer-term clinical studies will be needed to confirm these preliminary results 
on epi-LASIK.
GENERAL SIDE EFFECTS oF LASER REFRACTIVE SURGERY
Although the many developments in keratorefractive surgery techniques have 
improved the clinical outcome and shown great success rates, several quality of 
vision problems have been reported. Qualitative visual disturbances can affect 
patients’ daily activities and include subjective complaints such as glare, halos 
and difficulty with night driving. These problems have been reported in several 
clinical studies after refractive surgery, ranging from 12% to 57% in patients.8, 
10, 14, 149-151 They are known to often diminish after the first six postoperative 
months.13-15, 36, 58, 79, 150, 152-155 Glare, halos and night vision complaints (NVC) are 
among the primary complaints that have been reported by patients, which may 
be attributed to a loss of contrast sensitivity or low-contrast visual acuity. These 
complaints have been described after all refractive surgery techniques, varying 
in degree of incidence.36 After RK, the reported incidence of moderate to severe 
glare disability in the first 3 to 6 months ranges from 50% to 60%, diminishing 
to 0–5% after 1 year and even further after 2 years.36
Risk factors for night vision complaints after laser refractive surgery
Reports on patient satisfaction after LASIK treatment8, 13, 150 showed that predic-
tors for NVC can be:
1. Preoperative level of myopia (more than 5 D)
2. Preoperative uncorrected visual acuity
3. Preoperative contrast sensitivity levels
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4. Increasing age
5. A flatter preoperative corneal curvature
6. Surgical enhancements
7. optical zones smaller than 6 mm
8. Postoperative residual refractive error higher than 0.5 D from emme tropia
9. Postoperative residual cylinder.
Remarkably, pupil size was not shown to be a significant predictor of NVC in 
any of these studies. There is variable evidence in the literature on excluding 
patients with large pupils.8, 14, 150, 156 It has been suggested in the past that a large 
pupil in combination with a small optical zone is a dominant factor leading to 
increased NVC, but other recent data show that the correlation between pupil 
size and NVC or between NVC and the pupil-optical zone disparity is much 
less critical than previously thought.8, 10, 13, 36, 150, 154, 155 Pupil size seems to indeed 
be a significant predictor of glare and halos after LASIK, especially in the first 
postoperative month, yet it was demonstrated that pupil size is not a significant 
variable 6 or 12 months after treatment.13, 158 Postoperative remodeling of the 
corneal shape by the epithelium may be responsible for these findings.
Other postoperative reasons for dissatisfaction after laser refractive surgery
Common subjective complaints after refractive surgery in dissatisfied patients are 
blurred distance vision (59%) and glare and night-vision disturbances (44%).8, 14, 76, 
85, 150, 159 Common complications are under- and overcorrection (30%), irregular 
astigmatism (30%), dry eyes (4% to 30%), glare (up to 48%) and difficulty with 
night driving (17%).74, 76, 82, 85, 86, 159 Common recommendations for manage-
ment are non-surgical treatments (68%) consisting primarily of medication (e.g. 
miotics) and rigid gas permeable (RGP) contact lenses.85, 159-161
WAVEFRoNT AND LASER REFRACTIVE SURGERY
In 2000, the first results of wavefront-guided laser ablation were demonstrated.162 
Higher order aberrations (HoA) can cause glare and halos and lead to decreased 
quality of vision. Wavefront technology was developed to categorize and limit 
the amount of HoA induced by refractive surgery.163 Customized corneal abla-
tion combines wavefront sensing and wavefront correction. The wavefront 
sensor measures defocus, astigmatism and total and individual HoA. Defocus 
and astigmatism, also known as second-order aberrations, are the most impor-
tant determinants of the refractive error. An older term for HoA is “irregular 
astigmatism”, which can be somewhat misleading, since most of them have no 
relation to astigmatism.
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over the last decade, several clinical reports have studied HoAs in refractive 
surgery patients, especially in LASIK studies.58, 69, 164-170 Some of these studies have 
shown an increase in patient satisfaction and reduced night vision complaints 
after wavefront-guided treatments.165, 166, 170-175 Reports studying changes in the 
HoA profile after laser refractive surgery suggest that, overall, spherical aberra-
tion is induced the most postoperatively, whereas the mean change in trefoil and 
coma tend to be the least.170, 176, 177
Current problems with wavefront-guided treatments are the lack of predictability 
for correcting the amount of HoA by the treatment.69, 177, 178 Several studies have 
indicated the advantages of wavefront-guided over conventional ablations in 
terms of decreased HoA and subjective complaints, but more and larger good 
randomized studies are needed to further analyze this.166, 170, 174, 179 At the present 
time it is not very clear whether the excellent results are due to a better postop-
erative asphericity profile or a consequence of treating the preexistent HoAs.
HoA in symptomatic post-LASIK patients have been shown to be an average of 
2.3 times greater in comparison to normal post-LASIK patients.174 Recent studies 
indicate that customized ablation based on corneal topography (“topography-
guided ablation”) is safe and effective, can lead to fewer NVC and less increase of 
HoA compared to conventional ablation.180-182
Phakic IOLs
For the past decade, laser refractive surgery techniques such as LASIK have been 
the preferred surgical procedure for most patients seeking independence of spec-
tacles or contact lenses. For patients with high degrees of ametropia, LASIK is 
a less desirable procedure. For these patients, phakic IoLs represent a safe alter-
native for vision correction. Increasing amounts of refractive surgeons perform 
phakic IoL implantations. With the US Food and Drug Administration (FDA) 
approving the first phakic IoL in September 2004, the popularity of phakic IoLs 
has increased tremendously.
Compared to aphakic IoLs, phakic IoLs have a relatively smaller anatomic space 
in which they are implanted. Proper positioning, with adequate stability, must be 
achieved between the corneal endothelium and the anterior lens capsule. over 
the last decade, there have been continuous improvements in IoL technology, 
microsurgical techniques, ocular viscosurgical devices, which have made these 
lenses to become an excellent alternative for the correction of moderate and high 
refractive errors with excellent levels of efficacy, predictability, and safety.
Phakic IoLs can be grouped into anterior chamber and posterior chamber lenses. 
Regardless of the location, accurate sizing and positioning are critical for a 
successful outcome.
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Anterior chamber phakic IOLs
The use of anterior chamber lenses was first described in 1954 and the 5-year 
results were presented by Barraquer in 1959. In 1975, the Dutchman Binkhorst 
was the first who described the optical design of anterior chamber IoL implants 
used in cataract surgery. The lens was studied by several authors. Anterior 
chamber phakic IoLs can be further grouped into angle-supported and iris-
fixated lenses.
Angle-supported phakic IOLs
Rigid anterior chamber angle-supported phakic IoLs were introduced in the 
1950s. The first generation of these lenses lead to severe postoperative complica-
tions, such as corneal edema, chronic iritis, severe pupil ovalization and pupillary 
block glaucoma. These complications eventually lead to an abandonment of this 
first generation of lenses. A second generation of these lenses were reintroduced 
in the late 1980s by Baikoff.183 The results of this second generation of angle-
supported lenses showed better visual and refractive outcomes and less postopera-
tive complications, due to substantial improvements in design.183-193
Pupil ovalization is a known side-effect of this lens type, which may be caused 
by inadequate lens sizing (iris traction and consequent retraction).183, 184, 187, 191-194 It 
has also been suggested to have an ischemic component, caused by compression 
of the iris vascularisation by the lens footplates and resulting in partial atrophy of 
the iris.187 This complication can lead to night glare and halos. The use of foldable 
lens models were expected to lead to a decrease in this complication. However, 
in 2007, the French government ordered a recall of 3 types of angle-supported, 
anterior chamber phakic IoLs, due to alarming concerns about excessive 
endothelial cell loss 2 to 3 years postoperatively as demonstrated by several cases 
of explantation of these lens models. The lenses removed from the market were 
Corneal’s Icare and Ioltech/Zeiss Vivarte and NewLife phakic IoLs. The cause 
of the sudden drop in endothelial cells is not clear. Therefore, ophthalmologists 
have been strongly recommended caution when performing new phakic IoL 
implantations and closely monitor patients every 6 to 12 months. This recall will 
undoubtedly have an important impact on future developments in the field of 
anterior chamber phakic IoLs.
Coullet et al recently described 3 eyes in which a foldable angle-supported phakic 
IoL was implanted to correct high myopia, and in which rapid and severe post-
operative endothelial cell loss occurred. In this article he attempted to illustrate 
the importance of accurate sizing of foldable angle-supported anterior chamber 
phakic IoLs to avoid excessive vaulting.195
Retinal complications can also occur, probably related to vitreous instability. one 
report showed a significant increase in the incidence of retinal detachment after 
implantation of this lens in eyes with an axial length larger than 30.4 mm.196
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Iris-fixated phakic IOLs
The Artisan toric phakic IoL is composed of non-foldable, inert polymethyl 
methacrylate (PMMA), which is centered over the pupil with special haptics 
that are called “claws” which are fixed over the midperipheral iris. The lens 
was designed by Worst and Fechner in the late 1980s; and described by van der 
Heijde. It is a rigid lens with a fixed optical zone of 5 or 6 mm, depending on the 
dioptric power of the lens. The lens has a convex-concave optic with a spherical 
anterior surface and a sphero-cylindrical posterior surface with a 5-mm optical 
zone.
The short-term (up to 3 years) safety and efficacy of iris-fixated phakic IoLs 
have been demonstrated in many studies (Table 3).59, 76, 197-208 It has been stated 
that better UCVA, BCVA, contrast sensitivity, quality of vision, and exchange-
ability are the main advantages of Artisan lens implantation.59, 76 This might be 
related to the fact that since the refractive power of phakic IoLs is not dependent 
on corneal wound healing, these lenses have the potential of offering a more 
accurate refractive correction than LASIK, especially in high myopes.
A toric version of the iris-fixated phakic IoL exists and can be used for the 
correction of astigmatism. Toric IoLs are available with the cylinder in line with 
the haptics or at an angle of 90º with the haptics.209 An IoL with the cylinder in 
line with the haptics is recommended when the preoperative cylinder is between 
0° and 45° or between 135° and 180°. The toric phakic Artisan IoL is available 
in cylindrical powers up to 7.5 D. Recent results of the toric phakic Artisan IoL 
in eyes with myopia or hyperopia with astigmatism show that 63% to 73% of 
eyes reached ± 0.50 D of the predicted refraction with a BCVA improvement in 
65.7% to 70% of eyes.209-211
A foldable version of the spherical Artisan lens, the Artiflex iris-fixated phakic 
IoL, is a newer development in the area of lenticular refractive surgery for the 
correction of myopia and is currently being evaluated in a European multi-centre 
study. Important advantages of the foldable Artiflex lens over the PMMA Artisan 
lens are the smaller incision size of 3.4 mm (compared to the 5.5- to 6.5-mm 
incisions needed for the rigid model), which could reduce surgically induced 
astigmatism and may lead to a faster visual recovery period. Recent results on the 
Artiflex lens showed that 70% of eyes reached ± 1.0 D of the targeted refraction, 
with 66% of eyes showing an improvement of ≥ 1 BCVA lines.212 Another recent 
study comparing the Artiflex and the Artisan lens showed that 77.4% of Artiflex-
treated patients reached a UCVA of >20/40 after 1 year, compared to 51.6% for 
Artisan-treated eyes.198
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Side effects and complications after iris-fixated phakic IOL implantation
The modernization of these types of IoLs has seen a decrease in the occurrence 
of postoperative complications, especially in the case of iris-fixated phakic IoLs. 
Vision-threatening complications are rare with the modern type of Artisan lenses. 
The risk of complications in phakic hyperopes is greater than in phakic myopes, 
due to the shallower nature of the anterior chamber depth and less angle space.
Complications that can occur after the implantation of iris-fixated phakic IoLs 
are pupil ovalization213, IoL decentration200, 214-216, low-grade postoperative 
uveitis217 endothelial cell loss59, 201, 204, 218, pupil-block glaucoma200, 209, 219, cata-
ract200, 202, endophthalmitis220, 221, and retinal detachment200, 222, but are rare. The 
pupil plays an important role in centration of phakic IoLs, which is important 
in relation to the optical function of the lens. If the pupil size exceeds the optical 
zone diameter of the IoL, secondary effects such as glare and HoAs could be 
markedly increased and decrease visual performance and patient satisfaction. A 
study by Dick et al showed a reduced postoperative pupil size only under scotopic 
conditions or medical mydriasis, with a mean scotopic pupil diameter decrease 
of 1.1 mm in myopic eyes; the study suggested that the iris-fixated phakic IoL 
mechanically restricts pupil size changes under low-light conditions and could 
reduce the incidence of postoperative photic phenomena.213 IoL decentration 
can develop and is often surgeon-dependent, but can also occur after blunt 
trauma with loosening of the haptic(s). The necessity of re-fixation depends on 
the amount of decentration, vision, glare complaints and most importantly, the 
risk of endothelial damage.223, 224 Chronic inflammation can occur after Artisan-
Artiflex IoL implantation. The literature contains a study that showed chronic 
subclinical inflammation between 1 and 2 years after implantation of this and an 
angle-supported IoL type.217 Two other studies suggested that pigment disper-
sion and subsequent inflammatory reaction after Artisan phakic IoL implantation 
may be caused by abnormal pressure on the iris, which can become sandwiched 
between the crystalline lens and the phakic IoL.223, 224 In some cases, explanta-
tion and exchange of the IoL can be necessary.225
Night vision complaints after iris-fixated phakic IOL implantation
After laser refractive surgery, the chance of experiencing glare and halos increases 
when treating higher degrees of myopia, since more corneal tissue is removed and 
the size of the optical zone needs to be smaller to prevent excessively deep abla-
tions. Glare complaints and their relation to night vision and night driving have 
been described. Laser refractive surgery studies have suggested that the source 
of glare and halos is the disparity between the pupil size and the optical zone.36, 
226 This explanation for glare and halos can probably also be applied in Artisan 
phakic lens patients, especially when the pupil size exceeds the lens optical zone 
diameter in dim-light conditions.200, 213, 227 The finding that phakic IoLs decrease 
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the horizontal component of dilation more than the vertical component could 
also explain glare and halos in this patient group.213, 228, 229 The percentage of glare 
complaints in patients with Artisan phakic IoLs varies between about 14% to 
25%.59, 76, 199-201, 203, 204, 207, 209, 211, 214, 218 The Stiles-Crawford effect can be considered 
as a corrective mechanism, protecting patients with a pupil-optical zone disparity 
from increased levels of glare after Artisan PIoL implantation, thereby possibly 
offering a partial explanation for the high satisfaction rates despite reports glare 
complaints.230
Endothelial cell response after iris-fixated phakic IOL implantation
The endothelial cell density (ECD) is known to decrease over time with a physi-
ologic rate of 0.6% per year after age 18.231 Several short-term and a few recent 
longer term studies have evaluated corneal ECD loss after Artisan phakic IoL 
implantation, showing an average ECD loss of 0.7% to 11.7% over 3 years time.59, 
200, 201, 204, 218, 232-234 An anterior chamber depth (measured from the epithelium) of 
at least 3.0 mm has been suggested to be an adequate safety measurement for the 
implantation of the Artisan phakic IoL.200, 201, 211 Surface quality of the Artisan 
phakic IoL has been shown to be excellent and no contraindications related 
to surface quality could be found for the implantation of this lens into phakic 
eyes.235
Relative gains in ECD after Artisan phakic IoL implantation have also been 
shown and can be due to variations in cell density measurements and small study 
sample sizes.236 The corneal endothelial recovery capability after intraocular 
surgery might be higher than previously assumed; cells in the corneal endothe-
lium might be renewed by stem cells located in a niche at the posterior limbus and 
increased cell renewal may occur after intraocular surgery.237 Both central and 
peripheral corneal endothelial cells seem to be capable of dividing. 236 Peripheral 
corneal ECD seems to be significantly higher than centrally, and function as a 
physiologic reserve for endothelial cells, which is important for corneal clear-
ness after phakic IoL implantation. Improved endothelial cell morphology after 
discontinuation of contact lens wear might be another explanation.238 Corneal 
remodeling, rather than ongoing cell loss, following implantation of a phakic 
posterior chamber IoL, was also presented as an explanation for corneal endothe-
lial cell loss.232, 239
Cataract after iris-fixated phakic IOL implantation for correction of myopia
Another concern with phakic IoLs is cataract formation. High myopia in general 
is known to be associated with cataract formation.240 Until now, no clear asso-
ciation has been shown between Artisan phakic IoL implantation and cataract 
development. Previous studies have shown non-progressive lens vacuoles probably 
Tahzib_Boek_06.indb   27 11-8-2008   11:32:19
28 Chapter 1
caused by intra-operative contact with the crystalline lens or by over-inflation of 
the anterior chamber with the ocular viscoelastic device.203
Studies have reported a low cataract incidence of 1.5% to 3.0% after Artisan 
phakic IoL implantation with a follow-up of up to 4 years.199-201, 207 An increased 
incidence of late cataract has not been reported with the Artisan lens.200, 202
The surgical procedure of phakic IoL implantation and the presence of the phakic 
IoL in the eye are not assumed to be the only factors resulting in cataract.209, 211, 
241 The literature suggests that eyes with early changes of the nucleus might 
promote the development of a clinically significant nuclear cataract after phakic 
IoL implantation and that pre-cataractous lens changes might be a contraindica-
tion for phakic IoL implantation in eyes with high myopia.202 Recent studies on 
the Artisan toric phakic IoL implantation showed no early development of lens 
opacities.241
Higher order aberrations after iris-fixated phakic IOL implantation
optical aberrations are optical abnormalities that can occur naturally and after 
intraocular surgery and play a role in optical quality after refractive surgery.242 
optical aberrations may influence postoperative visual outcome and patient satis-
faction and need to be included in the preoperative evaluation and selection of 
refractive surgery candidates.
Most studies on phakic IoLs addressed the refractive outcome, safety profile and 
complications. Until now, only a few reports have discussed changes in HoA 
after phakic IoL implantation. An earlier study revealed no tendency toward 
deterioration of the optical performance after the insertion of an iris-fixated 
Artisan lens for the treatment of high myopia.242 Similar results were demon-
strated by a later study with a 12-month follow-up on the foldable iris-fixated 
Artisan lens which showed no increase in HoA.243 Two other recent studies 
demonstrated a tendency for myopic eyes to show increased amounts of HoA 
under photopic conditions and in the presence of large pupils.244, 245
Phakic posterior chamber IOLs
In 1986, Fyodorov developed a model of a silicone phakic posterior chamber 
(PPC) IoL for the implantation into phakic eyes with high myopia, meant to be 
implanted into the ciliary sulcus, immediately in front of the natural crystalline 
lens. This model initially seemed to lead to good refractive results246, 247, but 
eventually appeared to result in a high incidence of cataract formation and high 
endothelial cell loss.248-256 In 1993, Staar Surgical Inc. PPC IoL, the implantable 
contact lens (ICL), was introduced, which is a modified version of the PPC IoL 
for the correction of high myopia. Several studies have demonstrated good visual 
and refractive outcomes, with good efficacy and safety.249, 250, 254, 255, 257-259
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However, concerns in relation to increased crystalline lens opacification and cata-
ract formation after PPC IoL implantation remain. The rate of cataract develop-
ment after PPC IoL implantation has been shown to greatly vary between 9.5% 
to 43%.250, 258, 260-262 It is not clear though whether the cataract formation is related 
to the ICL design itself, to direct surgical trauma, to direct contact between the 
PPC IoL and the crystalline lens, or to high myopia. Sizing is an important issue 
for PPC IoLs.250 A PPC IoL that is too large would cause undesirable vaulting, 
and one that is too small could become unstable and decentered, leading to 
reduced central PPC IoL vaulting over the crystalline lens with an increased 
risk for lens opacification.258 It has been suggested that central vaulting greater 
than 0.09 mm protects the crystalline lens from cataract formation.263 However, 
there are reports that do not support this hypothesis.255, 256, 264-267 Improvement 
of the predictability of PPC IoL vaulting and the choice of lens size has been 
attempted by measurements of the white-to-white distance, the ciliary sulcus 
diameter and the posterior chamber width. These measurements did not prove to 
be helpful, however, due to the lack of correlation between the white-to-white 
measurements and the ciliary sulcus diameter.268, 269 Recently, it was suggested 
that the use of ultrasound biometry is a better method for the prediction of the 
sulcus-to-sulcus horizontal diameter.270
Pigmentary glaucoma and pupillary block glaucoma have also been reported 
after PPC IoL implantation.255, 263 The dispersion of pigment could result from 
continuous contact and friction between the PPC IoL and the pigmented 
epithelium of the iris occurring during iris movements and accommodation. 
This liberated pigment and possibly narrowing of the iridocorneal angle can lead 
to an increase in intraocular pressure.
Endothelial cell loss remains another concern after PPC IoL implantation; 
reports have shown that endothelial cell loss after PPC IoL implantation varies 
from 4.41%-4.91% after 6 months to about 12.3% after 4 years after surgery.239, 255, 
256, 271 The endothelial cell loss is attributed to the traumatic effect of surgery, but 
it might also be that the PPC IoL itself induces endothelial cell loss as a result of 
chronic subclinical inflammation.271
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REFRACTIVE SURGERY AFTER CoRNEAL SURGERY
Leading indications and clinical outcome of penetrating keratoplasty (PK)
Worldwide, PK is one of the most common and successful tissue transplantations. 
Annually, about 40,000 PK procedures are performed in the US and 750 in the 
Netherlands. The main goal of PK is the improvement of visual performance. 
The leading indications for corneal transplantations are bullous keratopathy, 
Fuchs’ dystrophy, keratoconus, corneal scarring, and herpetic disorders. It has 
been demonstrated that PK is a safe and effective treatment for the corneal diseases 
commonly transplanted.272-277 Few PK studies have reported up to 10-years 
follow-up, showing the 10-year graft survival rate to be 50% to 80%.272, 275, 276, 278
Reasons for corneal graft failure have been shown to be mainly caused by 
endothelial failure (in allogeneic PK’s the rate of endothelial cell loss is 67% after 
10 years)273, 274 and immunologic graft rejection (75% in less than 2 years and 
10% after 4 years)279, but can also be caused by ocular surface disease, increased 
intraocular pressure (15% higher than 21 mmHg)273, suture events279 and post-
operative astigmatism.280, 281 In fact, despite the presence of a clear corneal graft, 
functional vision is often hampered by high levels of post-keratoplasty ametropia 
and astigmatism.
Post-keratoplasty astigmatism
High astigmatism is one of the most common and difficult problems after grafting, 
representing one of the major vision-limiting factors after PK. Some known 
causes for post-keratoplasty astigmatism are size thickness and shape differences 
between donor and host eccentric placement, irregular scarring at host junction 
and asymmetric forces in the cornea resulting in shape alterations.282, 283 Despite 
substantial improvement in visual acuity after PK and a clear graft, significant 
postoperative astigmatism can remain and limit visual performance and decrease 
patient satisfaction after successful PK. A thorough study that classified astigma-
tism patterns after PK found that 24% showed regular astigmatic patterns and 
72% showed irregular astigmatic patterns.284 We know that patients generally do 
not tolerate more than 3-4 D of anisometropia and/or astigmatism.285
Treatment of post-keratoplasty astigmatism
Currently, there is no standard approach for the management of astigmatism after 
PK. Treating this type of astigmatism remains a challenge and many techniques 
can be applied. Various methods have been tried to treat post-keratoplasty astig-
matism and include wedge resections, relaxing incisions, customized laser abla-
tion such as PRK, LASIK and LASEK and the implantation of (toric) intraocular 
lenses.
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Contact lens fitting for treatment of post-PK astigmatism
Visual rehabilitation after PK usually implies wearing spectacles or contact lenses 
to correct residual refractive error. Contact lens fitting is usually the first treat-
ment of choice for correcting astigmatism after keratoplasty. They are fitted in 
10%-30% of post-keratoplasty patients overall and in post-keratoplasty keratoconus 
patients this may increase up to 50%. Irregular astigmatism can be corrected by 
fitting RGP contact lenses or scleral lenses, with varying levels of tolerance.286-290 
Usually, contact lenses can be worn with sutures in place. However, the higher 
the post-keratoplasty astigmatism, the more difficult it becomes to correct it and 
to improve visual performance using contact lenses (e.g. a flat donor corneal 
flap in combination with a steep recipient). High post-keratoplasty astigmatism 
can lead to spectacle and contact lens fitting problems, causing quality of life 
problems such as subjective blur. In cases of contact lens problems (such as dry 
eye, blepharitis, corneal neovascularization) or contact lens intolerance, a surgical 
approach may be considered.
Relaxing incisions and compression sutures for treatment of post-keratoplasty astigmatism
When successful fitting of contact lenses or spectacles is prevented, by excessive 
regular or irregular post-keratoplasty astigmatism, an attempt can be made to 
minimize the amount of astigmatism by performing relaxing incisions in the 
steep corneal meridian and/or, additional compressive sutures in the flat corneal 
meridian (Table 4).291, 292 Wedge resections or compression sutures aim to steepen 
the flat meridian; in this procedure a wedge of tissue is excised from the flat 
corneal meridian of the recipient or the donor cornea. Relaxing incisions aim to 
flatten the steep axis. Both procedures result in a “coupling effect”: flattening of 
the steep meridian results in steepening of the flat meridian. These techniques 
can correct about 4-5 D of astigmatism, with the postoperative astigmatism effect 
being proportional to the preoperative astigmatism value.293 However, relaxing 
incisions and compression sutures have a low predictability and a minimal effect 
on the spherical equivalent.280, 291-300
Recently, the initial results of wedge resections using the femtosecond (FS) laser 
have shown that the use of the FS laser is a safe and effective alternative for 
the manual wedge resection techniques, allowing easier, more controlled, and 
more precise excision of tissue in width, length, and depth, probably leading to 
improved reproducibility of the technique.301
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Excimer laser ablations such as PRK, LASIK and LASEK
More recently, excimer laser PRK and LASIK have been used for the correction 
of post-keratoplasty astigmatism. It is important to note that the goal of thera-
peutic PRK or LASIK for visual rehabilitation after PK is not by definition the 
same as for the correction of myopia or astigmatism in virgin eyes and the results 
are less predictable and less effective.
It should be emphasized that the primary goal of laser ablation treatment of post-
keratoplasty astigmatism is the correction of sufficient myopia and astigmatism to 
allow correction by spectacles or contact lenses.
PRK treatment of post-keratoplasty astigmatism
The effects of PRK on a corneal transplant may be different to effects of PRK 
on a virgin eye, due to changes in corneal wound healing in a corneal graft as 
opposed to normal corneal wound healing. PRK for the treatment of post-PK 
astigmatism has been shown to lead to a reduction in cylindrical refractive error 
up to 48% (Table 5).280, 302-308 Previous studies show that PRK after PK lead to a 
higher rate of regression of the refractive effect and that significant corneal haze 
formation may be more prevalent after PRK for post-PK refractive errors and 
may lead to irregular astigmatism. PRK using a prophylactic topical application 
of a diluted MMC solution may prevent corneal haze formation and regres-
sion.138, 309-311
LASIK treatment of post-keratoplasty astigmatism
LASIK can also be used to treat post-PK astigmatism, being relatively safe and 
effective, and leading to a reduction in cylindrical refractive error up varying 
from 48% to 88% (Table 6).280, 312-326 The literature suggests that LASIK may be 
preferable over PRK for treatment of post-kerastoplasty astigmatism, leading to 
rapid visual rehabilitation, decreased stromal scarring, minimal risk of regression 
and the ability to treat greater ranges of refractive error. It has been suggested to 
wait at least one year after keratoplasty and at least 3 months after suture removal. 
Adequate wound apposition and sufficient endothelial cell counts are essential in 
order to avoid interface fluid pockets.
However, there is concern in performing LASIK in eyes with keratoconus, since 
the lamellar flap is made into an ectatic recipient bed. This may make the patient 
with preexisting corneal ectasia more likely to develop progressive corneal 
ectasia and recurrent keratoconus in the graft. Although LASIK can treat higher 
amounts of post-keratoplasty refractive error, the corneal graft thickness and the 
amount of ametropia and astigmatism suitable for correction limit the efficacy 
of the procedure.312, 313, 318, 320, 324-326 other drawbacks in performing LASIK after 
PK are the risk of wound dehiscence due to the high vacuum pressure327-329, flap 
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complications in steep corneas312-314, 325, 329, and a high rate of enhancements (upto 
53% of cases).313, 318, 320, 325 other LASIK-related complications like diffuse lamellar 
keratitis313, 314, buttonhole flaps330, wound dehiscence and epithelial ingrowth have 
also been reported.313
LASIK for treatment of post-keratoplasty can also be carried out as a 2-step 
procedure, first to create the corneal flap and some months later to perform 
excimer laser ablation (Table 6). Because the effect of the flap cut alone may 
induce a significant reduction of refractive astigmatism in up to 50% of some 
patients and because of the high enhancement rate, a 2-stage LASIK procedure 
has been proposed. The 2-step approach could lead to an improved visual outcome 
in post-PK eyes. Studies have suggested that the 2-step procedure has a better 
predictability profile than the 1-step procedure in eyes with post-keratoplasty 
astigmatism, leading to a more precise and better refractive outcome. The appro-
priate time between the lamellar cut and the laser ablation has not been deter-
mined, but it has been shown that a 3-month period, during which 2 successive 
corneal topographies performed 1 month apart are stable, is sufficient to improve 
the outcome of LASIK.331-335
Topographically-guided laser ablations for treatment of post-keratoplasty astigmatism
Topographically-guided laser ablations have been suggested to improve results 
in eyes with decentered or small optical zones after LASIK or PRK and can be 
useful in eyes with irregular astigmatism after PK.308, 311, 336, 337
LASEK for treatment of post-keratoplasty astigmatism
A recent study reported on initial results of LASEK with application of MMC 
for the correction of ametropia and irregular astigmatism after keratoplasty311, 
demonstrating 62.5% of eyes achieving a SE within ± 1D of the intended correc-
tion, with a mean cylinder reduction of 57% and significant reduction of HoA. 
There was good refractive stability for over 18 months follow-up. Iatrogenic haze 
typically occurred, but appeared to be less with adjunctive use of intra-operative 
MMC. The optimal dose and exposure time for MMC are currently not known; 
concentration times vary from 0.01% to 0.02% and exposure times vary from 12 
sec to 120 sec. 138, 338, 339
Phakic toric IOL implantation for treatment of post-keratoplasty astigmatism
Surgical options for correction of post-keratoplasty astigmatism include the 
implantation of toric phakic IoLs. The advantage of these surgical techniques is 
the fact that the implantation requires no direct manipulation or ablation of the 
donor cornea.
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The iris-fixated toric Artisan IoL has a power range of 7.5 D of cylinder and 
-20.5 D of myopia to +12.0 D of hyperopia and can provide a wide field for 
correction of post-keratoplasty astigmatism and ametropia. A study by Nuijts et 
al demonstrated the safety and efficacy of this procedure, showing a 91.0% reduc-
tion of the refractive cylinder, which is higher than LASIK post-PK studies have 
shown. None of the treated eyes lost BCVA lines and 50% gained at least 2 lines 
of BCVA. They also showed that the postoperative refractive error remained 
stable up to 12 months after the Artisan lens implantation. They reported an 
endothelial cell loss of reported a cell loss of 7.6% at 3 months, 21.7% at 6 months, 
and 16.6% at the last follow-up (mean of 8.4 months).340 Moshirfar et al have 
described 2 successful cases of implantation of the iris-fixated phakic IoL for 
the correction of myopic refractive error after keratoplasty, demonstrating no 
significant endothelial cell loss.341 A more recent study by Moshirfar et all showed 
2 cases of Artisan lens implantation post-PK, demonstrating an endothelial cell 
loss of 25.6% in one case and 42% in the other.342
After routine PK, the mean annual rate of endothelial cell loss from 3 to 5 years 
seems to be 7.8% per year and from 5 to 10 years it seems to be 4.2% per year.274, 
275, 343, 344 The corneal endothelium seems to remain relatively stable between 10 
and 15 years after PK and it has also been suggested that the rate of endothelial 
cell loss from 10 to 15 years after surgery may be similar to that of normal corneas. 
It was hypothesized that late endothelial cell loss may be caused by an aspecific, 
non-rejection-like inflammation, or perhaps a chronic breakdown of the blood 
aqueous barrier, but not by an allograft rejection mechanism.
Risk factors that may lead to higher levels of endothelial cell loss after PK are low 
donor endothelial cell count, older donor age, aphakia, pseudophakia, and older 
recipient age.
In addition, the implantation of the Artisan lens in post-keratoplasty eyes could be 
more traumatic for the corneal endothelium, relating to decreased visualisation, 
as compared to virgin eyes. This could lead to higher endothelial cell loss in the 
post-keratoplasty group. Endothelial cell loss after Artisan phakic IoL implanta-
tion in virgin phakic eyes seems to vary from 0.7% to 11.7% over 3 years time.59, 
76, 199, 202, 204, 207, 211 The higher cell loss in the post-keratoplasty group is probably 
explained by the increased vulnerability of the corneal graft endothelium that 
usually has low cell densities and may cause a higher rate of endothelial cell loss.
Thus, it cannot be excluded that the implantation of an Artisan iris-fixated IoL 
after PK with low cell densities may cause a higher rate of endothelial cell loss due 
to the compromised endothelium. It should be taken into account that accuracy 
of non-contact specular microscopy for determining endothelial cell density, 
which is usually around 5%, is not known in grafts with low cell counts and may 
introduce bias in the interpretation of our results. Risk factors for endothelial 
decompensation in corneal grafts with low cell densities have not been clearly 
defined.
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A potential drawback of implanting an Artisan toric IoL for treatment of post-
keratoplasty astigmatism is surgically induced astigmatism, related to the required 
5.3 mm incision size. The biomechanical response of the corneoscleral tissue to 
the incision may be somewhat unpredictable after PK, and a greater variability 
in surgically induced astigmatism may be seen. A recent study on implantation 
of the Artisan toric lens for correction of myopia or hyperopia with astigma-
tism in virgin non-operated eyes, showed a surgically induced astigmatism of 
0.53 D.209 However, in a post-keratoplasty astigmatism treatment group a lesser 
predictability of astigmatism reduction may be acceptable, since the primary goal 
of treating of astigmatism after PK is the correction of sufficient myopia and 
astigmatism in order to enable patients to wear spectacles or contact lenses.
Finally, another option is the implantation of a toric pseudophakic posterior 
chamber IoL to correct post-keratoplasty astigmatism. A few studies have 
described post-PK eyes in which standard phaco-emulsification and subsequent 
implantation of this toric IoL were performed. The serrated Z-design haptic 
of the lens is intended to prevent risk of lens rotation and subsequent change in 
the angle of the corrective cylinder. These studies suggest that this toric lens can 
provide a very good refractive outcome for eyes suffering from high degrees of 
post-keratoplasty astigmatism without significant effects on graft survival.345-348
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ABSTRACT
Purpose: To compare a handheld and a digital pupillometer in determining pupil 
size in a population of refractive surgery candidates (group 1) and after Artisan phakic 
intraocular lens (PIoL) implantation for correction of myopia (group 2).
Methods: The pupil size was measured with the Colvard and Procyon pupillometer in 
121 eyes of group 1 and in 83 eyes of group 2, respectively.
Pupil sizes measured with Colvard were compared to the scotopic, mesopic-low- and 
mesopic-high measurements of the Procyon pupillometer in both groups. Analysis of 
comparison between pupil measurements was performed according to methods described 
by Bland and Altman.
Results: The mean Colvard scotopic pupil diameter, scotopic, mesopic-low and mesopic-
high Procyon pupil diameters were 5.86 ± .81 mm, 6.42 ± .88 mm, 5.55 ± .95 mm and 
4.21 ± .73 mm in group 1 and 5.32 ± .67 mm, 6.14 ± .81 mm, 5.33 ± .78 mm and 4.02 ± 
.55 mm in group 2, respectively. The Colvard diameter compared most favourably with 
the Procyon mesopic-low diameter (group 2, P = .78)
Conclusions: Measurements of pupil diameter with the Colvard pupillometer corre-
lated best with measurements taken by the Procyon pupillometer under standardized 
mesopic-low light conditions. We believe that digital binocular infrared pupillometry is 
advantageous for standardized measurement of the pupil size.
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INTRoDUCTIoN
Pupil size as an influential factor for the development of night vision complaints 
(NVCs) including halos, starbursts and glare after refractive surgery has been 
under great discussion lately (Fan-Paul et al. 2002). Although many authors 
suggest that a disparity between the pupil size measured under dim light condi-
tions and the optical zone size of the laser ablation or the PIoL may be respon-
sible for subjective NVCs, recent reports argue the role of the pupil size in the 
pathophysiology of NVCs (Bailey et al. 2003; Klyce 2004; Pop & Payette 2004; 
Probst 2004; Schallhorn et al. 2003).
Methods for measuring pupil size over the years have included the use of pupil 
charts, photo cameras, and more recently, digital and handheld infrared pupil-
lometers (Boxer Wachler & Krueger 2000; Colvard 1998; Kohnen et al. 2003; 
Pop et al. 2002; Schnitzler et al. 2000). To study potential correlations between 
pupil size and NVCs the measurement of the pupil size should reflect real-time 
situations and should be performed under standardized illumination conditions. 
The two most popular instruments for measuring pupil size under dim light 
conditions are currently the Colvard pupillometer and the Procyon pupillometer 
(Colvard 1998; Kohnen et al. 2003; Schnitzler et al. 2000).
The purpose of this study was to compare the Colvard infrared pupillometer and 
the Procyon pupillometer in determining pupil size in a population of refractive 
surgery candidates and after Artisan PIoL implantation.
PATIENTS AND METHoDS
The Artisan PIoL has a convex-concave optic with either a 6-mm (for intraocular 
lens powers up to –15.5 diopters (D)) or a 5-mm (for intraocular lens powers from 
–16.0 D up to –24.0 D) and is available in 0.50 D steps (ophtec B.V., Groningen, 
the Netherlands). This single-piece lens is composed of polymethyl methacrylate. 
The PIoL is iris claw-fixated.
The study consisted of the comparison of pupil size measurements with the 
Colvard (oasis Medical, Glendora, CA) and the Procyon (P2000 SA pupillo-
meter, Procyon Instruments Ltd.) pupillometers in two populations: a population 
of 121 eyes (group 1) selected randomly out of refractive surgery screening candi-
dates and a population of 83 eyes (group 2) after Artisan PIoL implantation. 
Patients were enrolled at the Academic Centre for Refractive Surgery, University 
Hospital Maastricht, the Netherlands. The mean age ± standard deviation (SD) in 
years of group 1 was 48.8 ± 9.1 (range 27 to 61 years) and 43.8 ± 8.7 (range 28 to 
56 years) for group 2. This study was conducted in accordance with the Helsinki 
Declaration and informed consent was obtained from all patients. Investigational 
review board approval was obtained from the Academic Hospital Maastricht, the 
Netherlands.
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Postoperative pupil diameters in group 2 were obtained 3 months after surgery. 
Exclusion criteria included iris abnormalities and systemic diseases that might 
affect pupil function.
Pupil size measurements
The handheld Colvard pupillometer uses light amplification technology. The 
patient is asked to fixate on a red light, produced by an IR-LED inside the device 
while the examiner is able to focus the iris and pupil by moving the pupillometer 
slightly forward and back. A millimeter ruler is superimposed by a reticule in 
the device over the image and allows direct measurement. The examiner was 
instructed to estimate the horizontal pupil diameter size with a precision of 0.25 
mm. Surrounding background room illumination of 0.15 lux was measured with 
a luxmeter.
The Procyon pupillometer is a digital infrared device for binocular simultaneous 
measurements of pupil diameter at 3 levels of luminance (scotopic [0.04 lux], 
mesopic-low [0.4 lux], and mesopic-high [4.0 lux]). Infrared light-emitting 
diodes illuminate the eyes with long-wave light that does not affect pupil size but 
is recognized by the charge-coupled device camera in the system. For both eyes, 
10 images were acquired at each level of luminance, and stored into a computer. 
The patient looks into the device and fixates on a black spot at a virtual distance 
of 10 m. Rubber eyecups prevent the illumination level to rise above the adjusted 
level. The examiner could view the acquired images immediately and distorted 
images were removed. The mean and SD, and range of scotopic, mesopic-low, 
and mesopic-high pupil diameters were assessed by the software and displayed as 
a diagram.
Before each measurement with the Colvard and Procyon devices, a one-minute 
dark adaptation was taken into account. All Colvard and Procyon measurements 
were taken by one experienced examiner. Colvard measurements were taken 
prior to the objective Procyon measurements to minimize influence on read-
ings. 
Definitions on scotopic and mesopic levels of illumination were used according 
to the International Commission on Illumination, with scotopic being less than 
0.05 lux, and mesopic between 0.05 and 50 lux (National Physical Laboratory, 
London, United Kingdom) (Rosen et al. 2002).
Pupil sizes measured with Colvard were compared to each level of illuminance 
used during the Procyon measurement procedure, in both groups, to compare 
these devices. Differences between pupil sizes were calculated by subtracting the 
Procyon measured pupil sizes from the Colvard measured values.
In measuring the pupil size via the cornea and the anterior chamber, one should 
realize that not the natural pupil is seen, but its image, which is called the entrance 
pupil. Since in this study we are interested in comparing measured pupil sizes, it 
is appropriate to use the size of the entrance pupil. However, postoperatively the 
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size of the entrance pupil is also changed by the Artisan PIoL since the PIoL 
is positioned in front of the pupil entrance. optically, the natural pupil is first 
imaged by the Artisan PIoL and secondly by the cornea / anterior chamber 
system. The distance from pupil to lens is given by the back surface sagittal 
depth called the vault by the manufacturer (0.799 mm for powers up to –15.5 
D and 0.733 D for powers > -15.5 D). Since the Artisan PIoL is placed in the 
anterior chamber fluid (refractive index = 1.336) and is very close to the pupil, 
the object vergence is very high compared to the effective power of the Artisan 
PIoL, resulting in a smaller than 1% change in pupil size. Nevertheless, we have 
compensated our measured pupil size data for the influence of the Artisan PIoL 
using the following formula (obstfeld 1982):
1 1336
§ ·= ¨ ¸© ¹
vault of Artisan PIOLinmm Dioptric power of Artisan PIOLCorrected Entrance Pupil Measured pupil size inmm
 ×- ×
Statistical analysis
All data were expressed as mean ± SD. Measured pupil diameters were distributed 
normally (Kolmogorov-Smirnov test). Paired samples t-tests, and the method of 
Bland and Altman (Bland & Altman 1986; Bland & Altman 2003) were used for 
analysis. This method compares 2 methods by plotting their means against their 
differences. P-values less than 0.05 were considered statistically significant.
RESULTS
In group 1, the mean ± SD pupil diameter measured with the Colvard pupillo-
meter and the Procyon pupillometer under scotopic, mesopic-low and mesopic-
high light conditions were 5.86 ± .81 mm, and 6.42 ± .88 mm, 5.55 ± .95 mm 
and 4.21 ± .73 mm, respectively. For all three light conditions of the Procyon 
pupillometer there was a significant difference with the Colvard measurements. 
The lowest mean difference was .31 ± .60 mm for the mesopic-low light condi-
tion (Table 1.1, Figures 1.1-1.2).
After Artisan PIoL implantation (group 2) pupil diameters measured with the 
Colvard pupillometer and the Procyon pupillometer were 5.32 ± .67 mm and 
6.14 ± .81 mm, 5.33 ± .78 mm and 4.02 ± .55 mm, respectively. Analysis of the 
mean difference in pupil size after Artisan PIoL implantation, measured with 
the Colvard and the Procyon pupillometer, showed comparable measurements 
between Colvard and Procyon under mesopic-low conditions (-.02 ± .59 mm, 
P = .78)
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According to the 95% Confidence Interval, the systematic difference is less 
than 0.15 mm under mesopic-low conditions in group 2. In the first group, this 
systematic difference is the smallest (0.42 mm) in the mesopic-low condition as 
well. Accordingly, Colvard systematically measures 0.63 mm (group 1) to 0.97 
mm (group 2) less than Procyon scotopic, and 1.45 mm (group 2) to 1.77 mm 
(group 1) more than Procyon mesopic-high.
Considering the other mean differences and 95% CI’s (Tables 1.1 and 1.2), we 
may conclude that the Colvard measurements correlated favourably to mesopic-
low conditions in the Procyon device.
Table 1.1 Differences in pupil size measured with the Colvard versus the Procyon pupil-
lometer under three light conditions in a population of refractive surgery screening candi-
dates (n = 121, group 1)
Illumination level
Mean Difference 
± SD (mm)
95% CI* Mean Differ-
ence Lower/Upper
Significance 
(2-tailed)
Colvard vs. Scotopic -0.56 ± 0.40 -0.63 / -0.49 P < 0.05
Colvard vs. Mesopic-low 0.31 ± 0.60 0.20 / 0.42 P < 0.05
Colvard vs. Mesopic-high 1.65 ± 0.65 1.53 / 1.77 P < 0.05
Table 1.2 Differences in pupil size measured with the Colvard versus the Procyon pupil-
lometer under three light conditions in a population after Artisan PIoL* implantation 
(n = 83, group 2) 
Illumination level
Mean Difference 
± SD (mm)
95% CI† Mean Differ-
ence Lower/Upper
Significance 
(2-tailed)
Colvard vs. Scotopic -0.48 ± 0.58 -0.97 / -0.71 P < 0.05
Colvard vs. Mesopic-low -0.02 ± 0.59 -0.15 / 0.11 P = 0.78
Colvard vs. Mesopic-high 1.30 ± 0.66 1.16 / 1.45 P < 0.05
*PIoL: Phakic Intraocular Lens; †CI: Confidence Interval
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Fig. 1.3 
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Figure 1.3 Agreement of measurements 
between the Colvard and the Procyon 
pupillometer under scotopic illumina-
tion in a population after Artisan PIoL 
implantation. A solid line represents 
mean value; an interrupted line repre-
sents mean ± 2 SD
 
Fig. 1.1 
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Figure 1.1 Agreement of measurements 
between the Colvard and the Procyon 
pupillometer under scotopic illumina-
tion in a population of refractive surgery 
candidates. A solid line represents mean 
value; an interrupted line represents 
mean ± 2 SD
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Figure 1.2 Agreement of measurements 
between the Colvard and the Procyon 
pupillometer under mesopic-low illu-
mination in a population of refractive 
surgery candidates. A solid line represents 
mean value; an interrupted line represents 
mean ± 2 SD
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Figure 1.4 Agreement of measurements 
between the Colvard and the Procyon 
pupillometer under mesopic-low illumi-
nation in a population after Artisan PIoL 
implantation. A solid line represents 
mean value; an interrupted line repre-
sents mean ± 2 SD
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DISCUSSIoN
Recently, the measurement of the scotopic pupil size and its relation with NVCs 
after refractive surgery has become a very important topic in corneal and lentic-
ular refractive surgery (Fan-Paul et al. 2002). Although it is generally believed 
that a large scotopic pupil size may put patients at an increased risk for NVCs 
after refractive surgery (Holladay et al. 1991; Martinez et al. 1998; o’Brart et 
al. 1995; Roberts & Koester 1993), more recent research argues the importance 
of the scotopic pupil size (Bailey et al. 2003; Klyce 2004; Pop & Payette 2004; 
Probst 2004; Schallhorn et al. 2003).
In addition, in a recent patient satisfaction study after LASIK for correction of 
myopia, no significant correlation was found between pupil size or pupil-optical 
zone disparity and NVCs or glare scores (Tahzib et al. 2005). In another patient 
satisfaction study after implantation of Artisan PIoL for correction of myopia, risk 
factors such as scotopic and mesopic-low pupil size, pupil-optical zone disparity 
and decentration of the PIoL were investigated and related to satisfaction scores 
of glare, night vision and night driving. Correlation was found between glare 
scores and these risk factors. In contrast, no correlation was found between pupil 
size and night vision or night driving scores (Tahzib et al. 2006). However, most 
authors agree that a standardized measurement of pupil size under defined light 
conditions with good repeatability is of utmost importance for screening patients 
eligible for refractive surgery (Kohnen et al. 2003; Rosen et al. 2002). It has been 
shown that the digital Procyon pupillometer has a low variation in measuring 
pupil size and has good interrater repeatability (Kohnen et al. 2003; Spadea et 
al. 2005). 
The variation in scotopic pupil size measured with different devices emphasizes 
the need for an objective measurement method. In addition, well-defined illumi-
nation conditions enhance comparison of future studies on pupillometry. There-
fore, we compared the measurements between the more subjective handheld 
Colvard pupillometer and the digital Procyon device under defined illuminance 
levels. The mean differences in the pupil diameters measured by the Colvard 
and the Procyon devices for the scotopic and mesopic-low illuminance levels 
were comparable as has been described before (Kohnen et al. 2003; Schmitz et 
al. 2003). Measurements with the Procyon device under mesopic-low condi-
tions compared most favourably to measurements of the Colvard device in a 
group of refractive surgery screening candidates as well as in a group of patients 
after Artisan PIoL implantation. on average, the Colvard measurement was 0.31 
mm larger than the Procyon mesopic-low measurement in the refractive surgery 
screening group, while in the Artisan PIoL group the Procyon mesopic-low 
measurement was 0.02 mm larger than the Colvard measurement. 
Despite the fact that pupil size measurements with the Colvard pupillometer 
have been classified as scotopic pupil size measurements, the results show more 
correlation with the Procyon measurements under mesopic-low light conditions 
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as compared to the Procyon measurements under scotopic conditions. This states 
the fact that ambient light conditions are of utmost importance in measuring a 
scotopic pupil size for refractive surgery when using the Colvard pupillometer. 
The measurements with the Colvard pupillometer are monocular and subject to 
fluctuations in room illumination. In addition, the relevance of the binocular 
measured pupil size under well-defined illumination levels has to be related to 
illumination levels for specific activities in real life, e.g. during driving at night. 
Binocular measurements may imitate the patient’s life conditions more realisti-
cally (Kurz et al. 2004). Therefore, we believe that digital binocular infrared 
pupillometry is advantageous for standardized measurement of the pupil size 
since it approximates real life conditions more closely. Hence, these standard-
ized measurements may facilitate a more robust evaluation of the relationship 
between night vision complaints and pupil size under various light conditions. 
Better predictability of possible visual disturbances may be established and 
thereby diminish the incidence of glare or possible night vision disturbances 
after refractive surgery.
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3Evaluation of pupil dynamics after implantation of Artisan phakic intraocular lenses
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ABSTRACT
Purpose: To compare preoperative and postoperative horizontal and vertical pupil 
dia meters after horizontal Artisan phakic intraocular lens (PIoL) implantation for 
correction of myopia.
Materials and Methods: The preoperative and postoperative scotopic pupil diameters 
measured by the Colvard pupillometer were compared in 71 eyes after Artisan PIoL 
implantation (Artisan Colvard group). Analysis of pupil shape (vertical vs. horizontal 
diameter, V/H ratio) after horizontal Artisan PIoL implantation was performed with the 
Procyon pupillometer in 121 eyes (Artisan Procyon group) under scotopic, mesopic-low 
and mesopic-high conditions and compared to an age and refraction matched control 
group of 121 eyes of refractive surgery candidates (Procyon control group).
Results: After horizontal Artisan PIoL implantation, the mean horizontal pupil dia meter 
decreased from 6.23 ± .70 mm preoperatively to 5.34 ± .68 mm after surgery in the 
Artisan Colvard group (P < .01). The mean horizontal scotopic diameter was 5.60 ± .66 
mm, the mesopic-low diameter was 4.94 ± .71 mm and the mesopic-high diameter was 
3.98 ± .54 mm for the Artisan Procyon group. The mean horizontal scotopic diameter 
was 6.29 ± .91 mm, the mesopic-low diameter was 5.40 ± .96 mm, and the mesopic-high 
diameter was 4.16 ± .80 in the Procyon control group. There was a significant increase 
in V/H ratio under scotopic, mesopic-low and mesopic-high conditions from 1.02, 1.02 
and 1.01 in the Procyon control group to 1.17, 1.12 and 1.06 in the Artisan Procyon 
group (P < .01).
Conclusions: Horizontal pupil size was significantly decreased after horizontal Artisan 
PIoL implantation and might be attributed to a mechanical restriction of the iris in the 
horizontal meridian.
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INTRoDUCTIoN
Pupil size as an influential factor for the development of night vision complaints 
(NVCs) including halos, starbursts and glare after corneal refractive surgery 
has been under great discussion lately.1 Although many authors suggest that a 
disparity between the pupil size measured under dim light conditions and the 
optical zone size of the laser ablation or the phakic intraocular lens (PIoL)2 may 
be responsible for subjective NVCs, recent reports argue the role of the pupil 
size in the pathophysiology of NVCs.3-7 Implantation of Artisan myopia PIoLs 
has been proven a successful method for correction of moderate to high myopia 
over the recent years.8-13 Changes in pupil size like pupil ovalization after ante-
rior chamber angle supported lens implantation have not been described after 
implantation of the Artisan iris-fixated PIoL.2, 14 Recently, a change in pupil 
size has been described after iris-fixated toric PIoL.15 However, the effect of the 
Artisan iris-fixated PIoL on the pupil dynamics has not been evaluated.
Methods for measuring pupil size over the years have included the use of pupil 
charts, photo cameras, and more recently, digital and handheld infrared pupil-
lometers.16-20 To study potential correlations between pupil size and NVCs the 
measurement of the pupil size should reflect real-time situations and should be 
performed under standardized illumination conditions. The two most popular 
instruments for measuring pupil size under dim light conditions are currently the 
Colvard pupillometer and the Procyon pupillometer.17, 19, 20 The measurements 
with the Colvard pupillometer are monocular and subject to fluctuations in 
room illumination, while with the Procyon pupillometer the measurements are 
binocular and the levels of illumination are prefixed and standardized. Therefore, 
Procyon pupillometer measurements may reflect patient’s real life conditions, e.g. 
driving at night, more realistically.21
The purpose of this study was to evaluate the effect of horizontal implantation of 
the Artisan PIoL on the size and shape of the pupil.
MATERIALS AND METHoDS
The Artisan PIoL was designed by Professor J. Worst and was formerly known 
as the Worst-Fechner claw lens.22 The lens has a convex-concave optic with 
either a 6-mm (for intraocular lens powers up to –15.5 diopters (D)) or a 5-mm 
(for intraocular lens powers from –16.0 D up to –24.0 D) and is available in 0.50 
D steps (ophtec B.V., Groningen, the Netherlands). This single-piece lens is 
composed of polymethyl methacrylate. The PIoL is iris claw-fixated. Patients 
were enrolled at the Academic Centre for Refractive Surgery, University Hospital 
Maastricht, the Netherlands and were operated for myopia by the same surgeon 
(RN). The Artisan PIoL was enclavated at the 0 - 180° meridian in all patients.
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In the first part of the study, maximal horizontal pupil diameters were measured 
in 71 eyes of 37 patients (Artisan Colvard group) before and after the horizontal 
Artisan PIoL implantation, using the handheld Colvard (oasis Medical, Glen-
dora, CA) pupillometer.
The second part of the study, consisted of the pupil size measurements with the 
Procyon (P2000 SA pupillometer, Procyon Instruments Ltd.) pupillometer in 
two populations: a population of 121 eyes of 62 patients (Artisan Procyon group) 
after horizontal Artisan PIoL implantation and a population of 121 eyes selected 
out of refractive surgery candidates (Procyon control group) which was matched 
for age and refraction. The Artisan Procyon and the Procyon control group were 
compared to evaluate differences in the horizontal and vertical pupil diameters.
Postoperative pupil diameters were obtained 3 months after surgery. Exclusion 
criteria included iris abnormalities and systemic diseases that might affect pupil 
function. Gonioscopy was used to exclude patients with a plateau iris or a convex 
iris configuration.
Pupil size measurements
The handheld Colvard pupillometer uses light amplification technology. The 
patient is asked to fixate on a red light, produced by an IR-LED inside the device 
while the examiner is able to focus the iris and pupil by moving the pupillometer 
slightly forward and back. A millimeter ruler is superimposed by a reticule in 
the device over the image and allows direct measurement. The examiner was 
instructed to estimate the horizontal pupil diameter size with a precision of 0.25 
mm, while covering the contralateral eye with the other hand.
The Procyon pupillometer is a digital infrared device for binocular simultaneous 
measurements of pupil diameter at 3 levels of luminance (scotopic [0.04 lux], 
mesopic-low [0.4 lux], and mesopic-high [4.0 lux]). Infrared light-emitting 
diodes illuminate the eyes with long-wave light that does not affect pupil size but 
is recognized by the charge-coupled device camera in the system. For both eyes, 
10 images were acquired at each level of luminance, and stored into a computer. 
The patient looks into the device and fixates on a black spot at a virtual distance 
of 10 m. Rubber eyecups prevent the illumination level to rise above the adjusted 
level. The examiner could view the acquired images immediately and distorted 
images were removed. The mean and standard deviation (SD), and range of 
scotopic, mesopic-low, and mesopic-high pupil diameters were assessed by the 
software and displayed as a diagram. 
Before each measurement, a one-minute dark adaptation was taken into account. 
Surrounding room illumination was measured no more than 0.15 lux. Defini-
tions on scotopic and mesopic levels of illumination were used according to the 
International Commission on Illumination as scotopic being less than 0.05 lux 
and mesopic between 0.05 and 50 lux (National Physical Laboratory, London, 
Tahzib_Boek_06.indb   74 11-8-2008   11:32:28
75Pupil and Artisan PIOL
United Kingdom).23 All Colvard and Procyon measurements were taken by one 
experienced examiner. 
Digital images from the Procyon measurements were converted to Adobe Photo-
shop 5.0 software program (1989-1998 Adobe systems Inc.). Horizontal and 
vertical diameters were obtained using the measurement tool inside the program 
(Figure 1). The ratio between the vertical and horizontal pupil diameters, the 
so-called V/H ratio, was calculated from measurements with the Procyon device 
under all three light conditions. A ratio of 1.00 represents a perfect circular pupil 
shape.
In measuring the pupil size via the cornea and the anterior chamber one should 
realize that not the natural pupil is seen, but its image which is called the entrance 
pupil. Since in this study we are interested in comparing measured pupil sizes, it 
is appropriate to use the size of the entrance pupil. However, postoperatively the 
size of the entrance pupil is also changed by the Artisan PIoL since the PIoL 
Figure 1. ovalization of the pupil after Artisan Phakic Intra-
ocular Lens implantation under mesopic-low light conditions 
using Procyon pupillometry.
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is positioned in front of the pupil entrance. optically, the natural pupil is first 
imaged by the Artisan PIoL and secondly by the cornea / anterior chamber 
system. The distance from pupil to lens is given by the back surface sagittal 
depth called the vault by the manufacturer (0.799 mm for powers up to –15.5 
D and 0.733 D for powers < -15.5 D). Since the Artisan PIoL is placed in the 
anterior chamber fluid (refractive index = 1.336) and is very close to the pupil, 
the object vergence is very high compared to the effective power of the Artisan 
PIoL, resulting in a smaller than 1% change in pupil size. Nevertheless, we have 
adjusted our measured pupil size data for the influence of the Artisan PIoL using 
the following formula 24 :
1 1336
§ ·= ¨ ¸© ¹
vault of Artisan PIOLinmm Dioptric power of Artisan PIOLCorrected Entrance Pupil Measured pupil size inmm
 ×- ×
Statistical analysis
All data were expressed as mean ± SD. Measured pupil diameters were distrib-
uted normally (Kolmogorov-Smirnov test). Independent and paired-samples 
t-tests were used for analysis. P-values less than 0.05 were considered statistically 
significant (SPSS for Windows, SPSS Inc., Chicago, IL).
RESULTS
The mean ± SD horizontal pupil diameter measured with the Colvard pupil-
lometer (Artisan Colvard group) after horizontal Artisan PIoL implantation 
decreased from 6.23 ± .70 mm preoperatively to 5.34 ± .68 mm after surgery (P 
< .01) (Table 1). This is a mean reduction of 13.8 ± 10.6 % in horizontal pupil 
diameter after implantation. 
Horizontal pupil diameters measured with the Procyon device after horizontal 
Artisan PIoL implantation (Artsian Procyon group) were 5.60 ± .66 mm 
(scotopic), 4.94 ± .71 mm (mesopic-low) and 3.98 ± .54 mm (mesopic-high). In 
the Procyon control group, the mean ± SD horizontal pupil diameter measured 
with the Procyon pupillometer was 6.29 ± .91 mm (scotopic), 5.40 ± .96 mm 
(mesopic-low) and 4.16 ± .80 mm (mesopic-high) (Table 1 and Table 2).
There was a decrease in the horizontal pupil diameter after horizontal Artisan 
PIoL implantation under all three light conditions (P < .01). In contrast, no 
change occurred in the vertical axis (Table 2). In the Procyon control group, the 
mean V/H ratio for scotopic, mesopic-low and mesopic-high light conditions 
was 1.02, 1.02 and 1.01. After horizontal Artisan PIoL implantation (Artisan 
Procyon group) the mean V/H-ratio significantly increased to 1.17, 1.12 and 1.06 
(Table 2, Figure 2).
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Table 1. Horizontal pupil diameter in millimeter for all three groups. A V/H-ratio* has 
been given for the Artisan Procyon and the Procyon control groups. The Procyon diameters 
represent scotopic conditions
Horizontal diameter [SD†] V/H-ratio
Artisan Colvard group before implantation 6.23 [0.70]
after implantation 5.34 [0.68]
Artisan Procyon group after implantation 5.60 [0.66] 1.17
Procyon control group 6.29 [0.91] 1.02
* V/H-ratio: Ratio between the vertical and horizontal pupil diameters;
† SD: Standard deviation
Figure 2. Box-plot showing the range of Vertical/Horizontal-
ratios measured in the post-Artisan Phakic Intraocular Lens 
implantation group (Artisan Procyon group) and the refractive 
surgery screening group (Procyon control group) under scotopic 
condition (n = 121 for both groups). The diff erence between the 
groups is signifi cant (P < .01).
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DISCUSSIoN
Recently, the measurement of the scotopic pupil size and its relation with 
NVCs after refractive surgery has become a very important topic in corneal 
and lenticular refractive surgery.1 Although it is generally believed that a large 
scotopic pupil size may put patients at an increased risk for NVCs after refractive 
surgery25-28, more recent research argues the importance of the scotopic pupil 
size.3-7 However, most authors agree that a standardized measurement of pupil 
size under defined light conditions with good repeatability is of utmost impor-
tance for screening patients eligible for refractive surgery.20, 23 In addition, the 
relevance of the binocular measured pupil size under well-defined illumination 
levels has to be related to illumination levels for specific activities in real life, 
e.g. during driving at night. Binocular measurements may imitate the patient’s 
life conditions more realistically.21 It has been shown that the digital Procyon 
pupillometer has a low variation in measuring pupil size and has good inter-
rater repeatability.20 The variation in scotopic pupil size measured with different 
devices emphasizes the need for an objective measurement method. In addition, 
well-defined illumination conditions enhance comparison of future studies on 
pupillometry.
After implantation of PIoLs, especially with anterior chamber angle-fixated 
lenses, progressive changes like pupil ovalization and atrophy of iris stroma due 
to infarction of iris vessels in the chamber angle have been reported.2, 14, 29 It 
has been suggested that the Artisan PIoL has no influence on pupil dynamics 
because of the enclavation of the haptics in the mid-periphery of the iris, far away 
from the vulnerable chamber angle structures.30 Consequently, the implanta-
tion of iris-fixated PIoLs has become increasingly popular and has been proven 
successful for the correction of moderate to high refractive errors. For Artisan 
PIoLs with a 6-mm optical zone, the manufacturer prefers that the Artisan PIoL 
lenses not be implanted in eyes with a scotopic pupil size over 6 mm. This is 
stated because of the presumed correlation between NVCs including contrast 
sensitivity loss, glare, and halos and a disparity of the optical lens zone with the 
pupil diameter. However, we do not know the methods and illumination levels 
that have been used by the manufacturer to formulate this advice. To evaluate 
the effect of the iris fixation mechanism of the Artisan lens on pupil dynamics, 
we measured the horizontal scotopic pupil size with the Colvard device before 
and after horizontal Artisan PIoL implantation. In addition, we calculated the 
ratio between the vertical and horizontal pupil diameter after horizontal Artisan 
lens implantation (V/H ratio). After horizontal Artisan lens implantation, the 
horizontal pupil diameter decreased on average by 13.8%. The relation between 
individual vertical and horizontal pupil diameters in normal subjects was recently 
investigated and provided comparable results to our findings, e.g. a ratio of 1.01 
to 1.03.31 Dick et al.15 described a change in pupil size after implantation of 
toric PIoLs using pharmacological mydriasis and flash slit lamp photography. 
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our study demonstrates a restriction in the dilation of pupils in the horizontal 
axis after horizontal Artisan myopia PIoL implantation under physiological light 
conditions. A possible explanation for this restriction could be the mechanically 
induced prevention of pupil dilatation by the iris claw. It seems unlikely that the 
function of the dilator pupillae muscle is impaired by the induction of ischemia 
by the enclavation of the iris claw itself, since this has not been supported by 
fluorescein angiography studies in the past.30 
The main finding of this study was the detection of a decreased horizontal 
meridian of the pupil after horizontal Artisan PIoL implantation, as compared to 
the vertical meridian, at all 3 levels of illuminance, i.e. scotopic, mesopic-low and 
mesopic-high. The postoperative constriction in the horizontal axis and subse-
quent smaller scotopic pupil diameter may have implications for the inclusion 
criteria for implantation, since a relatively larger proportion of patients would fit 
the currently formulated inclusion criteria where the optical zones should be at 
least as large as the scotopic pupil size. 
In summary, horizontal pupil size is diminished after horizontal Artisan PIoL 
implantation and a significant change in V/H ratio was measured under three 
levels of illumination leading to a vertical ovalization of the pupil. The decrease 
in the postoperative pupil area could be beneficial for reduction of aberrations 
and thereby diminish the incidence of night vision disturbances. A digital infra-
red pupillometer not only is advantageous for standardized measurement of the 
horizontal pupil diameter, but also may give insight into the mechanical effects 
of PIoLs on pupillary dynamics.
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ABSTRACT
Purpose: To determine subjective patient satisfaction and self-perceived quality of vision 
after laser in situ keratomileusis (LASIK) to correct myopia and myopic astigmatism.
Setting: Department of ophthalmology, Academic Hospital Maastricht, the Nether-
lands.
Methods: A validated questionnaire consisting of 66 items was self-administered by 
142 consecutive patients. Seven scales covering a specific aspect of quality of vision 
were formulated including global satisfaction, quality of uncorrected and corrected 
vision, quality of night vision, glare, daytime driving and night driving. Main outcome 
measures were responses to individual questions and scale scores and correlations with 
clinical parameters including refractive outcome, uncorrected visual acuity (UCVA) and 
best-corrected visual acuity (BCVA), ablation depth, and scotopic pupil-optical zone 
disparity were obtained. 
Results: The mean score for the overall satisfaction was 4.1 ± 0.71 (scale 0 to 5.0). 92.2% 
of patients were satisfied or very satisfied with their surgery, 93.6% considered their main 
goal of surgery achieved and 92.3% would choose to undergo LASIK surgery again. 
Satisfaction with uncorrected vision was 3.03 ± 0.71. The mean score for glare was 3.0 
± 0.9. At night, glare from lights was believed to be more important than before surgery 
by 47.2%. Glare from oncoming car headlights after surgery was reported by 58.4%, and 
was believed to be more bothersome for night driving than before surgery by 52.8%. 
Night driving was rated more difficult by 39.4% than before surgery, while 59.3% had 
less difficulty driving at night. There was a significant correlation between uncorrected 
vision score and postoperative spherical equivalent (SE) (r = .245) and postoperative 
astigmatism (r = .265), respectively. There was no correlation between the glare or night 
vision scores and the degree of correction, the amount of ablation depth or the disparity 
between the scotopic pupil and the optical zone.
Conclusion: Self-perceived uncorrected vision after LASIK surgery for the correction 
of myopia and myopic astigmatism appears to be very good and is related to the post-
operative residual error. Although the majority of patients postoperatively experienced 
glare, particularly with driving at night, this was not related to the pupil-optical zone 
disparity or degree of correction.
.
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INTRoDUCTIoN
Studies of the medical outcome of laser refractive surgery for the treatment of 
ametropia, including myopia and astigmatism have shown great success.1, 2 Like-
wise, patient satisfaction after laser in situ keratomileusis (LASIK) reportedly 
ranges from 82% to 98%.3-6
Despite the high success rate, quality of vision problems after refractive surgery 
techniques such as photorefractive keratectomy (PRK) and LASIK have been 
reported in many clinical studies.6-13 Glare and halos and subsequent night 
vision complaints (NVCs) are among the prime complaints reported by patients. 
These problems may be attributed to a loss of contrast sensitivity or low-contrast 
visual acuity.6, 14, 15 Reports have linked the relationship between the ablation 
zone and the dim light pupil size to NVCs early postoperatively after refractive 
surgery.8 Many surgeons in the past have recommended that LASIK should not 
be performed on patients whose pupil size is larger than the treatment optical 
zone.16, 17 For a long time, pupil size has been suspected to be a direct cause of 
NVCs, a role that has been assigned hypothetically based on optical theory.10 
Recent studies show that pupil size is indeed a significant predictor of glare and 
halos after LASIK, especially in the first postoperative month, yet they demon-
strate that pupil size is not a significant variable 6 or 12 months after treatment.8 
It appears that pupil size only partially explains the differences in reports about 
quality of vision after LASIK.8-13
The necessity for a more precise assessment of subjective quality of vision and 
patient satisfaction after refractive surgery has increased with the discovery of 
persistent NVCs. The aim of our study was to determine subjective patient 
satisfaction and self-perceived outcome after LASIK surgery for the correction 
of myopia and myopic astigmatism. We investigated possible determinants of 
postoperative visual complaints such as refractive status, the ablation depth, the 
pupil size and the disparity between pupil size and the optical zone.
METHoDS
The questionnaire used in our study is a psychometric instrument that was 
developed and validated by Brunette et al. and has been previously used for the 
evaluation of patient satisfaction after PRK and to assess postoperative visual 
symptoms.1, 2 The questionnaire was translated into the Dutch language from 
the original English. The instrument has proven to be reliable by a high level of 
internal consistency with Cronbach’s alpha coefficients superior or equal to 0.83. 
For analysis purposes, the 66 items of the questionnaire were grouped in seven 
distinct scales which were self-administered by patients. Scale scores increased 
with satisfaction, ranging from 1 (very dissatisfied) to 5 (very satisfied). Each of 
the seven scales covered a specific aspect of quality of vision, including global 
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satisfaction, quality of uncorrected and corrected vision, quality of night vision, 
glare, daytime driving and night driving. The entry of all data from the ques-
tionnaires was performed by one independent physician (N.T.), not involved in 
the treatment or follow-up of the patients.
All treatments were performed by a single surgeon (R.N.) at the Academic Center 
for Refractive Surgery, University Eye Clinic of Maastricht. Patients had either 
standard LASIK (PlanoScan, Bausch & Lomb, Munich, Germany) or wavefront-
guided LASIK (Zyoptix, Bausch & Lomb, Munich, Germany). Included patients 
had at least stable myopia for 2 years and were examined preoperatively and at day 
1, week 1, month 1, month 3, month 6, and from then at 6 months intervals. Pre- 
and postoperatively, subjective and objective refraction, slit-lamp microscopy, 
applanation tonometry, fundus examination and corneal topography (orbtek 
orbscan II, version 3.10.31, Bausch & Lomb, Munich, Germany) were assessed. 
Scotopic (dim light) pupil size was measured with the handheld Colvard pupil-
lometer (oasis Medical, Glendora, CA).16, 18 It is said to use light amplification 
technology, that enables the examiner to focus the iris and pupil by moving the 
pupillometer slightly forward and back. Patients had a one-minute dark adapta-
tion before measurements and were then asked to fixate on an infrared light-
emitting diode, which emits red light at very low levels. A millimeter ruler was 
superimposed by a reticle in the device. The largest horizontal scotopic pupil 
diameter was estimated with a precision of 0.1 mm. Illumination conditions were 
no more than 0.15 lux throughout the examination room. The pupil-optical 
zone disparity, which is defined as the difference between the scotopic pupil size 
and the optical zone of the laser treatment, was calculated.
Patients who were treated within the period January 2001 to December 2003 
received a questionnaire by regular mail, including a brief accompanying letter 
indicating the aim of the study. Patients with a minimum of 4 months of follow-
up and a stable postoperative refraction were included in the study. Investigational 
review board approval was obtained from the Academic Hospital Maastricht, the 
Netherlands.
For statistical purposes, uncorrected and corrected visual acuity in logMAR of 
the best eye was used for calculations, which means the lower the value, the 
better the vision. Correlations between the scale scores and clinical parameters 
were assessed with the Pearson r coefficient of correlation and the Spearman 
rank correlation (SPSS for Windows, SPSS Inc., Chicago, IL). The strength of 
the correlation between two variables was defined as strong (r ≥ .60), moderate 
(.30 ≤ r < .60), or weak (.10 ≤ r < .30). All values in the text are mean ± standard 
deviation (SD).
As to the surgical technique, in a first step, a flap with a diameter of 9.5 mm and a 
thickness of 160 μm was created with a superior hinge with a Hansatome micro-
keratome (Bausch & Lomb, Munich, Germany). The ablation was performed 
using the 193 nm 217z scanning-spot excimer laser system with a combined 2.0 
mm and 1.0 mm spot in the Zyoptix group. The PlanoScan was treated with 
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a 2.0 mm scanning spot. The PlanoScan and Zyoptix software programs were 
used for the standard and wavefront-guided treatments, respectively. Before each 
treatment, the laser was calibrated by a fluence test and the eye-tracking system 
was tested. The radiant exposure was 0.2 J/cm² in the treatment plan and the 
repetition frequency of the laser was 120 Hz. After the photoablation, the lamella 
was repositioned and the interface floated with a balanced salt solution. ofloxacin 
0.3% (Trafloxal®, Tramedico, Weesp, the Netherlands) and fluoromethalone 0.1% 
(FML Liquifilm®, Allergan, Co. Mayo, Ireland) drops were used 4 times daily for 
2 days. Sodium hyaluronate 0.18% drops (Vislube®, TRB Chemedica, Newcastle 
under Lyme, United Kingdom) were given 4 times daily for 1 week.
RESULTS
A total of 142 patients were included in our study. Population characteristics are 
listed in Table 1. The mean patient age was 43 ± 10.0 years (SD) (range 21-67 
years). The mean follow-up time for the medical outcome was 11 ± 4.29 months 
(range 4-36 months). Tables 2 to 7 show the scores for all seven quality of vision 
scales. The mean time interval for the self-administration of the questionnaire 
was 24.06 ± 11.01 months (range 4-36 months). of our patients, 48.6% self-
administered the questionnaire within the first 2 years and 51.4% within the 
third year after surgery.
Patient satisfaction and self-perceived outcome 
The most frequently reported motivations for desiring surgical correction were 
to be less dependent on glasses (12.5%), intolerance to contact lens wear (8.3%) 
and problems in handling contact lenses (7.2%).
Global satisfaction. The mean score for the overall satisfaction was 4.10 ± 0.71 
(5 meaning totally satisfied). The majority of patients (93.6%) reported that their 
main goal had been achieved and would be willing to have the surgery done 
again if they could do it over (92.3%). Global satisfaction did not show a correla-
tion with patient age. 
Quality of daytime vision without correction. The mean score for all 
patients was 3.03 ± 0.71; Uncorrected distance vision was characterized as slightly 
or much better than preoperative corrected vision by 40% of patients.
Symptoms reported to be more frequent than before surgery included blurred 
vision (33.1%), sensitivity to smoke (27.4%) and distortion of fine details (21.8%), 
a double outline of images (7.7%), and ghost images (7.0%).
Uncorrected near vision was characterized as slightly or much better than the 
preoperative corrected near vision by 9.3% of patients. 
Quality of daytime vision with correction. The mean score for patients 
wearing glasses for quality of daytime vision was 2.95 ± 1.08. Wearing glasses 
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or contact lenses for distance vision on a regular basis was reported by 13.4% and 
1.4% of patients, respectively. Near vision correction was used by 23.2%. 
Quality of Night Vision. The mean score for night vision was 3.1 ± 0.7. Night 
vision was considered worse or much worse than before surgery by 33.8% of 
patients.
Glare. The mean glare score was 3.0 ± 0.9. After surgery, 47.2% of patients 
experienced more glare from lights at night than before surgery. 
Driving. The mean scores for daytime and night driving were 4.5 ± 1.1 and 
3.2 ± 1.3, respectively. Among the patients with a driving permit, only 8.0% 
reported a night driving score of 5 after surgery. After surgery, 40.9% of patients 
reported to experience more difficulty with night driving than before surgery.
Table 1. Population Characteristics
Characteristics
Mean ± SD
or % patients
Median Range
Age (yrs) 43.0 ± 10.0 42.0 21.0 to 67.0
Follow-up time medical outcome (mos) 10.5 ± 4.29 12.0 4.0 to 36.0
Before surgery (n=142)
Mean SE (diopters [D]) -4.96 ± 2.15 -5.0 -9.13 to -0.50
Simulated keratometry values (D)
Steep meridian 44.10 ± 1.73
Flat meridian 42.78 ± 1.66
Mean BCVA 20/20 or better 80%
BCVA between 20/20 and 20/40 100%
BCVA 20/40 or worse 0%
Mean pupil diameter (mm) 5.9 ± 0.84 6.0 3.1 to 7.50
At the last follow-up (n=142)
Visual acuity in the best eye (n=142)
UCVA 20/20 or better 73%
UCVA between 20/20 and 20/40 99.3%
UCVA 20/40 or worse 0.7%
Loss of 1 line of BCVA 11.3%
Loss of 2 lines of BCVA 1.4%
Refraction (n=142)  
Mean SE (D)  –0.17 ± 0.36 0.0 -1.0 to 0.75
Mean SE within 1.00 D of emmetropia 97%
Mean SE within 0.5 D of emmetropia 86.8%
Simulated keratometry values (D)
Steep meridian 40.0 ± 2.05
Flat meridian 39.1 ± 2.01
BCVA = best-corrected visual acuity; SE = spherical equivalent; UCVA = uncorrected 
visual acuity.
Table 2. Global Satisfaction Scale Score
Global Satisfaction Mean ± SD* or % Range
Mean score 4.1 ± 0.7 1.2 – 5.0
Main goal achieved 93.6
Satisfied with result 92.2
Surgery was good choice 92.3
Would do the surgery again 92.3
Expected quality of vision achieved 88.0
Independence of correction considered 
best result
76.1
Improved quality of life at work 27.2
Improved quality of social life 37.0
Improved quality of family life 23.3
*Scores 0-5 (5 meaning totally satisfied).
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Table 3. Uncorrected Vision Scale Score
Uncorrected Vision Mean ± SD* or % Range
Mean score 4.1 ± 0.7 1.1 – 5.0
Uncorrected distance vision better than preoperative 
corrected vision
40.0
Uncorrected distance vision same as preoperative 
corrected vision
29.3
Uncorrected distance vision worse than preoperative 
corrected vision
30.7
Uncorrected near vision better than preoperative 
corrected vision
9.3
Uncorrected near vision same as preoperative 
corrected vision
53.6
Uncorrected near vision worse than preoperative 
corrected vision
37.1
Newspaper headlines more easily read without 
correction after surgery
9.3
Computer screen more easily read without correc-
tion after surgery
14.8
*Scores 0-5 (5 meaning totally satisfied).
Table 4. Corrected Vision Scale Score
Uncorrected Vision Mean ± SD* or % Range
Mean score 2.95 ± 1.08 1.0 – 5.0
Wearing glasses for distance vision on a regular basis 13.4
Wearing contactlenses for distance vision on a 
regular basis
1.4
Wearing near vision correction on a regular basis 23.2
*Scores 0-5 (5 meaning totally satisfied).
Table 5. Night Vision Scale Score
Uncorrected Vision Mean ± SD* or % Range
Mean score 3.1 ± 0.7 1.4 – 4.5
Night vision considered same or better than before 
surgery
66.2
Night vision considered worse or much worse than 
before surgery
33.8
Halos (before/after) 28.1 / 52.8
Perception of stars around lights (before/after) 18.3 / 30.2
Distortion of details (before/after) 18.3 / 26.0
Double outline of images (before/after) 6.3 / 9.1
Ghost images (before/after) 4.2 / 5.6
*Scores 0-5 (5 meaning totally satisfied).
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Correlations between satisfaction scales and clinical parameters. 
Visual acuity. The mean postoperative logMAR UCVA in the best eye at the 
time of the questionnaire was -.027 ± .11 and showed a correlation with overall 
satisfaction, the uncorrected vision score, the night vision score and the driving 
scores (Table 8).
Refraction. The mean postoperative spherical equivalent (SE) was –0.17 ± 0.36 
D. In the population, 86.8% was within ± 0.5 D, and 97.0% was within ± 1.0 D 
from emmetropia, respectively. There was no correlation between the satisfac-
tion scores and the degree of preoperative SE. A significant correlation was found 
between the SE at the last follow-up (LFU) and the uncorrected vision score and 
the driving scores (Figure 1). The mean refractive astigmatism value at the LFU 
showed a correlation with the uncorrected vision score (Figure 2) and the driving 
scores.
The mean preoperative and postoperative simulated keratometry values of the 
steep and flat meridians were 44.10 D ± 1.73 and 42.78 D ± 1.66, and 40.0 D ± 2.05 
and 39.1 D ± 2.01, respectively. There were no significant associations between 
these keratometry values and the satisfaction scores. The mean preoperative and 
Table 6. Glare Scale Score
Uncorrected Vision Mean ± SD* or % Range
Mean score 3.0 ± 0.9 1.1 – 4.9
Glare from lights at night increased compared to before 
surgery
47.2
Glare from oncoming headlights considered bothersome 
before surgery
40.9
Glare from oncoming headlights considered bothersome 
after surgery
58.4
Glare after surgery considered more bothersome than 
before surgery
52.8
*Scores 0-5 (5 meaning totally satisfied).
Table 7. Daytime and Night Driving Driving Scale Score
Uncorrected Vision Mean ± SD* or % Range
Mean score 3.0 ± 0.9 1.1 – 4.9
Driving permit 96.5
Daytime driving score of 5 (totally satisfied) 62.3
Night driving score of 5 (totally satisfied) 8.0
More difficulty with night driving than before surgery 40.9
Less difficulty with night driving than before surgery 51.0
*Scores 0-5 (5 meaning totally satisfied).
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postoperative topographical astigmatism values did not correlate with the glare 
or night vision scores. 
Ablation depth. The mean ablation depth used during surgery was 90.7 ± 37.0 
μm. No significant correlation was observed between the night vision score and 
the ablation depth (r =-.55, P = .515) nor between the glare score and the abla-
tion depth (r = .083, P = .328).
Pupil size and pupil-optical zone disparity. Mean scotopic pupil sizes were 
6.0 ± .83 mm. No significant correlation was found between the scotopic pupil 
size or the pupil-optical zone disparity and any of the satisfaction scores (Figures 
3 and 4).
Wavefront-guided LASIK group
For the separate small group of 11 binocular wavefront-guided LASIK patients, 
the mean postoperative logMAR UCVA in the best eye at the time of the ques-
tionnaire was -0.072 ± .08. The mean postoperative SE was -0.11 ± 0.24 D and 
showed a correlation with the global satisfaction score (r = .66, P = .026). The 
mean preoperative and postoperative simulated keratometry values of the steep 
and flat meridians were 43.96 D ± 2.24 and 42.57 D ± 2.37, and 38.81 D ± 1.98 
and 38.01 D ± 2.04, respectively. No correlation was found between the glare 
or night vision scores and the degree of correction, the ablation depth or the 
pupil-optical zone disparity.
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Figure 2. Uncorrected vision score 
versus postoperative astigmatism value at 
last follow-up (LFU);
r = .284, P = .001
Figure 3. Night vision score versus the 
pupil-optical zone (oZ) disparity; 
r = -.059, P = .488
Figure 1. Uncorrected vision score versus 
postoperative spherical equivalent (SE) at 
last follow-up (LFU); 
r = .245, P = .003
Figure 4. Glare score versus the pupil-
optical zone (oZ) disparity; 
r = .027, P = .753
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DISCUSSIoN
overall, many reports have shown excellent medical outcome in terms of predict-
ability, efficacy and safety after LASIK.6, 19-25 Consequently, this has led to high 
patient satisfaction rates which range from 82% to 98% in recent studies.3-6 Patient 
satisfaction has been shown to remain high, also beyond the initial 6-month 
follow-up period.26
our study likewise showed an excellent medical outcome with a good predict-
ability and 86.8% of eyes within ± 0.5 D and 97.0% within ± 1.0 D from 
emmetropia. The mean score for the overall satisfaction was 4.10 ± 0.71 on a 
scale of 0 to 5 (a score of 5 meaning that the patient was totally satisfied). More 
than 90% of patients felt that their main goal of surgery had been achieved and 
would make the same decision if they could do it all over again. We observed 
direct correlations between subjective quality of vision scale scores and clinical 
parameters. The uncorrected vision score was directly correlated with the mean 
postoperative SE and the mean postoperative refractive astigmatism. In general, 
patients were more satisfied with a postoperative SE close to emmetropia. Similar 
findings have been shown in a previous study.1, 2
our study did not show a relation between increased age and decreased overall 
satisfaction. However, similar to previous studies, there was a relation between 
increased age and lower uncorrected vision scores.4, 6, 10 
Despite excellent medical outcome results and high patient satisfaction, quality 
of vision problems such as NVCs, glare and halos remain a problem. These 
problems have been reported in many clinical studies after refractive surgery, 
ranging from 12% to 57% in patients.2, 6, 10, 11, 27, 28 NVCs and problems from 
glare often diminish after the first six postoperative months.8, 10 In our study 
patients also appeared to have significant NVCs presenting as glare and affecting 
night driving. But, despite the high score of NVCs, 92.3% of patients reported 
that they would choose the same type of surgery again if they had to make 
their choice a second time. A possible explanation is that this is the result of a 
gradual adaptation to a new condition. Patients who wore rigid gas-permeable 
contact lenses and glasses before surgery might show an easier acceptance and 
an increased level of tolerance to glare and halos (57% of patients reported to 
have worn rigid gas permeable contact lenses at least six months preoperatively).2 
Another hypothesis is that patients get used to their altered night vision, with a 
consequential decrease in reported NVCs as shown in a previous study, which 
showed that NVCs decreased significantly over the first postoperative year.10
our study used a questionnaire which was self-administered by our patients, 
after they were sent to them by an independent physician, without verbal encour-
agement. We feel that self-administered tests, rather than physician-administered 
tests, enable a more objective view of patient satisfaction and quality of vision. 
When a test is administered by a physician, results may be biased and patients 
might feel compelled to always answer in the affirmative.2
Tahzib_Boek_06.indb   94 11-8-2008   11:32:32
95Satisfaction and LASIK
A limitation in our study was the lack of a more uniform postoperative interval 
for administering the questionnaire to our patients. Patient perception changes 
over time, due to both psychological factors and corneal healing. In addition to 
this, a longer follow up time makes it more difficult for a patient to accurately 
compare his / her preoperative and current quality of vision. A more proper 
analysis would have been made through administering the questionnaire preop-
eratively and again at a uniform postoperative interval.
Previous studies have designated the pupil size as a significant predictor of glare 
and halos after LASIK, especially in the first postoperative month.8, 17, 29 However, 
at six months postoperatively pupil size was not found to be a significant predictor 
anymore.8 Large pupils tend to increase the exposure of corneal aberrations, which 
can reduce visual acuity in LASIK patients and untreated patients as well.30, 31 
Smaller pupils have been associated with improved vision in patients after refrac-
tive surgery and in untreated patients.32 Although a thorough literature review 
on PRK and LASIK strongly suggests that a large pupil in combination with a 
small optical zone is a dominant factor leading to increased NVCs,33 recent data 
show that the correlation between pupil size and NVCs or between NVCs and 
the pupil-optical zone disparity is much less critical than previously thought.2, 6, 
8-10, 12, 33 Similar to these studies, our study of primarily conventional treatments 
and a small subset of wavefront-guided treatments, also showed no significant 
correlation between pupil size and glare or NVCs. 
Therefore, we feel that the precise role of pupil size and its exact relation to 
NVCs still remains unknown and controversial. Although pupil size quantifica-
tion has been previously described by various authors, further development and 
standardization of preoperative pupil size measurements is imperative to better 
define the exact role of pupil size in NVCs.2, 9, 10, 16, 18, 33-35 objective quantifica-
tion of NVCs also needs further elaboration, which remains difficult and faces 
us with challenges and limitations concerning the precise analysis of its nature. 
Previous authors have questioned whether the risk of NVCs is really attributable 
to LASIK or whether the general population has the same prevalence of NVCs. 
Questions have also arisen as to the possible roles of changes in the transition 
zone and of central neural adaptation in the slow decrease of NVCs.2, 36 Finally, 
the contribution of flap size and centration issues related to NVCs have been 
questioned.6, 9, 10, 12
In contrast to an earlier study, we found no correlation between the glare or night 
vision scores and the preoperative and postoperative corneal curvatures.6 We did 
show a correlation between the uncorrected vision score and the postoperative SE 
and refractive astigmatism values: the lower the postoperative residual refractive 
error was, the happier our patients were with their self-perceived uncorrected 
vision.
Interestingly, our results show that the mean score for patients wearing glasses for 
quality of daytime vision (2.95 ± 1.08) was slightly lower than the mean score 
for night vision for all patients (3.1 ± 0.7). This might be partially explained by 
the fact that these patients’ expectations were not fulfilled, i.e. to be spectacle-
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independent postoperatively, and therefore rated their satisfaction with their 
daytime vision as less.
In conclusion, our study demonstrates high patient satisfaction after LASIK 
surgery for the correction of myopia and myopic astigmatism. We show that 
this can be achieved when we aim for a postoperative SE close to emmetropia 
in combination with low residual postoperative astigmatism. No relation was 
found between the glare or night vision scores and the degree of correction, 
ablation depth or pupil-optical zone disparity. We agree with previous authors 
that further investigation needs to be done as to the objective quantification of 
pupil size and the assessment of NVCs.
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ABSTRACT
Purpose: To determine patient satisfaction after Artisan phakic intraocular lens (PIoL) 
implantation to correct myopia.
Design: Non-comparative prospective case-series.
Methods: one hundred and twenty eyes of 60 patients who had undergone Artisan PIoL 
implantation to correct myopia were analyzed. A validated questionnaire consisting of 
66 satisfaction items were self-administered by patients 12 months after surgery. Clinical 
parameters (PIoL decentration, the difference between pupil size and PIoL optical zone 
and optical aberrations) were measured. Main outcome measures were satisfaction scale 
scores (global satisfaction, quality of uncorrected and corrected vision, night vision, 
glare, day and night driving) and were analyzed. Correlations with clinical parameters 
were obtained. 
Results: After surgery, 98.3% of patients were satisfied and 73.3% considered their night 
vision to be the same or better; 44.1% reported more bothersome glare. The night vision 
score correlated with spherical aberration (r = -0.303, P = 0.020). The glare score corre-
lated with the difference between scotopic pupil size and PIoL optical zone (r = -0.280, 
P = 0.030) and vertical coma (r = -0.337, P = 0.009). The night driving score correlated 
with postoperative spherical equivalent (r = 0.375, P = 0.009), total root mean square 
aberrations (RMS) (r = -0.337, P = 0.017), higher order RMS (r = -0.313, P = 0.027) 
and vertical coma (r = -0.297, P = 0.036). 
Conclusion: overall satisfaction after Artisan PIoL implantation for myopia is excel-
lent. The quality of night vision and night driving were related to scotopic pupil size, 
individual higher order aberrations and residual refractive error.
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INTRoDUCTIoN
In general, high levels of patient satisfaction are reported after refractive surgery 
including photorefractive keratectomy (PRK), laser assisted in situ keratomi-
leusis (LASIK)1-8 and phakic intraocular lens implantation (PIoL).9, 10 However, 
numerous studies have outlined a decreased quality of vision after refractive 
surgery which may be attributed to contrast sensitivity loss and subsequent night 
vision complaints (NVCs). Proposed mechanisms for this decrease in quality of 
vision have been the use of small optical zones in patients with large preoperative 
scotopic pupil sizes and highly oblate corneal profiles after laser surgery.2, 11-14 
After corneal laser surgery it may be difficult to determine the exact effective 
optical zone size due to variations in the transition zones of current excimer 
lasers. Therefore, it is often difficult to establish the disparity between the optical 
zone size and the scotopic pupil size. In addition, in contrast to previous assump-
tions, several recent reports show that a large pupil size is probably not a major 
risk factor for NVCs after LASIK surgery.4, 5, 14, 15 
The purpose of this study was to assess patient satisfaction and to determine 
possible risk factors for the development of NVCs after Artisan PIoL implanta-
tion. The Artisan PIoL is a lens with a fixed optical zone of 5 or 6 mm, depending 
on the dioptric power of the lens, and is used for the correction of moderate to 
severe myopia. The risk factors that were investigated included the preoperative 
pupil size under dim light conditions, the disparity between the pupil size and 
the optical zone of the PIoL and the decentration of the PIoL. The presence of 
postoperative higher order aberrations (HoAs) was also assessed.
PATIENTS AND METHoDS
Questionnaire and study design
The study and data accumulation were carried out with approval from the Institu-
tional Review Board from the Academic Hospital Maastricht, the Netherlands.
The questionnaire used in our study was developed and validated by Brunette 
et al. and has been previously used for the evaluation of patient satisfaction after 
PRK and to assess postoperative visual symptoms.1, 16 The questionnaire was 
translated into the Dutch language from the original English without changes to 
the contents and construction of the original questionnaire. Later it was trans-
lated back into English, after which original and backtranslated versions were 
compared and minor inconsistencies were corrected. The instrument has proven 
to be reliable by a high level of internal consistency with Cronbach’s alpha coef-
ficients superior or equal to 0.83.5, 16 In the questionnaire, 66 items were self-
administered by the patients 12 months after the PIoL implantation procedure. 
For analysis purposes, these items were reformulated by applying factor analysis 
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into seven distinct scales.16 Scale scores increased with satisfaction, ranging from 
1 (very dissatisfied) to 5 (very satisfied). Each of the seven scales covered a specific 
aspect of quality of vision, including global satisfaction, quality of uncorrected 
and corrected vision, quality of night vision, glare, daytime driving and night 
driving.
Before the routine examination, the questionnaire was provided to the patient by 
an independent employee who had no interest or involvement with the patient 
and whom requested him / her to fill in the questionnaire. Patients were informed 
about the study procedure and provided informed consent.
Surgical procedure
All treatments were performed by a single surgeon (R.N.) at the Academic 
Center for Refractive Surgery, University Eye Clinic of Maastricht.
Exclusion criteria were a preoperative best-corrected visual acuity (BCVA) < 
20/50, an anterior chamber depth < 3.0 mm (determined by immersion A-scan 
biometry method), an endothelial cell count lower than 2000 cells/mm2 (Noncon 
RoBo Pachy SP-9000, Konan Medical Inc, Tokyo, Japan), glaucoma and retinal 
pathology.
The Artisan iris claw-fixated PIoL has a convex-concave polymethyl meth-
acrylate optic with either a 6-mm (for intraocular lens powers up to –15.5 D) 
or a 5-mm (for intraocular lens powers from –16.0 D up to –24.0 D) and is 
available in 0.50 D steps (ophtec B.V., Groningen, the Netherlands). Refractive 
error, refractive cylinder power, anterior chamber depth, and topographically 
derived keratometric dioptric values (orbtek orbscan II, version 3.10.31, Bausch 
& Lomb, Munich, Germany) were inserted into the Van der Heijde formula to 
calculate the dioptric power of the lens.17 The power of the lens was chosen to 
obtain emmetropia. When the emmetropic lens was not available, the power of 
the lens was estimated for a slight residual myopia. 
Surgery was performed under general anaesthesia. A two-plane 6.3 or 5.3 mm 
corneoscleral incision was centered at 12-o’clock. Two stab-incisions were 
performed at 2 and 10 o’clock and directed towards the enclavation sites. After 
an intracameral injection of acetylcholine and the insertion of a viscoelastic 
substance (Healon GV, Pharmacia, Uppsala, Sweden), the lens was introduced 
with a Budo forceps (Duckworth and Kent, Ltd, Baldock Herts, England). After 
subtle rotation of the lens, it was fixated in the horizontal axis with the use 
of a disposable enclavation needle (ophtec BV, Groningen, Netherlands). A 
slit iridotomy was performed at 12 o’clock to avoid pupillary block glaucoma. 
The viscoelastic substance was exchanged for balanced salt solution (Alcon, Fort 
Worth, Texas). The wound was sutured with 3 to 5 interrupted 10-0 nylon 
sutures (Alcon, Fort Worth, Texas). Postoperatively, topical tobramycin 0.3% 
combined with dexamethasone 0.1% (Tobradex, Alcon, Couvreur, Belgium) and 
ketorolactrometamol 0.5% (Acular, Westport Co., Mayo, Ireland) were used four 
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times daily for 3 weeks in a tapered schedule and three times daily for 1 week, 
respectively. Selective suture removal was performed depending on the subjec-
tive refraction. 
A surgical delay of one month between both eyes was established for all patients. 
Included patients showed a stable postoperative refraction and were examined 
preoperatively and at day 1, week 1, month 1, month 3, month 6, and from then 
at 6-month intervals. The routine examination consisted of the measurement of 
the Snellen UCVA and BCVA using subjective and manifest refraction, corneal 
topography, and intraocular pressure measurement with Goldmann applanation 
tonometry. Because no binocular visual acuity measurement was available, the 
UCVA and BCVA of the best eye were used for all calculations. When scales such 
as night vision, glare and night driving were assessed, the UCVA and BCVA of 
the worst eye were used. 
Pupil and wavefront measurements
The scotopic and mesopic-low pupil size was measured with a digital infrared 
pupillometer (P2000 SA pupillometer, Procyon Instruments Ltd., London, UK). 
This device performs binocular simultaneous measurements of the pupil diameter 
at 3 illuminance levels (scotopic [0.04 lux], mesopic-low [0.4 lux], and mesopic-
high [4.0 lux]). At each illuminance level, a sequence of 10 images is acquired 
within 2 seconds and stored in a portable computer.18 
Wavefront measurements were performed with a Hartmann-Shack wavefront 
sensor (Zywave aberrometer, software version 3.21, Bausch & Lomb-Technolas, 
Munich, Germany). The Zywave aberrometer uses a wavelength of 780 nm 
and an array of approximately 70 to 75 lenslets. Three Zywave measurements 
were taken under standardized mesopic light conditions after installation of 
phenylephrine 5% (Bournonville Pharma BV, the Hague, the Netherlands) and 
analyzed using the provided software. To avoid instrument accommodation, the 
eye is fogged about 1.0 diopter (D) during measurements. Wavefront errors were 
described using Zernike polynomials for a virtual pupil diameter of 6 mm that 
resembles pupil size under mesopic conditions. The Zywave measurements allow 
a Zernike approximation from second order to fifth order for 6-mm pupils. The 
aberrations used in this study are classified in terms of total root mean square aber-
rations (total RMS) of the wavefront error and higher-order aberrations (HoAs), 
including total higher order root mean square (total Ho-RMS) of the wavefront 
error, horizontal coma (Z
3
1), vertical coma (Z
3
-1), trefoil-x (Z
3
3), trefoil-y (Z
3
-3) 
and spherical aberration (SA) (Z
4
0).19-21
Data analysis
LogMAR values of the UCVA and the BCVA of the best eye were used for 
calculations.
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The amount of decentration of the PIoL was determined by measuring the 
deviation of the center of the PIoL from the center of the pupil using the 
digital photography mode within the Zywave aberrometer. The pupil-optical 
zone disparity, which is defined as the disparity between the pupil size and the 
optical zone of the PIoL, was calculated by subtracting the optical zone of the 
PIoL from the scotopic and mesopic-low pupil size as measured by the Procyon 
pupillometer. For parameters expected to have an adverse effect in relation to 
glare and NVCs, such as preoperative pupil size, the pupil-optical zone disparity, 
and the decentration of the PIoL, the greatest value of both eyes were taken 
for analysis. Wavefront analysis was performed for pupil diameters of 6.0 mm. 
Zernike coefficients up to the 4th order are currently included in the measure-
ments. Calculations were performed using total RMS, total Ho-RMS, hori-
zontal coma, vertical coma, trefoil-x, trefoil-y and SA. Changes in the quality 
of vision scale scores were determined by defining correlations with total HoAs 
and individual HoAs.
For statistical analyses, results from the wavefront examinations were transformed 
into absolute values and Snellen visual acuities were transformed to LogMAR 
values. 
Correlations between the scale scores and clinical parameters were performed 
for data obtained at the 12 month follow-up examination and assessed with the 
Pearson r coefficient of correlation and the Spearman rank correlation (SPSS for 
Windows, SPSS Inc., Chicago, IL). The Mann-Whitney test was used to compare 
satisfaction score differences between spectacle and non-spectacle or contact lens 
wearers before or after surgery. The ANoVA test was used to compare differ-
ences between patient age and the satisfaction scales. All values in the text are 
mean ± standard deviation (SD).
RESULTS
A total of a hundred and twenty eyes of 60 consecutive patients were included in 
this study. The patient group consisted of 39 females (65%) and 21 males (35%). 
Population characteristics and scale scores are listed in Tables 1 and 2. Data were 
provided only for patients subjected to the particular condition.
Patient satisfaction and self-perceived outcome. Before surgery, 71.7% of 
patients wore contact lenses on a regular basis. The most frequently reported 
motivations for desiring surgical correction were a general dislike of handling 
glasses (33.9%), intolerance to contact lens wear (18.6%), to be less dependent on 
glasses (15.3%), and a dislike of handling contact lenses (6.8%).
Global satisfaction. The mean overall satisfaction score was 4.22 ± .56 (5 
meaning totally satisfied). The majority of patients (96.7%) reported that their 
main goal of surgery had been achieved; 98.3% of patients were satisfied or very 
satisfied with the result of surgery; 98.3% reported that the surgery had been a 
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Table 1. Characteristics of Patient Population who received Artisan Phakic Intraocular 
Lens Implantation for the Correction of Myopia.
Characteristics
Mean ± SD  
or % of patients
Median Range
Age (yrs) 44.3 ± 8.7 45.0 26 to 63
Female 65.0%
Before surgery (n = 120 eyes of 60 patients)
Mean sphere (D) -11.14 ± 3.99 -10.50 -24.50 to -4.75
Mean cylinder (D) -0.97 ± 0.89 -0.75 -4.25 to 0.75
Mean SE (D) -12.09 ± 4.09 -10.88 -5.63 to -27.25
-12.00 ≤ SE < -5.63 61.7%
-18.00 ≤ SE < -12.00 30.0%
-27.25 ≤ SE < -18.00 8.3%
BCVA 20/20 or better 44.0%
BCVA between 20/20 and 20/40 39.9%
BCVA 20/40 or worse 16.1%
Mean pupil diameter (mm) (scotopic) 6.2 ± 0.79 6.2 4.6 to 7.6
At 12 months FU (n = 120 eyes of 60 patients)
UCVA 20/20 or better 25.8%
UCVA between 20/20 and 20/40 42.5%
UCVA 20/40 or worse 31.7%
Loss of 1 Snellen line of BCVA 5.8%
Loss of 2 Snellen lines of BCVA 0.8%
Gain of 2 Snellen lines or more of BCVA 23.3%
At 12 months FU (n = 120 eyes of 60 patients)
Refractive outcome
Mean SE (D) -0.60 ± 0.78 -0.50 -3.50 to 0.75
Mean SE ± 0.50 D of emmetropia 62.4%
Mean SE ± 1.00 D of emmetropia 81.5%
SD = standard deviation; D = diopter; SE = spherical equivalent; BCVA = best-corrected 
visual acuity; FU = follow-up; UCVA = uncorrected visual acuity.
Table 2. Scale Scores Descriptives after Artisan Phakic Intraocular Lens Implantation for 
the Correction of Myopia.
Scale Mean ± SD* Range
Global satisfaction 4.2 ± 0.56 1.9 - 5.0
Uncorrected daytime vision 3.2 ± 0.87 1.6 - 5.0
Corrected daytime vision 3.5 ± 0.90 2.0 - 5.0
Night vision 3.2 ± 0.65 1.6 - 4.4
Glare 3.0 ± 0.84 1.4 - 5.0
Daytime driving 4.7 ± 0.87 1.0 - 5.0
Night driving 3.2 ± 1.31 1.0 - 5.0
*Scores 0-5 (5 meaning totally satisfied). SD = standard deviation.
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good choice for them; 93.3% postoperatively experienced a quality of vision as 
they had expected; for 70.0% of patients, the best consequence of surgery was that 
they no longer felt dependent on their glasses or contact lenses. After surgery, no 
significant difference in global satisfaction was shown between patients wearing 
spectacles or contact lenses for distance vision (4.12 ± 0.64, n=36) and those who 
did not wear any type of correction (4.35 ± 0.44, n=24) before surgery.
Quality of daytime vision without correction. The mean score was 3.20 
± 0.87; 50.0% of patients reported that after surgery their self-perceived uncor-
rected vision for distance was slightly or much better than their preoperative 
corrected vision, 21.7% of patients considered it the same and 28.3% of patients 
reported it as being slightly or much worse.
Uncorrected near vision was characterized as slightly or much better than the 
preoperative corrected near vision by 28.3% of patients, the same by 37.3% of 
patients and slightly or much worse by 35.0% of patients.
Quality of daytime vision with correction. The majority of patients 
(73.3%) wore contact lenses before surgery; 26.7% of patients wore spectacles. 
After surgery, regular use of glasses for distance vision and near vision and of 
contact lenses was reported by 38.3% (n=23) and 38.3% (n=23), and 1.7% (n=1) 
of patients, respectively. The mean score for patients wearing glasses for quality of 
daytime vision was 3.47 ± 0.90. There was no correlation between the corrected 
vision score and patient age (r = -0.289, P = 0.087).
Quality of night vision. The mean night vision score was 3.16 ± 0.65. After 
surgery, 58.4% of patients were satisfied with their night vision. In comparison 
to before surgery, 73.3% of patients considered their night vision after surgery to 
be the same or better; 26.7% of patients considered it to be worse or much worse. 
NVCs after surgery included perception of stars around lights (41.7%), halos, 
fog, or haze around street lights (48.4%), double outline of images (6.7%), ghost 
images (8.3%), and distortion of details (33.3%). Patients recalled such symptoms 
before surgery in 33.3%, 35.0%, 6.6%, 6.7% and 21.6% of cases, respectively. 
Glare. The mean glare score was 3.02 ± 0.84. only one patient (1.7%) showed 
a score of 5 for the glare scale (totally satisfied). Patients reported glare or light 
sensitivity on sunny days, snowy weather conditions, foggy conditions, or when 
going from dim to bright light conditions in 50.8%, 42.6%, 12.5% and 35.0%, 
respectively. After surgery, daytime glare and glare from lights at night were 
considered more bothersome than before surgery by 32.8% and 44.1% of patients, 
respectively. Glare from oncoming car headlights was reported by 68.4% and 
believed to be more bothersome for night driving than before surgery by 
55.8%.
Driving. A total of 51 patients (85.0%) reported driving a car. The mean daytime 
driving score was 4.66 ± 0.87. The mean night driving score was 3.22 ± 1.31. 
A daytime and night driving score of 5 was reported by 80.4% and 15.7% of 
patients, respectively. 
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After surgery, 51% of patients reported to experience night driving problems, 
while 39.2% of patients reported having more difficulty during night driving 
than before surgery and 56.9% of patients reported having less difficulty. 
Correlations between Satisfaction Scales and Clinical Parameters.
Visual acuity. At the 12 month follow-up, 25.8% of eyes had an UCVA of 
20/20 or better and 76.6% had a UCVA of 20/40 or better (Table 1). Preopera-
tively, 44.0% had a BCVA of better than 20/20 and 90.6% had a BCVA of 20/40 
or better. There was a loss of 1 Snellen line of BCVA in 5.0% of eyes and a loss of 
2 Snellen lines of BCVA in 0.8% of eyes. In addition, there was a gain of at least 
2 Snellen lines of BCVA in 23.3% of eyes. 
The mean LogMAR UCVA of the best eye at the time of the questionnaire 
was 0.14 ± 0.17 and showed a correlation with the uncorrected vision score (r = 
-0.346, P = 0.007) (Table 3) (Figure 1). The mean preoperative LogMAR BCVA 
of the best eye was 0.07 ± 0.12 and did not correlate with any of the satisfaction 
scales. The mean difference between the preoperative LogMAR BCVA and the 
postoperative LogMAR UCVA was 0.07 ± 0.15 and showed a negative correla-
tion with the uncorrected vision score (r = -0.419, P = 0.001). The mean differ-
ence between the pre- and postoperative LogMAR BCVA was -0.09 ± 0.09. 
Refraction. Surgery was aimed at the correction of myopia. Preoperatively, the 
mean spherical equivalent (SE) was -12.09 ± 4.09 D. After surgery, the mean SE 
was -0.60 ± 0.78 D. In the population, 62.4% was within ± 0.5 D, and 81.5% 
was within ± 1.0 D from emmetropia, respectively. The postoperative sphere 
and SE showed a positive correlation with night driving (r = 0.309, P = 0.034 
and r = 0.375, P = 0.009, respectively). The postoperative cylinder showed a 
positive correlation with the uncorrected vision score (r = 0.417, P = 0.001). The 
difference in the postoperative SE between eyes was 0.08 ± 0.63 D and showed 
a negative correlation with global satisfaction and night driving (r = -0.336, P = 
0.009 and r = -0.351, P = 0.012 respectively). There was no correlation between 
night vision and the preoperative dioptric power (r = 0.060, P = 0.659) or the 
PIoL optical zone size (r = -0.041, P = 0.754).
Lens decentration. The mean ± SD amount of decentration of the PIoL was 
0.36 ± 0.14 mm (range 0.14 mm to 0.74 mm). Considering the centration of the 
PIoL on the center of the pupil, 86.4% was placed within 0.5 mm, and 100% was 
within 0.75 mm from the center, respectively. The amount of PIoL decentration 
showed a weak positive correlation with glare (r = 0.267, P = 0.041). There was 
no correlation between HoAs and the amount of decentration of the PIoL.
Pupil size and pupil-IOL optical zone disparity. Mean scotopic and 
mesopic-low pupil sizes for all eyes were 6.2 ± 0.79 mm (range, 4.6 to 7.6 mm) 
and 5.2 ± 0.79 mm (range, 3.5 to 7.2 mm), respectively. The scotopic and the 
mesopic-low pupil size showed a positive correlation with the uncorrected vision 
score (r = 0.273, P = 0.035 and r = 0.276, P = 0.033, respectively). The scotopic 
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and mesopic-low pupil-optical zone disparity showed a positive correlation with 
the uncorrected vision score (r = 0.340, P = 0.008 and r = 0.325, P = 0.011, 
respectively) and the corrected vision score (r = 0.362, P = 0.030 and r = 0.389, P 
= 0.019, respectively). The scotopic pupil size and the scotopic pupil-optical zone 
disparity showed a weak negative correlation with glare (r = -0.256, P = 0.049 
and r = -0.280, P = 0.030, respectively) (Figure 2). There was no correlation 
between pupil size and night vision or night driving scores (Table 3). 
Aberrations. All aberration measurements for the eye with the best UCVA and 
quality of vision scale scores are shown in Tables 4 and 5. The night vision score 
showed a positive correlation with spherical aberration (SA, Z
4
0) (r = 0.303, P = 
0.020). The glare score showed a negative correlation with total Ho-RMS and 
vertical coma (r = -0.284, P = 0.029; r = -0.337, P = 0.009) (Figure 3). The night 
driving score showed a negative correlation with total RMS, Ho-RMS and 
vertical coma (r = -0.337, P = 0.017; r = -0.313, P = 0.027; r = -0.297, P = 0.036, 
respectively) (Figure 4). The mesopic-low pupil size showed a positive correla-
tion with vertical coma (r = 0.274, P = 0.036). The amount of PIoL decentration 
showed a positive correlation with horizontal coma (r = 0.298, P = 0.022).
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Table 4. Aberration Descriptives after Artisan Phakic Intraocular Lens Implantation for the 
Correction of Myopia.
Type (µm) Mean ± SD Range
Total RMS 3.73 ± 1.73 1.32 – 7.77
Total Ho-RMS 1.05 ± 0.52 0.35 – 3.34
Horizontal coma (Z
3
1) 0.48 ± 0.34 0.01 – 2.30
Vertical coma (Z
3
-1) 0.36 ± 0.36 0.00 – 2.45
Trefoil-x (Z
3
3) 0.29 ± 0.19 0.02 – 0.89
Trefoil-y (Z
3
-3) 0.28 ± 0.26 0.01 – 0.82
SA (Z
4
0) 0.64 ± 0.33 0.13 – 1.89
SD = standard deviation; RMS = root mean square of the wavefront error; Ho-RMS = 
higher order root mean square of the wavefront error; SA = spherical aberration.
Table 5. Correlation Coefficients between Aberrations and Night Vision, Glare, Night 
Driving and Clinical Parameters after Artisan Phakic Intraocular Lens Implantation for the 
Correction of Myopia.
Total RMS Ho-RMS Z
3
1 Z
3
-1 Z
3
3 Z
3
-3 Z
4
0
Night Vision -0.208 -0.189 0.003 -0.179 0.067 0.013 -0.303*
Glare -0.180 -0.284* -0.029 -0.337† -0.060 -0.285* -0.228
Night Driving -0.337* -0.313* -0.211 -0.297* -0.073 -0.186 -0.257
Scotopic pupil (mm) 0.049 0.058 -0.033 0.181 -0.033 0.125 0.048
Mesopic-low pupil 
(mm)
0.071 0.068 -0.066 0.274* -0.057 0.124 -0.016
Scotopic PIoL 
disparity (mm)
0.097 -0.010 -0.112 -0.132 0.074 0.088 -0.066
Mesopic-low PIoL 
disparity (mm)
0.110 -0.007 -0.140 0.203 0.043 0.079 -0.121
Decentration PIoL 
(mm)
-0.057 0.103 0.298* -0.014 0.130 -0.053 0.035
RMS = root mean square; Ho-RMS = higher order root mean square; Z
3
1 = horizontal 
coma; Z
3
-1 = vertical coma; Z
3
3 = trefoil-x; Z
3
-3 = trefoil-y; Z
4
0 = spherical aberration; 
PIoL = phakic intraocular lens. † P < 0.01 level; * P < 0.05.
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Figure 3. Glare score versus vertical coma 
(Z
3
-1) after Artisan Phakic Intraocular Lens 
Implantation; 
r = -0.337, P = 0.009
Figure 1. Uncorrected vision score 
versus uncorrected visual acuity (UCVA) 
(LogMAR) at 12 months follow-up (LFU) 
after Artisan Phakic Intraocular Lens 
Implantation; 
r = -0.346, P = 0.007
Figure 2. Glare score versus scotopic 
pupil-optical zone disparity after Artisan 
Phakic Intraocular Lens Implantation; 
r = -0.280, P = 0.030
Figure 4. Night driving score versus vertical 
coma (Z
3
-1) after Artisan Phakic Intraocular 
Lens Implantation; 
r = -0.297, P = 0.036 
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DISCUSSIoN
In this study we analysed patient satisfaction and self-perceived quality of vision 
after Artisan phakic intraocular lens (PIoL) implantation for the correction of 
moderate to high myopia. 
For this purpose, a self-administered validated questionnaire was applied, which 
represented the quantification of perceived quality of vision after refractive 
surgery. The study demonstrated that overall patient satisfaction after the Artisan 
PIoL implantation procedure was excellent and showed comparable results to 
previous PIoL studies. 9, 10, 22 The results were also comparable to laser refractive 
surgery studies, 1, 3-5, 10, 22 which was unexpected, since it is well known that the 
predictability of satisfaction after refractive surgery decreases when higher levels 
of myopia are treated.3 
Functional outcome results considering uncorrected visual acuity (UCVA), 
spherical equivalent (SE), and the amount of decentration of the PIoL (86.4% 
had a decentration < 0.5 mm) were comparable to previous reports regarding 
anterior chamber PIoLs for the correction of myopia (Table 6).10, 22-25
our results showed a negative correlation between the quality of vision without 
correction and the difference between the postoperative LogMAR UCVA and 
the pre-operative LogMAR BCVA. In addition, better scores for quality of 
vision without correction were correlated to higher postoperative UCVA values. 
Similar findings have also been reported in two recent patient satisfaction studies 
after laser in situ keratomileusis (LASIK) surgery for the correction of myopia.4,5
We report that after surgery, 23 patients (38.3%) regularly wore glasses for 
distance vision. We do not believe that this finding is a suboptimal result, since 
most patients aimed to be less dependent on their high power spectacles, instead 
of being totally spectacle-free.
Secondary effects such as decreased night vision and glare remain the main 
downsides after refractive surgery. our study showed that after surgery night 
vision decreased and glare increased in 26.7% and 44.1% of patients. Despite these 
complaints, overall patient satisfaction remained high with more than 90% of 
patients reporting to be generally satisfied after surgery. This value is consistent 
with several other published reports on satisfaction levels after refractive surgery 
techniques.2, 4-6, 11-15, 24, 26
Recently, night vision complaints (NVCs) occurring after laser refractive surgery 
have been correlated to the scotopic and/or mesopic-low pupil-optical zone 
disparity. Presumably, a wider optical zone or a transition zone would decrease 
the incidence of NVCs.27, 28 The disparity between the pupil size and the optical 
zone is considered to be the main source of halos, starbursts and glare. This study 
demonstrated a weak negative correlation between the scotopic pupil-optical 
zone disparity and the glare score, but not with the “real-life” mesopic-low pupil 
size. our study also showed that the scotopic and mesopic-low pupil-optical 
zone disparity correlated with the uncorrected and corrected vision score. These 
Tahzib_Boek_06.indb   112 11-8-2008   11:32:37
113Outcome and satisfaction after Artisan PIOL
correlations may be explained by the fact that in eyes with a larger pupil size, 
more light energy was directed through the corrected optical zone of the PIoL. 
This finding could indicate a possible beneficial consequence of larger pupils 
in reference to postoperative vision after refractive surgery.4, 15, 29 In addition, 
the Stiles-Crawford effect probably protects patients with a pupil-optical zone 
disparity from increased levels of glare after Artisan PIoL implantation.30 These 
issues emphasize the importance of standardized preoperative pupil size measure-
ment. 
The average PIoL decentration value was 0.36 ± 0.14 mm. In contrast to 
expectations, higher levels of PIoL decentration did not lead to increased glare, 
showing that PIoL centration on the pupil center was not a significant predictor 
of postoperative glare levels. This might be related to the fact that the pupillary 
axis is known not to coincide with the visual axis in eyes with high myopia.31 
Wavefront aberrations can objectively measure the optical quality after corneal 
laser surgery. Several studies have reported on induced aberrations after corneal 
laser surgery.21, 28, 32-34 A recent case series demonstrated no tendency towards 
deterioration of the optical performance after the insertion of an Artisan lens for 
the treatment of high myopia.35 our study demonstrated a correlation between 
the three satisfaction scales night vision, glare and night driving, and the total root 
mean square (RMS), higher-order RMS, vertical coma, trefoil-y and spherical 
aberration. Correlations were also seen between the mesopic-low pupil size and 
vertical coma and between the amount of PIoL decentration and horizontal 
coma. However, this did not lead to increased glare complaints in our patient 
population. These findings are most probably explained by the proposed change 
Table 6. Comparison of Clinical outcome Measures Between This Study and Previous 
Studies on Artisan Phakic Intraocular Lens Implantation for the Correction of Myopia.
  Studies
Clinical outcome
El Danasoury et al. 
2002
Maloney et al. 
2002
Malecaze et 
al. 2002
our Study
Number of eyes 90 155 25 120
Mean preoperative 
SE (D)
-13.93 ± 2.9 -12.69 ± 3.80 -10.19 ± 1.56 -12.09 ± 4.09
FU (mos) 12 6 12 12
UCVA ≥ 20/40 (%) 88.4 85.0 60 76.6
Mean SE ± 1.0 D 
of emmetropia (%)
65.1 90.0 60.0 81.7
Mean SE ± 0.5 D 
of emmetropia (%)
25.6 48.0 n/a 62.4
SE = spherical equivalent; D = diopters; FU = follow-up; UCVA = uncorrected visual acuity.
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in pupil dynamics after PIoL implantation, resulting in a larger vertical than 
horizontal pupil diameter after pupil dilation,36 thereby increasing the amount 
of vertical coma and other aberrations. A limitation in our study was the lack 
of preoperative wavefront measurement data, which would have enabled us to 
objectively determine the effect of PIoL implantation on wavefront aberrations. 
However, the wavefront aberrometer used in this study cannot accurately measure 
aberrations in eyes with a myopic SE of more than -12.0 D, while the average SE 
in our patient group was -12.09 D (range, -5.63 to -27.25 D).
In conclusion, patient satisfaction after Artisan PIoL implantation for myopia 
is excellent, despite the occurrence of NVCs. We feel that accurate measure-
ments of the “real-life” pupil size under dim light conditions remain vital when 
selecting suitable refractive surgery candidates. Future research and PIoL design 
modifications should aim to limit higher order aberrations and PIoL decentra-
tion effects to optimize night vision and minimize glare. Until the outcome of 
refractive surgery is fully predictable, patients should be educated on the potential 
side effects of PIoL implantation.
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ABSTRACT
Purpose: To determine the long-term performance of the Artisan phakic intraocular 
lens (PIoL) for the correction of myopia.
Design: A long-term (10 years) retrospective follow-up study.
Participants: Eighty-nine eyes of 49 patients who underwent Artisan PIoL implanta-
tion for the correction of myopia.
Methods: Comparisons were made between preoperative clinical data and the clinical 
data at 1, 6 and 10 years after surgery. 
Main Outcome Measures: Refractive stability, refractive predictability, safety, efficacy, 
best-corrected visual acuity (BCVA), uncorrected visual acuity (UCVA), intraocular 
pressure, intra-operative problems, corneal endothelial cell density (ECD), corneal 
endothelial cell loss and glare levels were evaluated.
Results: The mean spherical equivalent (SE) after 10 years was -0.70 ± 1.00 D (range, 
-4.00 to 2.00 D), with no significant change in mean SE between 1, 6, and 10 years. At 
10 years, 68.8% of all eyes were within 1.0 D of the intended correction. At 10 years, 
31.2% (n=24) gained 1 or more Snellen lines of BCVA and 2.6% (n=2) lost more than 2 
Snellen lines of BCVA; 93.3% reached a BCVA of 20/40 or better and 82.0% reached a 
UCVA of 20/40 or better. The mean intraocular pressure remained stable and was 15.5 ± 
3.5 mmHg (range, 7 to 25 mmHg) at 10 years. The mean endothelial cell loss was -8.86% 
± 16.01 (range, -51.69 to 34.43%) at 10 years.
Conclusion: Long-term results demonstrate that the implantation of an Artisan PIoL 
for the correction of moderate to high myopia is a stable, predictable and safe method 
when strict inclusion criteria for surgery are applied. There was no significant loss of 
corneal endothelial cells and no long-term glare reports.
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INTRoDUCTIoN
To be able to evaluate the results of any corneal refractive surgical technique, it 
is essential to monitor the long-term refractive stability, refractive predictability, 
safety and efficacy of that particular procedure. Several published clinical reports 
have demonstrated the excellent short-term performance of the Artisan phakic 
intraocular lens (PIoL).1-10 When evaluating surgical results of PIoL implanta-
tions, the assessment of corneal endothelial cell loss over time is an additional 
important factor in determining the long-term safety. 
The long-term accuracy of excimer laser refractive surgery is known to decline 
with higher levels of myopia.11-13 Additionally, secondary effects such as glare and 
halos are common downsides after excimer laser treatment for moderate to high 
myopia, because more corneal tissue is removed and the optical zone needs to 
be smaller to prevent excessively deep ablations.14-16 The surgical implantation of 
PIoLs offer advantages in the correction of high myopia in that they provide the 
best chance of maintaining the best-corrected visual acuity (BCVA).3, 17 Specific 
concerns related to the implantation of PIoLs are the safety of the surgical proce-
dure for the corneal endothelium, the stability of the refractive results and the 
long-term biocompatibility with the ocular tissue.7, 10
Implantations of PIoLs have been at the center of scientific interest for the 
surgical correction of moderate to high myopia, for example in patients who 
are intolerant to contact lenses and/or spectacles. of the three currently existing 
phakic lens models (iris-fixated, angle-supported and posterior chamber), we 
evaluated the Artisan iris-fixated convex-concave PIoL.
Since PIoLs are implanted in healthy and phakic eyes, it is required that the 
implanted device provides a long-term tolerance by the ocular tissues. A lack of 
reports on the long-term stability and predictability of these types of refractive 
surgery procedures remains an important issue among eye surgeons. The implan-
tation of the lens leading to chronic stress on the corneal endothelium with a 
concomitant corneal endothelial cell loss is of particular concern. Short-term 
clinical reports have demonstrated that corneal endothelial cell loss after Artisan 
PIoL implantation varies from 0.7% to 2.4% after 1 year and 0.7% to 11.7% after 
3 years.1-3, 5, 6, 8-10 
The purpose of this study was to assess the long-term (10-year) performance of the 
Artisan PIoL for the correction of moderate to severe myopia. The Artisan PIoL 
is a lens with a fixed optical zone of 5.0 or 6.0 mm, depending on the dioptric 
power of the lens. The main outcome measures that were investigated included 
refractive stability, refractive predictability, safety, efficacy, BCVA, uncorrected 
visual acuity (UCVA), intraocular pressure, intra-operative problems and corneal 
endothelial cell loss over a period of 10 years.
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METHoDS
Patient population and study design
Patients were originally identified and had surgery in 1991. The initial study 
group consisted of 177 eyes of 89 patients who had undergone surgical implanta-
tion of an Artisan PIoL for the correction of moderate to high myopia. of the 
original group of 177 eyes of 89 patients, a group of 89 eyes of 49 patients were 
evaluated 1, 6 and 10 years after the surgical procedure. Data from the remaining 
88 eyes were excluded from analyses in the study, because of differing time points 
of clinical evaluation.
Comparisons of pre- and postoperative clinical data were made for all eyes. 
Institutional Review Board approval was obtained from the Academic Hospital 
Maastricht.
Inclusion criteria
Included patients had a stable refraction during the previous 2 years, an anterior 
chamber depth of 3.0 mm or more; an endothelial cell density (ECD) count of 
2000 cells/mm2 or more, a normal pupil and iris configuration; no history of 
glaucoma, no pre-existent corneal, lenticular or retinal pathology likely to alter 
vision and no history of chronic or recurrent uveitis. 
Clinical evaluation
Pre- and postoperatively, subjective and objective refraction was determined by 
measurement of the Snellen UCVA and BCVA. Slit-lamp microscopy, Gold-
mann applanation tonometry and fundus examination were performed. Pupil 
sizes were measured under mesopic conditions using the Goldmann visual field 
analyzer (Haag Streit, Bern, Switzerland).
Endothelial cell density
All ECD counts were performed by one independent employee. ECD counts 
were determined by manual counting before and after surgery using a specular 
microscope (Topcon SP-1000 and SP-2000P Non-Contact Specular Micro-
scope, Topcon Corp., Tokyo, Japan). During measurements, three consecutive 
endothelial images were obtained. The estimated ECD for each eye was measured 
using the mean value of the three consecutive ECD measurements. ECD loss was 
defined as the decrease in cell density between the preoperative examination and 
the postoperative (e.g. 1, 6 and 10 year) examination, expressed as a percentage 
of the preoperative ECD. 
Tahzib_Boek_06.indb   122 11-8-2008   11:32:38
123Artisan long term results
Surgical procedure
All surgical treatments were performed by one surgeon (C.B.) in a private clinic 
in St. Truiden, Belgium. The power of the PIoL was calculated using the Van 
der Heijde formula, which uses the mean corneal curvature (K), adjusted anterior 
chamber depth (ACD) (= ACD - 0.8 mm), and SE of the patient’s spectacle 
correction at a 12.0 mm vertex.18 The Artisan iris-fixated PIoL has a convex-
concave polymethyl methacrylate optic which is available with an optic of either 
a 6-mm (for intraocular lens powers up to –15.5 D) or 5-mm (for intraocular lens 
powers from –16.0 D up to –24.0 D) (ophtec B.V., Groningen, the Netherlands). 
For this study, only the Artisan myopia 5-mm optic lens (model 206) was used. 
The lens is 8.5 mm in overall length and has a vault of 0.8 mm, and is available 
in powers from -5.0 to -20.0 D. Before 1997, the lens was available in only 1.0 
D power increments; since 1997, it has been available in 0.5 D increments. The 
Artisan PIoL is positioned in the anterior chamber and held in place by fixation 
to the midperipheral iris stroma, creating a bridge over the optical axis. 
For all cases, surgery was performed under general anaesthesia. All eyes received 
identical surgical treatment. A two-plane 6.3 mm corneoscleral incision was 
centered at 12-o’clock. Two paracenteses were placed at 2- and 10 o’clock and 
directed towards the enclavation sites. Miosis was achieved through preoperative 
instillation of pilocarpine (Isopto® Carpine, Alcon, Fort Worth, Texas) and a 
peroperative intracameral injection of acetylcholine 1.0% (Miochol®, Bournon-
ville Pharma, The Hague, Netherlands) in order to prepare the iris for PIoL 
fixation, reduce the risk of lens-touch during implantation, and facilitate centra-
tion of the PIoL. A viscoelastic substance (Healon GV®, Pharmacia, Uppsala, 
Sweden) was inserted through the paracenteses and primary incision to main-
tain sufficient ACD, protect the endothelium, and facilitate adjusting the PIoL 
within the eye during fixation. The PIoL was introduced with a Budo forceps 
(Duckworth and Kent, Ltd, Baldock Herts, England). After subtle rotation of the 
PIoL, it was fixated in the horizontal axis with the use of a disposable enclavation 
needle (ophtec BV, Groningen, Netherlands). A slit iridotomy was performed 
at 12 o’clock to avoid pupillary block glaucoma. The viscoelastic substance was 
exchanged for balanced salt solution (Alcon, Fort Worth, Texas). The wound 
was sutured with 3 to 5 interrupted 10-0 nylon sutures (Alcon, Fort Worth, 
Texas). Postoperatively, topical tobramycin 0.3% combined with dexamethasone 
0.1% (Tobradex®, Alcon, Couvreur, Belgium) and ketorolactrometamol 0.5% 
(Acular®, Westport Co., Mayo, Ireland) were used four times daily for 3 weeks 
in a tapered schedule and three times daily for 1 week, respectively.
Glare
Glare levels were assessed using a questionnaire that has been previously used for 
the evaluation of patient satisfaction after refractive surgery.16, 18-20 The instrument 
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has proven to be reliable by a high level of internal consistency with Cronbach’s 
alpha coefficients superior or equal to 0.83. Glare scale scores ranged from 1 (high 
glare levels) to 5 (no glare).
Statistical analysis
BCVA in LogMAR was used for data reports, meaning, the lower the value the 
better the vision. Statistical analysis and comparisons between preoperative and 
postoperative data and between individual postoperative years were performed 
by paired students t-tests (P < 0.05 being significant) (SPSS for Windows, SPSS 
Inc., Chicago, IL). All values in the text are mean ± standard deviation (SD). 
Data from clinical evaluations at postoperative years 1, 6 and 10 years were used 
for analysis.
A linear decrease of 0.6% physiologic loss per year was applied for the preopera-
tive ECD value, after which paired t-tests were used to compare postoperative 
ECD values with the preoperative ECD values.
RESULTS
Patient population
Thirty-four patients were female and 15 were male. The mean preoperative age 
for all patients was 38.3 ± 10.5 years (range, 19 to 61 years). Population charac-
teristics are listed in Table 1.
The baseline parameters for all 89 eyes were a mean sphere of -9.78 ± 4.43 D 
(range, -3.50 to -25.00 D), a mean refractive cylinder of -1.26 ± 1.40 D (range 
-6.75 to 0 D) and a mean baseline SE of -10.36 ± 4.69 D (range, -3.75 to -25.25 
D).
The mean baseline LogMAR BCVA was 0.16 ± 0.23 (range, 0 to 1). The mean 
anterior chamber depth was 3.30 ± 0.28 mm (range, 3.00 to 4.20 mm) and the 
mean intraocular pressure was 14.7 ± 2.8 mmHg (range, 8.0 to 19.0 mmHg). 
The mean baseline ECD was 2817 ± 359 cells/mm2 (range, 2100 to 3900 cells/
mm2). The mean power of the implanted PIoL was -12.60 ± 4.20 D (range, -7.0 
to -20.0 D). The preoperative pupil size was 4.5 ± 0.9 mm (range, 3.0 to 7.0 mm), 
with a pupil size larger than 5.0 mm in 9.5% of eyes.
Refractive stability
After 1, 6 and 10 years, the mean SE was -0.70 ± 0.97 D (range, -4.88 to 1.75 D), 
-0.71 ± 0.99 D (range, -4.50 to 2.00 D) and -0.70 ± 1.00 D (range, -4.00 to 2.00 
D), respectively. No significant change in mean SE was found between the 1, 6, 
and 10 years after surgery (P = 0.94 and P = 0.71) (Table 2) (Fig 1).
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Table 1. Summary of population characteristics and preoperative data.
Variable Mean ± SD Range
Mean patient age (yrs) 38.35 ± 10.50 19-61
Number of females 34
Number of eyes 89
Right eyes 44
Left eyes 45
Sphere (D) -9.78 ± 4.43 -3.50 to -25.00
Cylinder (D) -1.26 ± 1.40 -6.75 to 0.00
SE (D) -10.36 ± 4.69 -3.75 to -25.25
ACD (mm) 3.30 ± 0.28 3.00 to 4.20
IoP (mmHg) 14.7 ± 2.8 8.0 to 19.0
ECD (cells/mm2) 2817 ± 359 2100 to 3900
Implanted lens power (D) -12.60 ± 4.20 -7.00 to -20.0
SD = standard deviation; D = diopters; SE = spherical equivalent; ACD = anterior 
chamber depth; IoP = intraocular pressure; ECD = endothelial cell density.
Table 2. Mean ± SD spherical equivalent before and after Artisan phakic intraocular lens 
implantation for the correction of moderate to high myopia.
Mean ± SD Number of eyes Range P value*
Before surgery -10.37 ± 4.67 89 -25.25 to -3.75
After surgery
1 year -0.70 ± 0.97 89 -4.88 to 1.75 -
6 years -0.71 ± 0.99 89 -4.50 to 2.0 0.94
10 years -0.70 ± 1.00 89 -4.00 to 2.0 0.71
SD = standard deviation. * Mean spherical equivalent value as compared to the mean 
value at 1 year after surgery.
Figure 1. Graph demonstrating the 
stability of postoperative spherical 
equivalent after Artisan phakic 
intraocular lens implantation for the 
correction of moderate to high myopia. 
Mean ± standard deviation spherical 
equivalent before implantation (-10.36 
± 4.69, n = 89) and after 1 year (-0.70 
± 0.97, n= 89), 6 years (-0.71 ± 0.99, 
n = 89) and 10 years (-0.70 ± 1.02, 
n = 69) are demonstrated (P > 0.05). 
D = diopters
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Refractive predictability-spherical equivalent
The deviation of the achieved SE correction from the calculated (intended) 
refractive SE correction was calculated. After 1, 6 and 10 years, 38.3% (n=34), 
50.5% (n=45) and 43.8% (n=39) of eyes were within ± 0.5 D of the desired 
refraction, respectively. After 1, 6 and 10 years, 74.2% (n=66), 65.1% (n=58) and 
68.8% (n=61) of eyes were within ± 1.0 D of the desired refraction, respectively. 
After 1, 6 and 10 years, 94.4% (n=84), 93.3% (n=83) and 93.3% (n=83) of eyes 
were within ± 2.0 D of the desired refraction, respectively (Table 3) (Fig 2).
Figure 2. Scatterplot demonstrating the refractive predict-
ability of the spherical equivalent 10 years after Artisan phakic 
intraocular lens implantation for the correction of moderate to 
high myopia; 65.2% (n = 45) were within ± 1.0 diopter (D) 
of the desired refraction. The red line is the line where the 
intended correction equals the achieved correction.
Table 3. overview of refractive predictability after Artisan phakic intraocular lens implan-
tation for the correction of moderate to high myopia.
Refractive Predictability
Year 1
Number of eyes (%) 
(n = 89)
Year 6
Number of eyes (%) 
(n = 89)
Year 10
Number of eyes (%) 
(n = 89)
± 0.5 D 38.3 (32) 50.5 (45) 43.8 (39)
± 1.0 D 74.2 (66) 65.1 (58) 68.8 (61)
± 2.0 D 94.4 (84) 93.3 (83) 93.3 (83)
D = diopter.
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Refractive predictability-astigmatic correction
After 1, 6 and 10 years, the mean refractive cylinder was -1.02 ± 0.85 D (range, 
-4.00 to 0 D, n=89), -1.00 ± 0.90 D (range, -4.00 to 0 D, n=89) and -0.94 ± 0.79 
D (range, -4.00 to 0 D, n=89), respectively. A postoperative refractive cylinder 
of more than 1.5 D was found in 15.7% (n=14), 20.2% (n=18) and 12.4% (n=11) 
after 1, 6 and 10 years, respectively (Table 4).
Safety
The mean preoperative LogMAR BCVA for all 89 eyes was 0.16 ± 0.23 (range, 0 
to 1). After 1, 6 and 10 years, the mean LogMAR BCVA was 0.07 ± 0.09 (range, 
-0.08 to 0.30), 0.12 ± 0.17 (range, -0.08 to 1.30) and 0.12 ± 0.21 (range, -0.08 
to 1.30), respectively. A BCVA of 20/40 or better was found in 100%, 96.6% and 
93.3% of eyes after 1, 6 and 10 years, respectively. A BCVA of 20/20 or better 
was found in 70.8%, 50.6% and 52.8% of eyes after 1, 6 and 10 years, respectively. 
After 1, 6 and 10 years, 40.3% (n=31), 26.0% (n=20) and 31.2% (n=24) gained 1 
or more Snellen lines of BCVA, respectively. After 1, 6 and 10 years, 1.3% (n=1), 
2.6% (n=2) and 2.6% (n=2) of eyes lost more than 2 Snellen lines of BCVA, 
respectively (Fig. 3). The safety index (meaning, the ratio of the mean postopera-
tive BCVA to the mean preoperative BCVA) was 1.12, 1.10 and 1.10 after 1, 6 
and 10 years, respectively. 
Efficacy
After 1, 6 and 10 years, the mean LogMAR UCVA for all 89 eyes was 0.16 ± 
0.16 (range, -0.08 to 0.60), 0.24 ± 0.23 (range, 0 to 1.30) and 0.27 ± 0.29 (range, 
-0.08 to 1.30), respectively. A UCVA of 20/40 or better was found in 86.5%, 
78.7% and 82.0% of eyes after 1, 6 and 10 years, respectively. The efficacy index 
(meaning, the mean post-operative UCVA to mean pre-operative BCVA) was 
0.96, 0.83 and 0.80 after 1, 6 and 10 years, respectively. 
Table 4. overview of refractive cylinder values after Artisan phakic intraocular lens 
implantation for the correction of moderate to high myopia.
Mean ± SD Range Number of eyes
Before surgery -1.26 ± 1.40 -6.75 to 0.0 89
After surgery
Year 1 -1.02 ± 0.85 -4.0 to 0.0 89
Year 6 -1.0 ± 0.90 -4.0 to 0.0 89
Year 10 -0.94 ± 0.79 -4.0 to 0.0 89
SD = standard deviation.
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Intraocular pressure
The mean preoperative intraocular pressure for all 89 eyes was 14.7 ± 2.8 mmHg 
(range, 8 to 19 mmHg) and changed to 15.3 ± 3.3 mmHg (range, 9 to 26 mmHg), 
15.6 ± 3.8 mmHg (range, 9 to 24 mmHg) and 15.5 ± 3.5 mmHg (range, 7 to 25 
mmHg) at 1, 6 and 10 years after surgery.
Endothelial cell density and endothelial cell loss
After 1, 6 and 10 years, the mean ± SD postoperative ECD was 2928 ± 351 cells/
mm2 (range, 2200 to 3900 cells/mm2) (n=87), 2734 ± 360 cells/mm2 (range, 
2163 to 4500 cells/mm2) (n=89) and 2800 ± 292 cells/mm2 (range, 1849 to 
3850 cells/mm2) (n=89), respectively (Fig 4). In order to compare preoperative 
values with postoperative values, we assumed a linear decrease of 0.6% physi-
ologic loss per year for the preoperative value. After this adjustment, we found a 
mean decrease of -9.39% ± 18.56 (range, -57.47 to 17.36%) (P = 0.002), -3.26% ± 
18.96 (range, -72.89 to 27.62%) (P = 0.494) and -8.86% ± 16.01 (range, -51.69 to 
34.43%) (P = 0.001) at 1, 6 and 10 years follow-up, respectively (Tables 5 and 6). 
For the relative standard deviation we found a within-subjects variation of 4 %. 
The coefficient of repeatability was 344.21-23 No significant correlation was found 
between the preoperative anterior chamber depth and endothelial cell changes 
after 10 years (r = -0.050, P = 0.747, respectively).
Intra-operative problems and adverse events
There were no intra-operative problems. Throughout all follow-up years, a total 
of 5 eyes of 3 patients demonstrated a loss of more than 2 Snellen lines of BCVA. 
For follow-up year 1 (n=1), the loss was caused by the development of a myopic 
maculopathy. For follow-up years 6 (n=2) and year 10 (n=2) the loss in Snellen 
lines was due to the development of a corneal guttata dystrophy and due to a 
visually significant cataract and were the same eyes in both years.
Glare
After 10 years follow-up, the scores for three optical side effects for all 49 patients 
were assessed. The mean score for perception of stars around lights, distortion of 
details and double outline of images were 4.49 ± 0.65, 4.69 ±, 0.59, 4.69 ± 0.62, 
respectively (Table 7).
Secondary surgical intervention
To correct a significant postoperative undercorrection, 1 eye underwent an 
uneventful additional excimer photorefractive keratectomy procedure 4 months 
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after the surgical implantation. Due to a visually significant age-related cataract 
which developed 6 years after surgery, 2 eyes underwent explantation of the 
Artisan PIoL with subsequent phaco-emulsification and the implantation of a 
posterior chamber intraocular lens.
Table 5. Mean ± SD endothelial cell density counts before and after Artisan phakic 
intraocular lens implantation for the correction of moderate to high myopia.
Number 
of eyes
ECD ± SD (range) 
in cells/mm2
Range ECD loss ± 
SD (%)
P value*
Before surgery 89 2817 ± 359 2100 - 3900
After surgery
1 years 89 2928 ± 351 2200 - 3900 -9.39 ± 18.56 0.002
6 years 89 2734 ± 360 2163 - 4500 -3.26 ± 18.96 0.494
10 years 89 2800 ± 292 1849 - 3850 -8.86 ± 16.01 0.001
ECD = endothelial cell density; SD = standard deviation.
* Mean postoperative endothelial cell loss as compared to the mean preoperative value.
Table 6. Comparison between previous studies and our study.
Studies
Menezo  
et al.
Budo  
et al. 
El Danasoury  
et al.
Pop  
et al.
our study
Number of eyes 111 518 43 765 89
FU (mos) 6-48 6-36 12 6-24 12-144
Mean patient 
age (yrs)
34.9 36.4 N/A N/A 38.3
Lens power (D) -8.0 to -20.0 -5.0 to -20.0 -9.0 to -19.0 -5.0 to -24.0 -7.0 to -20.0
ECD change (%)
- 1 year FU  6.59 ± 2.93 2.4 ± 1.0 0.7 ± 1.1 -0.87 ± 16.35 -9.39 ± 18.56
- 3 years FU 11.68 ± 4.18 0.7 ± 1.0 N/A N/A -8.86 ± 16.01*
FU = follow-up; D = diopter; ECD = endothelial cell density.
* Long-term (10-year) data mentioned for our study
Table 7. Glare scores 10 years after Artisan phakic intraocular lens implantation for the 
correction of moderate to high myopia (n = 49).
Mean ± SD* Range
Perception of stars around lights 4.49 ± 0.65 3-5
Distortion of details 4.69 ± 0.59 3-5
Double outline of images 4.69 ± 0.62 3-5
*Scores 0-5 (0 meaning high glare levels, 5 meaning no glare).
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Figure 3. Bar graph demonstrating the lost and gained Snellen 
lines of best-corrected visual acuity (BCVA) after Artisan phakic 
intraocular lens implantation for the correction of moderate to 
high myopia. After 1, 6, and 10 years, 1.3% (n = 1), 2.6% (n = 2), 
and 3.6% (n = 2) of eyes lost more than 2 Snellen lines of BCVA, 
respectively.
Figure 4. Graph demonstrating the mean ± standard deviation 
endothelial cell density before Artisan phakic intraocular lens 
implantation for the correction of moderate to high myopia (2817 ± 
359, n = 89) and after 1 year (2928 ± 351, n = 89), 6 years (2734 ± 
360, n = 89) and 10 years (2776 ± 321, n = 69).
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DISCUSSIoN
The purpose of this retrospective study was to evaluate the long-term (10 year) 
refractive stability, refractive predictability, safety and efficacy of the Artisan 
phakic intraocular lens (PIoL) for the correction of moderate to high myopia 
and to monitor changes in corneal endothelial cell density (ECD) over time. A 
potential drawback of long-term studies in the field of refractive surgery is the 
variation in follow-up time. In our study, out of the 177 eyes of 89 patients who 
initially had undergone Artisan PIoL implantation, we were able to include 89 
eyes of 49 patients in the study, in order to perform a paired comparative analysis 
between the individual follow-up years 1, 6 and 10. Data from the excluded 88 
eyes were measured at different time points, and therefore not suitable for the 
intended comparative analysis. However, none of these eyes had lost 2 or more 
lines of BCVA at their last follow-up visit.
Long-term refractive stability
The short-term results of Artisan PIoL implantation have been demonstrated in 
several clinical reports with a follow-up time of up to 4 years.1, 3-7, 9, 10, 24 These 
reports demonstrate that stabilisation of the postoperative refraction occurs 
within the first few years after surgery with more than 90% of eyes that achieve 
a refraction within 1 diopter (D) of the intended correction and a high safety 
index.
The long-term data demonstrated in this study showed comparable results to 
the above-mentioned short-term studies on refractive stability. Ten years after 
Artisan PIoL implantation for the correction of moderate to high myopia, the 
mean ± standard deviation (SD) spherical equivalent (SE) was -0.70 ± 1.00 
D (range, -4.00 to 2.00 D) and remained stable over time. This finding is in 
accordance with the short-term literature, which demonstrated stabilisation of 
the postoperative refraction within the first few years after surgery (see above). 
The mean SE values of -0.7 D after 1, 6 and 10 years indicate a slight average 
undercorrection. The SE was aimed at slight myopia, since the lens was available 
in only 1.0 D power increments before 1997 (since 1997, the lens has been avail-
able in 0.5 D increments) and care was taken to avoid a postoperative hyperopic 
overcorrection that certainly would decrease patient satisfaction in our highly 
myopic group of patients. In addition, we believe that a mean postoperative SE 
of -0.7 D in this highly myopic group with a preoperative SE of -10.36 is an 
acceptable result.
At 10 years postoperative, 65.2% and 92.8% of eyes were within ± 1.0 D and ± 
2.0 D of the desired refraction with an excellent stability of the postoperative 
refractive cylinder; the mean ± SD refractive cylinder being -0.99 ± 0.81 D 
(range, -4.00 to 0 D) at 10 years.
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Visual outcome and visual complications
Short-term data showed that after Artisan PIoL implantation, over 85% of eyes 
demonstrated a best-corrected visual acuity (BCVA) of 20/40 or better and more 
than 60% of eyes gained 2 or more Snellen lines of BCVA.1, 3-7, 9, 10, 24
our long-term data show great similarity to the short-term data. After 10 years, 
patients reached a BCVA of 20/40 or better in 92.5% of eyes and a UCVA of 
20/40 or better in 79.7% of eyes. With respect to safety, we showed that after 10 
years, 3.6% (n=2) of eyes lost more than 2 Snellen lines of BCVA. Throughout all 
follow-up years, 5 eyes in total demonstrated a loss of more than 2 Snellen lines 
of BCVA. For year 1 (n=1), the loss was caused by the development of a myopic 
maculopathy. For follow-up year 6 (n=2) and 10 (n=2), the loss in one eye of the 
same patient was due to the development of a corneal guttata dystrophy without 
preexistent signs of corneal guttata or a low endothelial cell count and in the eye 
of a another patient by a visually significant cataract. We believe that the loss of 
visual acuity was not related to the implantation of the PIoL but to the nature 
of myopic eye disease and earlier development of cataract in myopia. In the eye 
with cornea guttata it is unclear whether the cornea guttata had developed in 
the 6 years after the surgical procedure, or whether they were actually present at 
the time of patient inclusion which may have escaped diagnosis. Endothelial cell 
counts of greater than 2000 cells/mm2 may be possible in patients with cornea 
guttata, due to the variations in regional endothelial cell density.25
From 1 to 10 years after surgery there was a slight decrease in the safety index 
and a larger decrease in the efficacy index of the Artisan procedure. After 10 years 
we found a safety index of 1.10 as compared to 1.12 at one year. The efficacy 
index decreased from 0.96 at one year to 0.80 after 10 years. We believe that this 
decrease is not related to the surgical procedure, but to the development of age- 
and high myopia related changes, like earlier development of lens opacities and 
maculopathy in this group of highly myopic patients whose average patient age 
after 10 years was 48.3 years.1, 5, 26-28. It can be expected that a sample size of about 
100 cases can detect unanticipated severe adverse events (SAE) to occur about 
3% of the time. our study sample demonstrated unanticipated SAE to occur at a 
rate of less than 5%.
Long-term endothelial cell loss
Several short-term studies evaluated corneal ECD after Artisan PIoL implanta-
tion (Table 6).1, 3-10, 24, 29 In 1998, Menezo et al9 showed data of 111 eyes with an 
Artisan PIoL with subsequent ECD loss of 11.7% at 3 years follow-up. In 2000, 
Budo et al1 reported 3-year follow-up data of 518 patients which demonstrated a 
relatively low amount of ECD loss and stabilization over time (2.4% after 1 year 
and 0.7% after 3 years). In 2004, Pop et al10 reported data which did not show any 
statistically significant postoperative endothelial cell loss for up to 2 years after 
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Artisan PIoL implantation. No strong evidence can be found in the literature 
for concerns on the long-term safety of the current Artisan PIoL design. In 
2000, an experimental study used scanning electron microscopy to analyse the 
surface quality of the Artisan lens.30 The study stated that the surface quality 
of this lens is excellent and that no contraindications related to surface quality 
could be found for the implantation of these lenses into phakic eyes. In addi-
tion, reports that have studied changes in ECD in healthy emmetropic eyes, 
demonstrate a correlation between patient age and ECD. With age, the number 
of cells decreases, with a physiologic rate of 0.6% per year after age 18.31 This 
means that after 10 years, a loss of about 6% could be found. In the present study, 
however, we could not find an endothelial cell loss of this magnitude. our data 
demonstrated that there was no long-term corneal endothelial cell loss over time 
with a relative gain in ECD after year 1 (gain of 8.73% ± 18.45) and year 10 (gain 
of 3.62% ± 16.97) follow-up. No correlation was found between endothelial cell 
loss at 10 years and the preoperative anterior chamber depth, which supports the 
hypothesis that an anterior chamber depth of at least 3.0 mm is an adequate safety 
measure for the implantation of the Artisan PIoL.10 Previous studies have also 
attempted to explain the gain in ECD after Artisan PIoL implantation, among 
which a large variation in cell density measurements and small sample sizes which 
enabled the large variations.4, 5 Specular microscopy measurements have been 
reported to be reproducible within 7%, of which approximately one third is the 
result of the precision of the technique and the remaining two thirds is the result 
of the variance of the ECD population within each eye.10, 31, 32 Another report 
stated that ECD assessment may be considered less valid when evaluating corneal 
endothelial cell loss caused by a surgical technique.33 In the present study, ECD 
was measured with the Topcon 1000 specular microscope until 2002, after which 
measurements were taken with the Topcon 2000-P. The Topcon 1000 has been 
mentioned in several studies33-36, although no studies have compared this specular 
microscope to the newer Topcon 2000-P. A small comparative study in our 
department showed a high correlation for endothelial cell density between the 
two microscopes (unpublished data). Therefore, we do not expect that the switch 
in these instruments significantly contributed to a bias in ECD measurements.
Another explanation for a relative gain in ECD after implantation could be that the 
recovery capability of the corneal endothelium after intraocular surgery might be 
higher than previously assumed. A recent report by Whikehart et al.37 suggested 
that cells in the corneal endothelium might be renewed by stem cells located in 
a niche at the posterior limbus and that increased cell renewal may occur after 
mechanical trauma, such as intraocular surgery. Data reported by Konomi et al.38 
indicated that both central and peripheral corneal endothelial cells are capable 
of dividing and that age had a greater influence on proliferative capacity than 
relative position of the cells. Data by Amann et al.25 demonstrated that the ECD 
in the peripheral cornea is significantly higher than in the central cornea, which 
plays an important role in the wound healing response of the corneal endothe-
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lium after PIoL implantation, since the peripheral cornea provides a physiologic 
reserve for endothelial cells. Published data of a clinical study using a different 
type of PIoL (the Implantable Contact Lens) suggested that corneal endothelial 
cell loss between the first and third postoperative years is explained by prolonged 
corneal ECD remodeling following the surgical procedure rather than ongoing 
cell loss.39 
Finally, a trend toward improvement and recovery of the corneal endothelial 
cell morphology after discontinuation of contact lens wear has been previously 
reported40, including an improvement in endothelial morphology parameters 
after photorefractive keratectomy (PRK)41, 42 and laser in situ keratomileusis 
(LASIK)43, 44. This improvement was attributed to the discontinuation of contact 
lens and/or switching to spectacle-wear. This might be another explanation for 
the relative gain in ECD after the implantation in our study, since many of our 
patients were long-term contact lens wearers prior to the implantation and many 
discontinued wearing their contact lenses postoperatively. Unfortunately, due to 
insufficient data, we were not able to analyze the relation between preoperative 
contact lens or spectacle use and postoperative endothelial cell values.
Comparison to other long-term studies of refractive surgery
Recently, a study was published on the long-term (12-year) results of patients who 
underwent myopic photorefractive keratectomy for the correction of myopia. 
The range of the preoperative SE was −1.5 to −17.5 D. Seventy-five percent of 
patients who underwent a −2 D correction and 65% of patients who received a 
−3 D correction were within 1 D of intended correction at 12 years. Fifty-seven 
percent of the −4 D group and 50% of the −5 D group were within 1 D, and this 
was further reduced to 25% and 22% in the −6 D and −7 D groups, respectively. 
In our study of Artisan PIoL implantation, 65.2% and 92.8% of patients were 
within ± 1.0 D and ± 2.0 D of the desired refraction after 10 years. The PRK 
study demonstrated that after 12 years, 94% had a BCVA better than or equal to 
the preoperative BCVA. A loss of 1 Snellen line of BCVA was shown in 4.0% 
and of 2 Snellen lines of BCVA in 1.4% of patients. our data at 10 years showed 
a BCVA of 20/40 or better in 92.5% of patients and a loss of more than 2 Snellen 
lines of BCVA in 3.6%.13
Late complications
No intra-operative or postoperative complications occurred in the patient group. 
Previous studies on Artisan PIoL implantation have discussed intra- and post-
operative complications1, 5, 9, 24 These studies demonstrated that intraoperative 
problems that can occur are usually minimal and typically related to the learning 
curve required to master the special implantation technique for the Artisan lens. 
We believe that the 2 eyes which developed a visually significant cataract 6 years 
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after surgery were age- and high myopia related and not caused by the surgical 
implantation of the Artisan PIoL.
Glare
Glare levels were evaluated after 10 years follow-up. For this purpose, a validated 
questionnaire was applied, which represented the quantification of glare levels 
after the surgical procedure.16, 18, 19 The results demonstrated that glare levels after 
the Artisan PIoL implantation procedure were low and showed comparable 
results to previous PIoL studies.1, 20 
In conclusion, this study has demonstrated that after the implantation of Artisan 
PIoLs for the treatment of moderate to high myopia, refractive stability was 
maintained for up to 10 years. There was no evidence of late-onset complications 
or long-term endothelial cell loss. However, to achieve these results, a meticulous 
surgical technique of PIoL implantation by an adequately trained surgeon is 
needed and strict inclusion criteria must be applied.
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ABSTRACT
Purpose: To determine the three year follow-up of efficacy and safety of Artisan toric 
iris-fixated lens implantation after penetrating keratoplasty to correct high ametropia 
and astigmatism.
Design: Prospective, noncomparative case series with a minimal follow-up of 1 year.
Participants: Artisan toric lens implantation was performed in 36 eyes of 35 patients 
who were contact lens intolerant or unable to wear glasses due to anisometropia and/or 
high astigmatism.
Intervention: Thirty-six eyes of 35 consecutive patients received Artisan toric lens 
implantation for postkeratoplasty astigmatism and/or anisometropia.
Main Outcome Measures: Manifest refraction, uncorrected and spectacle-corrected 
visual acuity (UCVA and BCVA), and corneal topography were performed before 
surgery, and at 3, 6, 12 months and yearly intervals up to 4 years after surgery. Efficacy, 
safety, percent reduction of refractive astigmatism, anisometropia of defocus and the 
astigmatism correction index were determined. A patient satisfaction questionnaire and 
specular microscopy were assessed.
Results: The mean ± standard deviation of preoperative refractive cylinder was –7.06 ± 
2.01 (range –3.0 to –11.0) diopters (D), which was reduced to –1.73 ± 1.25 D, –1.69 ± 
1.15 D, -1.94 ± 1.68 D, -2.02 ± 1.93 D and -2.00 ± 1.53 D at 6 months (n=36), 1 year 
(n=36), 2 years (n=29), 3 years (n=15) and the last follow-up examination (28.5 ± 12.5 
months, n=36), respectively (P < 0.001 for all time points, paired t-test). The spherical 
equivalent was reduced from –3.19 ± 4.31 D (range, +5.5 to –14.25 D) preoperatively 
to –1.03 ± 1.20 D (range, +1.0 to –5.25 D) at the last follow-up. The UCVA and BCVA 
were ≥ 20/40 in 31.6% and 80.6%, respectively. There was a loss of BCVA of greater than 
2 lines in 8.3% of eyes and a gain of at least 2 lines in 8.3% of eyes. The percent reduction 
in refractive astigmatism and anisometropia of defocus were 88.8 ± 29.5% and 77.8 ± 
19.3%, respectively. The astigmatism correction index was 96.0 ± 24.2%. Satisfaction 
increased from 3.6 to 8.0 (scale 0 to 10) post-implantation. The endothelial cell loss as 
compared to preoperatively was 13.8 ± 18.7% (n=34), 21.2 ± 21.8% (n=33), 29.6 ± 27.3% 
(n=26), 30.4 ± 32.0% (n=18), and 34.8 ± 26.3% (n=6) at 6 months (P=0.001), 1 year 
(P<0.001), 2 years (P<0.001), 3 years (P=0.001), and 4 years postoperatively (P=0.1), 
respectively. In two patients irreversible graft rejections occurred and in one patient 
gradual endothelial decompensation occurred.
Conclusion: Artisan toric lens implantation after penetrating keratoplasty was effec-
tive for reduction of refractive astigmatism and ametropia. All patients were suitable for 
spectacle correction after implantation. There was a continuing endothelial cell loss from 
6 months to 3 years postoperatively. In 3 cases corneal graft failure developed.
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INTRoDUCTIoN
The purpose of the present study was to determine the three year efficacy and 
safety of toric iris-fixated intraocular lens (IoL) implantation for the reduc-
tion of anisometropia and astigmatism to allow spectacle wear in patients with 
contact lens intolerance after keratoplasty. Although visual function may show 
substantial improvement after keratoplasty1, report significant astigmatism of 4 to 
5 diopters.2-5 It is well-known that patients do not tolerate spectacle correction 
for more than 3 to 4 diopters (D) of astigmatism or anisometropia. Therefore, 
contact lenses are fitted in 10% to 30% of postkeratoplasty patients overall and 
in postkeratoplasty keratoconus patients this may increase up to 50%.6, 7 Contact 
lenses may be effective in 80% of cases but contact lens intolerance in the post-
keratoplasty population may be high due to ocular problems such as topographical 
abnormalities, blepharitis and dry eye, poor manual dexterity, occupational prob-
lems and lack of motivation. Surgical correction of postkeratoplasty astigmatism 
has been performed by corneal relaxing incisions8, 9, wedge resections10, and IoL 
exchange or piggy-back implantation.11, 12 Recently, excimer laser photorefractive 
keratectomy (PRK) and laser in situ keratomileusis (LASIK) have been used for 
corneal tissue ablation. However, PRK causes significant haze in corneal grafts 
and induces irregular astigmatism and regression although recent adjunctive use 
of mitomycin C may prevent these side effects.13-16 LASIK surgery is able to treat 
a greater range of postkeratoplasty refractive error but the corneal graft thickness 
and the amount of ametropia and astigmatism suitable for correction limit the 
efficacy of the procedure. In addition, wound dehiscence due to the high vacuum 
pressure, flap complications in steep corneas and a high rate of retreatments may 
occur.17-25 Recently, we published the short-term preliminary results of Artisan 
toric lens implantation for the correction of postkeratoplasty refractive error.26 
The present series provides the results with respect to safety and efficacy in a 
larger series with a follow-up up to 4 years.
PATIENTS AND METHoDS
Patient population
The thirty-six eyes of 35 consecutive patients included in this study could not 
be corrected by spectacle wear because of anisometropia, the magnitude of 
refractive cylinder and/or were contact lens intolerant. Exclusion criteria were as 
follows: a preoperative spectacle best-corrected visual acuity (BCVA) worse than 
20/60, an anterior chamber depth less than 3.0 mm, glaucoma, retinal pathology 
likely to alter vision, or an endothelial cell count lower than 500 cells/mm2. 
Investigational review board approval was obtained from the Academic Hospital 
Maastricht.
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Examination findings
Patients were examined preoperatively and at day 1, week 1, month 1, month 
3, month 6, and from then at 6 months intervals. Preoperatively, uncorrected 
visual acuity (UCVA) and BCVA with subjective refraction, cycloplegic refrac-
tion, slit-lamp microscopy, applanation tonometry, corneal topography (Alcon 
Eyemap EH-290, Alcon, Fort Worth, TX), dilated fundus examination and pupil 
size measurement at dim illumination with the Colvard pupillometer (oasis, 
Glendora, CA) were performed. on postoperative day 1, UCVA and BCVA 
and biomicroscopic examination with registration of intraocular pressure were 
performed. Thereafter, UCVA and BCVA with subjective refraction, slit-lamp 
microscopy, applanation tonometry, and corneal topography were assessed. The 
simulated keratometry values of the steep and flat meridians were used for calcu-
lation of the topographically induced surgical astigmatism. Preoperatively and at 
6 months, 1 year, 2 years, and 3 years postoperatively, specular microscopy of the 
corneal endothelium using a noncontact specular microscope (Konan Noncon 
Robo, SP 8000, Konan, Hyogo, Japan) was performed.27, 28 Preoperatively and at 
6 months postoperatively, the patients were asked to rate the quality of vision of 
the eye with their present correction on a visual analog scale of 1 to 10 (1 is very 
poor, 10 is excellent), based on a previously validated questionnaire.29
Surgical technique
The Artisan toric IoL has a convex-concave toric optic with a spherical anterior 
surface and a sphero-cylindrical posterior surface (ophtec B.V., Groningen, the 
Netherlands). This single-piece lens is composed of polymethyl methacrylate 
and is manufactured using compression molding technology. The toric lens 
is iris claw-fixated and has a 5-mm optical zone (Figure 1). Refractive error, 
refractive cylinder power, anterior chamber depth, and topographically derived 
keratometric dioptric values were inserted into the Van der Heijde30 formula 
to calculate the dioptric power of the lens for two meridians. The axis of the 
cylinder identified by the subjective refraction was used to determine the axis 
of surgical enclavation. The power of the lens was chosen to obtain emmetropia 
(n=30) or a postoperative spherical equivalent of –1.0 D (n=4), -2.0 D (n=1) or 
+1.0 D (n=1) to match the ametropia in the untreated eyes. The IoL is available 
in dioptric powers of –3.0 to –20.5 D, +2.0 to +12.0 D and in cylindrical powers 
of 2.0 to 7.5 D. The cylinder is in line with the haptics or at an angle of 90º with 
the haptics. In 9 of 37 eyes the cylinder dioptric power of the toric lens was less 
than 75% of the calculated power required for full correction of the cylinder. The 
surgical techniques for lens implantation and the postoperative medical treatment 
have been described previously.16 
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Outcome measures and statistics
Main outcome measures were refractive and visual outcome as reflected by 
UCVA and efficacy (reduction in refractive and topographic astigmatism, reduc-
tion in anisometropia of spherical and defocus equivalent and number of eyes 
losing/gaining lines of UCVA, BCVA and safety (number of eyes losing more 
than 2 lines of BCVA). A patient satisfaction questionnaire, specular micros-
copy (endothelial cell loss) and incidence of complications were assessed. Snellen 
UCVA or BCVA was converted to logMar values to facilitate statistical analysis. 
Comparison between preoperative data and postoperative data was performed by 
paired t-test and comparison between groups by Pearson chi-square test (SPSS for 
Windows (SPSS Inc., Chicago, IL). All averages in the text are mean ± standard 
deviation (SD).
Analysis of astigmatism
Both vector analysis and non-vector analysis of the cylinder was performed. The 
efficacy of the procedure (i.e., the proportion of astigmatism correction achieved) 
was quantified using the correction index expressed as a percentage of the surgi-
Figure 1. Artisan toric lens implantation for correction of postkeratoplasty astigmatism 
(patient no. 2). Preoperatively, BCVA was 20/50 with +4.0 –8.0 x 120º. Six months after 
implantation of an Artisan toric lens with a power of +6.0 –7.0 x 90º and enclavated in the 
axis 30º, BCVA increased to 20/32 with –1.0 –1.50 x 125º and UCVA to 20/60. Four years 
after implantation UCVA is 20/30 with a clear graft. BCVA = best-corrected visual acuity; 
UCVA = uncorrected visual acuity.
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cally induced astigmatism (SIA) divided by the target induced astigmatism (TIA) 
for each individual eye and aggregated.31 The Holladay method to convert polar 
values (cylinder and axis ) to a Cartesian (X and Y) coordinate system was used to 
determine the mean ± SD value of the refractive and topographical keratometric 
astigmatism.32 The coordinates were plotted in a doubled-angle plot and the 
centroid was determined. 
RESULTS
Patient population
Twenty-seven patients were female and eight were male. The mean age was 
63.8 ± 17.0 (range, 23-82 years). The mean time interval between penetrating 
keratoplasty and toric lens implantation was 57.1 ± 30.2 months (range, 26 to 142 
months) and the interval between suture removal and lens implantation was 30.8 
± 28.2 months (range, 3 to 144 months). Twenty-five eyes were pseudophakic 
after previous implantation of a posterior chamber IoL and one eye was aphakic. 
The initial diagnosis requiring corneal transplantation was Fuchs endothelial 
dystrophy (33.3%), (pseudophakic) bullous keratopathy (13.9%), Herpes Simplex 
keratitis (16.7%), keratoconus (13.9%), corneal scarring (11.1%) re-grafting (8.3%) 
and high astigmatism (2.8%).
The baseline parameters were a mean sphere of 0.34 ± 4.36 D (range, + 9.0 to 
–10.0 D), a mean spherical equivalent refraction of –3.19 ± 4.31 D (range, +5.5 
to –14.25 D), a mean baseline refractive cylinder power of -7.06 ± 2.01 (range, 
-3.0 to –11.0 D), a mean defocus equivalent of 6.99 ± 2.59 D (range, 3.25 to 
14.25 D) and a mean baseline topographically derived simulated keratometric 
cylinder of 7.00 ± 2.27 D (range, +3.51 to +11.65 D). There were no significant 
differences for the baseline parameters between the pseudophakic eye group and 
the phakic eye group. The mean follow-up was 28.5 ± 12.5 months (range, 12 
to 51 months).
Visual acuity outcome
The mean logMar UCVA preoperatively was 1.39 ± 0.44 and increased to 0.55 ± 
0.35 at the last follow-up (P < 0.001, paired t-test). Postoperatively, 31.6% of eyes 
had a UCVA better than 20/40, 63.9% of eyes better than 20/80 as compared to 
0% preoperatively. In the phakic and pseudophakic eye groups 27.8% and 35.3% 
of eyes had a UCVA better than 20/40, respectively (P = 0.71, Pearson chi-square). 
The mean number of gained lines of UCVA in all eyes was 8.50 ± 5.51 (range, 
-2 to 18 lines). The mean logMar BCVA preoperatively was 0.26 ± 0.17 and 
postoperatively was 0.26 ± 0.24 (P = 0.802, paired t-test). Postoperatively, 80.6% 
of eyes had a BCVA better than 20/40 as compared to 69.4% preoperatively and 
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Figure 2. Percentage of eyes within given range of BCVA preoperatively and at last follow-
up after toric lens implantation. The safety-index (mean postoperative BCVA divided by 
mean preoperative BCVA) was 0.98. BCVA = best-corrected visual acuity.
Figure 3. The number of gained or lost lines of BCVA at last follow-up after toric lens 
implantation. BCVA = best-corrected visual acuity.
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25.0% had a BCVA better than 20/25 (Figure 2). In the phakic and pseudophakic 
eye groups 77.8% and 82.4% of eyes had a BCVA better than 20/40, respectively 
(P = 0.83, Pearson chi-square). The mean number of gained lines of BCVA in all 
eyes was -0.06 ± 2.14 (range, -6 to 4 lines). There was a loss of BCVA of greater 
than 2 lines in 8.3% of eyes and a gain of at least 2 lines in 8.3% of eyes (Figure 3). 
The predictability of intended versus achieved cylinder correction showed 26 of 
36 eyes (72.3%) within 2 D and 18 of 36 eyes (50.0%) within 1 D of the intended 
correction. In the phakic eye group 66.7% and 50.0% of eyes were within 2 D 
and 1 D of the intended correction, and in the pseudophakic eye group 76.5% 
and 52.9% of eyes were within 2 D and 1 D of the intended correction (P = 0.67 
and P = 0.59, Pearson chi-square). The predictability of intended versus achieved 
defocus equivalent showed 22 of 36 eyes (61.1%) within 2 D and 9 of 36 eyes 
(25.0%) within 1 D of the intended correction. 
Refractive outcome
The mean sphere at the last follow-up was –0.03 ± 1.23 D (range, + 2.50 to 
–3.75 D), the mean spherical equivalent refraction was –1.03 ± 1.20 D (range, 
+1.0 to –5.25 D), and the mean defocus equivalent was +1.65 ± 1.67 D (range, 
+7.13 to +0.0 D). The refractive cylinder was reduced to –1.73 ± 1.25 D, –1.69 ± 
1.15 D, -1.94 ± 1.68 D, -2.02 ± 1.93 D and -2.00 ± 1.53 D at 6 months (n=36), 1 
year (n=36), 2 years (n=29), 3 years (n=15) and the final follow-up examination 
(28.5 ± 12.5 months), respectively (P < 0.001 for all time points, paired t-test). 
There was no significant difference in refractive cylinder between the phakic eye 
group and the pseudophakic eye group at any of the postoperative time points. 
Concerning stability, there was no significant change in refractive cylinder values 
from 6 months postoperatively to 3 years postoperatively (Figure 4, P = 0.065, 
paired t-test). 
At the last follow-up 10 of 36 eyes (27.8%) had a refractive cylinder less than 1 
D, 21 of 36 eyes (58.3%) had a refractive cylinder less than 2 D, and 33 of 36 
eyes (91.7%) had a cylinder less than 4 D. The mean topographically derived 
simulated keratometric cylinder did not change significantly from 6.23 ± 2.26 
D at 3 months postoperatively to 6.68 ± 3.06 D at 12 months (P = 0.968, paired 
t-test), and to 6.59 ± 3.57 D (P = 0.894, paired t-test) at the last follow-up. The 
percent reduction in refractive and topographical astigmatism was 88.8 ± 29.5% 
and 7.8 ± 49.1%, respectively (Table 1). In 9 eyes the required dioptric power for 
correction of the refractive astigmatism exceeded the available maximal cylindric 
power of 7.5 D. There was a reduction of 103.6 ± 33.0% and 77.8 ± 19.3% in 
sphere and defocus equivalent (for eyes with preoperative defocus values > 3.0 D, 
n=24), respectively. The correction index (SIA/TIA) was 96.0 ± 24.2% at the last 
follow-up. The centroid (± SD) in the double angled plot changed from –2.83 D 
at 141.3° (± 6.43 D) preoperatively to –0.51 D at 91.9° (± 2.15 D) postoperatively 
(Figure 5), P < 0.001, (paired t-test). The mean surgically induced astigmatism of 
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the topographical cylinder by the placement of the corneoscleral incision centered 
at 90° was 2.53 ± 1.57 D (range, 0.25 D to 6.25 D) at 6 months postoperatively. 
Patient satisfaction increased from 3.6 preoperatively to 8.0 postoperatively (P < 
0.001, paired t-test).
The intraocular pressure (IoP) was 14.5 ± 2.9 mmHg preoperatively, 15.2 ± 
4.2 mmHg at 1 month postoperatively, 13.5 ± 3.2 mmHg at 6 months post-
operatively, and 12.9 ± 2.7 mmHg at the last follow-up (P = ns, paired t-test 
for all time points). The endothelial cell loss as compared to preoperatively was 
13.8 ± 18.7% (n=34), 21.2 ± 21.8% (n=33), 29.6 ± 27.3% (n=26), 30.4 ± 32.0% 
(n=18), and 34.8 ± 26.3% (n=6) at 6 months (P=0.001), 1 year (P<0.001), 2 years 
(P<0.001), 3 years (P=0.001), and 4 years postoperatively (P=0.1), respectively. 
In addition there was a progressive endothelial loss from 6 months to 12 months 
(P=0.004), to 24 months (P=0.002) and to 36 months (P=0.017), and from 12 
months to 24 months (P=0.016).
Complications
Two patients with irreversible graft rejections and one patient with gradual 
endothelial decompensation will be described. 
A 77-year-old male (patient no. 6) underwent penetrating keratoplasty of the 
right eye in April 1997 for HSV stromal keratitis. Seven months after implanta-
tion of an Artisan toric lens with a power of +5.0 –7.0 x 0º BCVA increased 
to 20/25 with +0.75 –1.50 x 155º. one month later, metastasized lung cancer 
was diagnosed and a recurrence of HSV keratitis followed by irreversible graft 
Figure 4. Mean refractive cylinder preoperatively and at postoperative time 
intervals. Number of patients at each time point are shown. D = diopters.
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rejection developed. Twenty-five months after Artisan implantation, BCVA was 
20/100 with +0.5 –1.50 x 160º. No further surgical treatment followed.
An 81-year-old female (patient no. 12) underwent penetrating keratoplasty of 
the left eye in September 1999 for pseudophakic bullous keratoplasty. Before 
Artisan implantation the endothelial cell density was 1384 cells/mm2. Five 
months after Artisan implantation (lens power of –1.50 –7.0 x 0º, enclavation axis 
162º) the BCVA was 20/30 with –0.75 –2.25 x 63º. At 12 months after Artisan 
toric lens implantation the endothelial cell density had decreased to 385 cells/
mm2. Twenty months after implantation, gradual endothelial decompensation 
occurred and BCVA decreased to 20/100 after metastasized colon cancer was 
diagnosed. Twenty-eight months after Artisan implantation, a re-keratoplasty, 
with explantation of the Artisan lens was performed. one year after re-kerato-
plasty the corneal graft was clear and BCVA was 20/30 with -6.5 0 x 0º.
A 62-year-old female (patient no. 18) underwent a re-penetrating keratoplasty 
of the right eye for graft failure in July 1999 after an intial keratoplasty for kera-
toconus in 1984. In May 2001, phacoemulsification with IoL implantation was 
performed followed by a reversible graft rejection in September 2001. In May 
2003, seven months after Artisan implantation (lens power of +8.0 –7.5 x 0º, 
enclavation axis 138º) the BCVA was 20/40 with –0.50 –1.50 x 50º. one month 
later an irreversible immunological graft failure occurred. In March 2004 a 
re-keratoplasty was performed with explantation of the toric Artisan lens. At the 
last follow-up in May 2005 the UCVA was 20/40 with a clear graft.
Figure 5. The centroid ± standard deviation (SD) in the double angled 
plot changed from –2.83 D at 141.3° (± 6.43 D) before Artisan toric lens 
implantation (blue squares, green centroid) to –0.51 D at 91.9° (± 2.15 D) 
at the last follow-up after implantation (yellow squares, red centroid).
D = diopters.
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In 6 patients signs of macular degeneration were noted. In patient no. 13 one 
haptic of the toric Artisan lens was repositioned 6 weeks after initial surgery 
because of axis misalignment and in patient no. 17 the Artisan lens was replaced 
because of an axis error in the delivered lens (lens power of +7.0 –7.5 x 0º in stead 
of +7.0 –7.5 x 90º), not noted at the time of surgery. No chronic inflammation of 
the anterior chamber or retinal detachment was seen in any of the patients.
DISCUSSIoN
This prospective study of 36 eyes demonstrates the three year efficacy and stability 
of the Artisan toric intraocular lens (IoL) for correction of postkeratoplasty 
astigmatism. Until now, laser in situ keratomileusis (LASIK) appears to be the 
preferred technique for correction of anisometropia and astigmatism after kerato-
plasty (Table 1).17-25 The use of the Artisan toric IoL with a power range of 7.5 
diopters (D) of cylinder and -20.5 D of myopia to +12.0 D of hyperopia, provides 
a wide field for correction of postkeratoplasty astigmatism and ametropia. In our 
series this is reflected by the magnitude of baseline spherical error (range + 9.0 
to –10.0 D) and cylindrical error (range -3.0 to –11.0 D), which is much higher 
than in most postkeratoplasty LASIK series. To our knowledge, the reduction of 
the refractive cylinder by 88.8 ± 29.5 (without any enhancements) is better than 
in most reported LASIK series. The reduction of refractive astigmatism after 
LASIK varies from 48% to 88% (Table 1). However, enhancements were reported 
in 9.1%33, 15%34, 42.9%18, 45%35 and 53%20 of cases and in one study LASIK was 
combined with arcuate incisions in the stromal bed in 54% of eyes.2
Improving the percentage of eyes with an uncorrected visual acuity (UCVA) of 
20/40 or better from 0% preoperatively to 31.6% at the last follow-up illustrates 
the efficacy of the Artisan toric IoL procedure in this patient group with highly 
ametropic eyes. In most LASIK series with lower preoperative ametropia UCVA 
better than 20/40 varied from 28% to 74%.2, 18, 20, 22, 33, 34 With respect to safety, 
there was a loss of best-corrected visual acuity (BCVA) of greater than 2 lines in 
8.3% of eyes and a gain of at least 2 lines in 8.3% of eyes. This is in accordance 
with two recent randomized studies in routine refractive surgery for the correc-
tion of high myopia that showed a greater gain of BCVA with Artisan phakic 
intraocular lens implantation as compared to a greater loss of BCVA with LASIK 
and a better quality of vision with the Artisan lens in moderate to high myopia.36, 
37 The loss of greater than 2 lines of BCVA in 8.3% in our series is comparable 
to series of LASIK for postkeratoplasty astigmatism that show a greater than 2 
lines loss of BCVA in 4.3%38, 7.1% 18, 9.1%.22 and 16%.23 However, the pattern of 
complications induced by the two techniques is very different. LASIK surgery 
may be complicated by flap complications in steep corneas and has limitations 
due to corneal graft thickness and amount of ametropia and astigmatism suitable 
for correction.17-25 LASIK related complications like diffuse lamellar keratitis34, 
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buttonhole flaps18, 22, wound dehiscence39 and epithelial ingrowth18 have been 
reported. Because the majority of eyes in the reported LASIK series were grafted 
in young patients for keratoconus with a rapid wound healing, wound dehiscence 
problems were less likely to occur than in a group of older patients grafted for 
Fuchs endothelial dystrophy or bullous keratopathy.40 Since the effect of the flap 
cut alone may induce a significant reduction of refractive astigmatism in up to 50% 
in some patients and because of the high enhancement rate a two-stage LASIK 
procedure has been proposed.17, 41-43 However, it is unclear whether a two-stage 
procedure bears a higher risk for complications like epithelial ingrowth, wound 
healing problems and flap dislocation. In our present Artisan series, irreversible 
corneal decompensation occurred in two patients after metastasized cancer was 
diagnosed. Before the diagnosis of malignant disease BCVA was 20/25 in both 
patients and no signs of immunological rejection had been noted. We believe that 
changes in the immune system due to the concomitant development of malig-
nant systemic disease might have initiated the graft failures. In a third patient 
with a re-keratoplasty for a graft failure after an initial diagnosis of keratoconus 
an immunological irreversible graft failure occurred. This was the second rejec-
tion period after the re-keratoplasty following a previous reversible rejection 
period 4 months after cataract surgery. We can not exclude that the last rejection, 
although 8 months after surgery, may have been related to the Artisan toric lens 
implantation. Two of the three cases with corneal decompensation underwent 
succesful regrafting with explantation of the toric Artisan intraocular lens. In 6 
patients signs of adult retinal macular degeneration that decreased best corrected 
visual acuity were seen as can be expected in this age group. No other complica-
tions like chronic inflammation of the anterior chamber or retinal detachment in 
any of the patients were noted.
The stability of the postoperative refractive cylinder after Artisan toric lens 
implantation up to 36 months was excellent. After LASIK however, progressive 
changes were seen in refraction and topography in 35.7% of cases after a mean 
follow-up time of 26.9 months.18 A potential limitation of the Artisan toric IoL 
for the correction of postkeratoplasty astigmatism is surgically induced astigma-
tism by implantation of the rigid polymethylmethacrylate IoL through a 5.3 mm 
incision. In a recent series of implantation of the Artisan toric IoL for correction 
of myopia or hyperopia with astigmatism the surgically induced astigmatism was 
0.53 D.44 However, after keratoplasty the biomechanical response of the corneo-
scleral tissue to the incision may be somewhat unpredictable and a greater vari-
ability in surgically induced astigmatism may be seen. Indeed, in our series the 
mean surgically induced astigmatism was 2.53 D six months postoperatively and 
varied from 0.25 D to 6.25 D. Due to this variability we believe that the surgi-
cally induced astigmatism cannot be incorporated into the power calculation 
of the lens. Since the goal of correcting postkeratoplasty astigmatism is mainly 
to reduce the refractive astigmatism and ametropia to enable patients to wear 
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spectacles we feel that a lesser predictability of astigmatism reduction may be 
acceptable. 
Concerns have been raised especially with respect to the development of compli-
cations such as endothelial cell loss, chronic inflammation and cystoid macular 
edema after Artisan toric lens implantation. A study using fluorometry showed 
inflammation comparable with cataract surgery at 6 months postoperatively45 
whereas a study using a flare-cell meter found chronic inflammation 1 to 2 years 
after implantation of the older Worst-Fechner intraocular lens.46 We found no 
chronic inflammation by slit-lamp examination in the present study and cystoid 
macular edema with concomitant loss of BCVA was not seen in the immediate 
postoperative phase.
The mean endothelial cell loss was 13.8 ± 18.7%, 21.2 ± 21.8%, 29.6 ± 27.3%, 
and 30.4 ± 32.0% at 6, 12, 24 and 36 months. There was a significant continuing 
progressive endothelial cell loss at each time point as compared to preoperative 
cell density levels and between 6 months as compared to 12, 24, and 36 months. 
For an experienced surgeon the implantation of the Artisan toric lens in post-
keratoplasty eyes does not appear to be more traumatic as compared to Artisan 
lens implantation in phakic eyes for correction of myopia. However, the cell loss 
in the present series is much higher than the reported cell loss in studies of Artisan 
lens implantation for correction of high myopia up to 2 years postoperatively 
which varies from 1.76%36, 0.87%47 and 7.2%48 at 1 year to 0.78%47 and 9.1%48 at 2 
years. Probably, the higher cell loss is explained by the increased vulnerability of 
the corneal graft endothelium that usually has low cell densities and may cause a 
higher rate of endothelial cell loss. After routine keratoplasty, the annual rate of 
endothelial cell loss from 3 to 5 years after keratoplasty is 7.8% per year49 and from 
5 to 10 years is 4.2% per year.49-51 A recent study showed that the rate of cell loss 
from 10 to 15 years after penetrating keratoplasty is similar to normal corneas.51 
At the time of toric Artisan lens implantation 50% of our patients were between 
3 to 5 years, 27.7% between 5 to 10 years and 5.6% longer than 10 years after 
penetrating keratoplasty. For our 24 months cohort, the cell loss rate was 14.8% 
per year and for the 36 months cohort 10.1% per year. If we correct these values 
for the expected cell loss induced by the penetrating keratoplasty, there appears 
to be an additional cell loss of 6% to 7% per year. Therefore, we can not exclude 
that the Artisan iris-fixated IoL in the presence of a corneal graft with low cell 
densities may cause a higher rate of endothelial cell loss due to the compromised 
endothelium. However, the accuracy of non-contact specular microscopy for 
determining endothelial cell density which is usually around 5% is not known 
in grafts with low cell counts and may introduce bias in the interpretation of 
our results.52, 53 Risk factors for endothelial decompensation in corneal grafts 
with low cell densities have not been clearly defined. Cell counts as low as 370 
cells/mm2 and 515 cells/mm2 have been measured before decompensation.54-57 
Although the only patient (patient no. 12) that developed corneal decompen-
sation (without concommittant immunological rejection) in our series had an 
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endothelial cell density of 1384 cells/mm2 before Artisan implantation, we feel 
that the endothelial cell density of at least 500 cells/mm2 as exclusion criterium 
probably should be increased to prevent corneal decompensation. However, one 
should bear in mind that in many of our cases with postkeratoplasty ametropia 
no other treatment modalities exist but corneal regrafting, and the Artisan lens 
is perfectly removable at future regrafting procedures as has been shown in two 
patients in our series. 
Based on the objective medical outcomes, the subjective patient satisfaction that 
increased from 3.6 preoperatively to 8.0 postoperatively (scale 1-10) and the 
suitability of all patients for spectacle correction Artisan toric lens implantation 
appears to be a valuable option for correction of postkeratoplasty astigmatism 
and anisometropia. However, a cautious use of Artisan toric lens implantation is 
needed since we found a progressive endothelial cell loss in these corneas with a 
compromised endothelium. Therefore, more patients with a longer follow-up up 
to 5 years are needed to identify the risk factors for progressive endothelial cell 
loss and a randomized study of Artisan toric lens implantation versus LASIK with 
larger numbers of patients could clarify the advantages and disadvantages of both 
techniques with respect to efficacy, safety and complications.
Tahzib_Boek_06.indb   153 11-8-2008   11:32:44
154 Chapter 7
REFERENCES
1. Brahma A, Ennis F, Harper R, Ridgway A, Tullo A. Visual function after penetrating 
keratoplasty for keratoconus: a prospective longitudinal evaluation. Br J ophthalmol 
2000;84:60-6.
2. Webber SK, Lawless MA, Sutton GL, Rogers CM. LASIK for post penetrating kerato-
plasty astigmatism and myopia. Br J ophthalmol 1999;83:1013-8.
3. Troutman RC, Lawless MA. Penetrating keratoplasty for keratoconus. Cornea 
1987;6:298-305.
4. Binder PS. The effect of suture removal on postkeratoplasty astigmatism. Am J 
ophthalmol 1988;106:507.
5. Seitz B, Langenbucher A, Kus MM, Kuchle M, Naumann Go. Nonmechanical corneal 
trephination with the excimer laser improves outcome after penetrating keratoplasty. 
ophthalmology 1999;106:1156-64; discussion 1165.
6. Lopatynsky M, Cohen EJ, Leavitt KG, Laibson PR. Corneal topography for rigid gas 
permeable lens fitting after penetrating keratoplasty. Clao J 1993;19:41-4.
7. Eggink FA, Nuijts RM. A new technique for rigid gas permeable contact lens fitting 
following penetrating keratoplasty. Acta ophthalmol Scand 2001;79:245-50.
8. Solomon A, Siganos CS, Frucht-Pery J. Relaxing incision guided by videokeratography 
for astigmatism after keratoplasty for keratoconus. J Refract Surg 1999;15:343-8.
9. Koay PY, McGhee CN, Crawford GJ. Effect of a standard paired arcuate incision 
and augmentation sutures on postkeratoplasty astigmatism. J Cataract Refract Surg 
2000;26:553-61.
10. Lugo M, Donnenfeld ED, Arentsen JJ. Corneal wedge resection for high astigmatism 
following penetrating keratoplasty. ophthalmic Surg 1987;18:650-3.
11. Fenzl RE, Gills JP, 3rd, Gills JP. Piggyback intraocular lens implantation. Curr opin 
ophthalmol 2000;11:73-6.
12. Gayton JL, Sanders V, Van der Karr M, Raanan MG. Piggybacking intraocular implants 
to correct pseudophakic refractive error. ophthalmology 1999;106:56-9.
13. Bilgihan K, ozdek SC, Akata F, Hasanreisoglu B. Photorefractive keratectomy for 
post-penetrating keratoplasty myopia and astigmatism. J Cataract Refract Surg 
2000;26:1590-5.
14. Tuunanen TH, Ruusuvaara PJ, Uusitalo RJ, Tervo TM. Photoastigmatic keratectomy 
for correction of astigmatism in corneal grafts. Cornea 1997;16:48-53.
15. Amm M, Duncker GI, Schroder E. Excimer laser correction of high astigmatism after 
keratoplasty. J Cataract Refract Surg 1996;22:313-7.
16. Chang DH, Hardten DR. Refractive surgery after corneal transplantation. Curr opin 
ophthalmol 2005;16:251-5.
17. Busin M, Arffa RC, Zambianchi L, Lamberti G, Sebastiani A. Effect of hinged lamellar 
keratotomy on postkeratoplasty eyes. ophthalmology 2001;108:1845-51; discussion 
1851-2.
18. Kwitko S, Marinho DR, Rymer S, Ramos Filho S. Laser in situ keratomileusis after 
penetrating keratoplasty. J Cataract Refract Surg 2001;27:374-9.
Tahzib_Boek_06.indb   154 11-8-2008   11:32:44
155Artisan toric IOL and postkeratoplasty astigmatism
19. Koay PY, McGhee CN, Weed KH, Craig JP. Laser in situ keratomileusis for ametropia 
after penetrating keratoplasty. J Refract Surg 2000;16:140-7.
20. Rashad KM. Laser in situ keratomileusis for correction of high astigmatism after 
penetrating keratoplasty. J Refract Surg 2000;16:701-10.
21. Nassaralla BR, Nassaralla JJ. Laser in situ keratomileusis after penetrating keratoplasty. 
J Refract Surg 2000;16:431-7.
22. Forseto AS, Francesconi CM, Nose RA, Nose W. Laser in situ keratomileusis to 
correct refractive errors after keratoplasty. J Cataract Refract Surg 1999;25:479-85.
23. Hardten DR, Chittcharus A, Lindstrom RL. Long term analysis of LASIK for the 
correction of refractive errors after penetrating keratoplasty. Cornea 2004;23:479-89.
24. Buzard K, Febbraro JL, Fundingsland BR. Laser in situ keratomileusis for the correc-
tion of residual ametropia after penetrating keratoplasty. J Cataract Refract Surg 
2004;30:1006-13.
25. Barraquer CC, Rodriguez-Barraquer T. Five-year results of laser in-situ keratomileusis 
(LASIK) after penetrating keratoplasty. Cornea 2004;23:243-8.
26. Nuijts RM, Abhilakh Missier KA, Nabar VA, Japing WJ. Artisan toric lens implantation 
for correction of postkeratoplasty astigmatism. ophthalmology 2004;111:1086-94.
27. Waring Go, 3rd. Standard graphs for reporting refractive surgery. J Refract Surg 
2000;16:459-66.
28. Koch DD, Kohnen T, obstbaum SA, Rosen ES. Format for reporting refractive 
surgical data. J Cataract Refract Surg 1998;24:285-7.
29. Nijkamp MD, Dolders MG, de Brabander J, van den Borne B, Hendrikse F, Nuijts 
RM. Effectiveness of multifocal intraocular lenses to correct presbyopia after cataract 
surgery: a randomized controlled trial. ophthalmology 2004;111:1832-9.
30. van der Heijde GL, Fechner PU, Worst JG. [optical consequences of implanta-
tion of a negative intraocular lens in myopic patients]. Klin Monatsbl Augenheilkd 
1988;193:99-102.
31. Alpins N. Astigmatism analysis by the Alpins method. J Cataract Refract Surg 
2001;27:31-49.
32. Holladay JT, Cravy TV, Koch DD. Calculating the surgically induced refractive change 
following ocular surgery. J Cataract Refract Surg 1992;18:429-43.
33. Donnenfeld ED, Solomon R, Biser S. Laser in situ keratomileusis after penetrating 
keratoplasty. Int ophthalmol Clin 2002;42:67-87.
34. Malecha MA, Holland EJ. Correction of myopia and astigmatism after penetrating 
keratoplasty with laser in situ keratomileusis. Cornea 2002;21:564-9.
35. Guell JL, Gris o, de Muller A, Corcostegui B. LASIK for the correction of residual 
refractive errors from previous surgical procedures. ophthalmic Surg Lasers 
1999;30:341-9.
36. Malecaze FJ, Hulin H, Bierer P, et al. A randomized paired eye comparison of two 
techniques for treating moderately high myopia: LASIK and artisan phakic lens. 
ophthalmology 2002;109:1622-30.
Tahzib_Boek_06.indb   155 11-8-2008   11:32:44
156 Chapter 7
37. El Danasoury MA, El Maghraby A, Gamali To. Comparison of iris-fixed Artisan lens 
implantation with excimer laser in situ keratomileusis in correcting myopia between 
-9.00 and -19.50 diopters: a randomized study. ophthalmology 2002;109:955-64.
38. Donnenfeld ED, Kornstein HS, Amin A, et al. Laser in situ keratomileusis for correc-
tion of myopia and astigmatism after penetrating keratoplasty. ophthalmology 
1999;106:1966-74; discussion 1974-5.
39. Ranchod TM, McLeod SD. Wound dehiscence in a patient with keratoconus after 
penetrating keratoplasty and LASIK. Arch ophthalmol 2004;122:920-1.
40. Abou-Jaoude ES, Brooks M, Katz DG, Van Meter WS. Spontaneous wound dehiscence 
after removal of single continuous penetrating keratoplasty suture. ophthalmology 
2002;109:1291-6; discussion 1297.
41. Busin M, Zambianchi L, Garzione F, Maucione V, Rossi S. Two-stage laser in situ 
keratomileusis to correct refractive errors after penetrating keratoplasty. J Refract Surg 
2003;19:301-8.
42. Alio JL, Javaloy J, osman AA, Galvis V, Tello A, Haroun HE. Laser in situ keratomi-
leusis to correct post-keratoplasty astigmatism; 1-step versus 2-step procedure. J Cata-
ract Refract Surg 2004;30:2303-10.
43. Dada T, Vajpayee RB, Gupta V, Sharma N, Dada VK. Microkeratome-induced reduc-
tion of astigmatism after penetrating keratoplasty. Am J ophthalmol 2001;131:507-8.
44. Dick HB, Alio J, Bianchetti M, et al. Toric phakic intraocular lens: European multi-
center study. ophthalmology 2003;110:150-62.
45. Perez-Santonja JJ, Bueno JL, Zato MA. Surgical correction of high myopia in phakic 
eyes with Worst-Fechner myopia intraocular lenses. J Refract Surg 1997;13:268-81; 
discussion 281-4.
46. Perez-Santonja JJ, Iradier MT, Benitez del Castillo JM, Serrano JM, Zato MA. Chronic 
subclinical inflammation in phakic eyes with intraocular lenses to correct myopia. J 
Cataract Refract Surg 1996;22:183-7.
47. Pop M, Payette Y. Initial results of endothelial cell counts after Artisan lens for phakic 
eyes: an evaluation of the United States Food and Drug Administration ophtec Study. 
ophthalmology 2004;111:309-17.
48. Landesz M, Worst JG, van Rij G. Long-term results of correction of high myopia with 
an iris claw phakic intraocular lens. J Refract Surg 2000;16:310-6.
49. Bourne WM, Hodge Do, Nelson LR. Corneal endothelium five years after transplan-
tation. Am J ophthalmol 1994;118:185-96.
50. Bourne WM, Nelson LR, Hodge Do. Continued endothelial cell loss ten years after 
lens implantation. ophthalmology 1994;101:1014-22; discussion 1022-3.
51. Patel SV, Hodge Do, Bourne WM. Corneal endothelium and postoperative outcomes 
15 years after penetrating keratoplasty. Am J ophthalmol 2005;139:311-9.
52. Binder PS, Akers P, Zavala EY. Endothelial cell density determined by specular micro-
scopy and scanning electron microscopy. ophthalmology 1979;86:1831-47.
53. Laing RA. Specular microscopy of the cornea. Curr Top Eye Res 1980;3:157-218.
54. Hoffer KJ. Corneal decomposition after corneal endothelium cell count. Am J 
ophthalmol 1979;87:252-3.
Tahzib_Boek_06.indb   156 11-8-2008   11:32:44
157Artisan toric IOL and postkeratoplasty astigmatism
55. Nuyts RM, Boot N, van Best JA, Edelhauser HF, Breebaart AC. Long term changes 
in human corneal endothelium following toxic endothelial cell destruction: a specular 
microscopic and fluorophotometric study. Br J ophthalmol 1996;80:15-20.
56. Breebaart AC, Nuyts RM, Pels E, Edelhauser HF, Verbraak FD. Toxic endothelial cell 
destruction of the cornea after routine extracapsular cataract surgery. Arch ophthalmol 
1990;108:1121-5.
57. Armitage WJ, Dick AD, Bourne WM. Predicting endothelial cell loss and long-term 
corneal graft survival. Invest ophthalmol Vis Sci 2003;44:3326-31.
Tahzib_Boek_06.indb   157 11-8-2008   11:32:44
158 Chapter 7
Tahzib_Boek_06.indb   158 11-8-2008   11:32:44
Toric Artisan after radial keratotomy 159
8
Artisan iris-fixated toric 
phakic and aphakic 
intraocular lens implantation 
for the correction of 
astigmatic refractive error 
after radial keratotomy
Tahzib NG, Eggink FAGJ, Odenthal MTP, Nuijts RMMA.  
 
J Cataract Refract Surg. 2007 Mar;33(3):531-5.
Tahzib_Boek_06.indb   159 11-8-2008   11:32:45
160 Chapter 8
ABSTRACT
We report two patients who had previously undergone radial keratotomy (RK) to correct 
myopia. The first patient developed a postoperative hyperopic shift and cataract. Nine 
years after the RK, she underwent an intracapsular cataract extraction and implantation 
of an Artisan aphakic intraocular lens (IoL). Twenty years post-RK, hyperopia and 
astigmatism progressed to +7.0 -5.75 x 100º with a best-corrected visual acuity (BCVA) 
of 20/20. Due to contact lens intolerance, the Artisan aphakic IoL was exchanged for 
an Artisan toric aphakic IoL. Three months later, the BCVA was 20/20 with +1.0 -0.50 
x 130º. The second patient demonstrated residual myopic astigmatism six years after 
bilateral RK and had become contact lens intolerant. We treated the patient by the 
implantation of an Artisan toric phakic IoL in both eyes. Four months later, the BCVA 
was 20/25 and 20/20 with a refraction of +0.25 -1.0 x 135º and -1.0 x 40º, respectively. 
Both patients were satisfied with their visual outcome.
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INTRoDUCTIoN
Before the introduction of excimer laser technology, radial keratotomy (RK) was 
the most commonly performed refractive surgical procedure to correct myopia. 
The development of a hyperopic shift and diurnal fluctuations in visual acuity are 
common and troublesome side effects after this refractive surgery procedure.1-4 
The development of high astigmatism after RK is a less common side-effect.1, 5
The implantation of an Artisan toric phakic or aphakic intraocular lens (IoL) 
offers a good alternative to correct astigmatic error, allowing spherical and 
cylindrical correction in one procedure.6-9 The lens is composed of polymethyl 
methacrylate and has a convex-concave optic with a spherical anterior surface 
and a sphero-cylindrical posterior surface with a 5-mm optical zone (ophtec 
B.V., Groningen, the Netherlands). The aphakic lens model is also available 
with a convex-convex optic configuration. Recent results on Artisan toric IoL 
implantations in normal virgin eyes show that 63% to 73% reach ± 0.50 diopters 
(D) of the predicted correction with a best-corrected visual acuity improvement 
in 65.7% to 70% of eyes.6-8
We demonstrate two patients, one with progressive hyperopia and astigmatism 
after a previous RK procedure for the correction of a moderate myopia followed 
by an intracapsular cataract extraction with the implantation of an Artisan 
aphakic IoL. The other patient presented with bilateral residual myopia after a 
previous bilateral RK procedure. The two patients were eventually treated by 
the implantation of an Artisan toric aphakic and an Artisan toric phakic IoL 
with a satisfactory refractive outcome. 
Case reports
For both patients, IoL power calculations were performed by ophtec BV 
Gro ningen, the Netherlands. The axis of the cylinder identified by the subjective 
refraction was used to determine the axis of surgical enclavation. Toric IoLs are 
available with the cylinder in line with the haptics or at an angle of 90º with the 
haptics.8 An IoL with the cylinder in line with the haptics is recommended when 
the preoperative cylinder is between 0° and 45° or between 135° and 180°. The 
toric phakic Artisan IoL is available in cylindrical powers up to +7.0 D and the 
toric aphakic Artisan IoL is available in cylindrical powers up to +4.0 D. These 
lenses are custom- and patient-designed. The IoL power was calculated in order 
to obtain emmetropia. The enclavation sites were marked on the limbus with a 
marker right before the surgical implantation, with the patient sitting upright.
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Case 1
A 74-year-old female was referred to our university clinic due to progressive 
visual complaints in her right eye. Twenty years earlier, she had undergone a 
bilateral uneventful radial keratotomy (RK) procedure for the correction of a 
moderate myopia of -5.0 D in both eyes. The procedure included 8 RK incisions 
in the right eye. The right eye demonstrated a progressive hyperopic shift after 
the RK procedure. Nine years after the RK procedure, the right eye underwent 
an uneventful intracapsular cataract extraction with a subsequent implantation 
of an Artisan aphakic IoL (IoL power 23.0 D). After this procedure, the best-
corrected visual acuity (BCVA) in the right eye was 20/25 with +3.0 -4.0 x 
120º. 
Twenty years after the RK procedure, the preoperative BCVA in the right eye was 
20/20 with a refraction of +7.0 -5.75 x 100º. Topographic keratometry (EyeMap 
EH-290, Alcon, Forth Worth, TX) values were 32.1 x 10º and 25.8 x 100º 
(Fig. 1). The endothelial cell density (ECD) was 1633 cells/mm2 (Noncon RoBo 
Pachy SP-9000, Konan Medical Inc, Tokyo, Japan). The anterior chamber depth 
(ACD) was 3.45 mm (oCT Visante, Carl Zeiss AG, Germany) and the axial 
length was 26.04 mm. The intraocular pressure was 13 mmHg.
Lens power calculations were performed (Haigis formula) using the topographi-
cally derived keratometric (K)1 (32.1 D) and K2 (25.8 D) meridians and the 
axial length. This resulted in IoL powers of 24.6 D (K1) and 30.5 D (K2) for 
emmetropia. In addition, the patient’s residual refractive error in her eye with the 
Artisan aphakia lens was taken into account for the selection of the necessary lens 
power. Because the maximal cylindrical power is +4.0 D, a lens with a power 
of +24.0 +4.0 x 0º was custom-made to be implanted in the 10-degree axis. 
Based on this (suboptimal) calculation for emmetropia, the residual refraction 
was estimated at +3.0 -2.5 x 100º, suitable for spectacle correction. 
The patient underwent an exchange of the Artisan aphakic IoL for an Artisan 
toric aphakic IoL through a 5.3 mm corneoscleral incision. After rotation, the 
lens was fixated in the 10-degree axis with the use of a disposable enclavation 
needle (ophtec BV, Groningen, Netherlands). The wound was sutured with four 
interrupted 10 - 0 nylon sutures (Alcon, Fort Worth, Texas). The postoperative 
medical regimen has been described before.10
Ten months after the IoL exchange, the patient reported that her visual complaints 
had disappeared. The BCVA was 20/20 with a refraction of +1.00 -1.00 x 120º. 
Topographic keratometry values were 34.0 x 20º and 26.9 x 110º. The endothe-
lial cell density was 1383 cells/mm2; endothelial cell loss as compared to the 
preoperative ECD was 15.3%. The intraocular pressure was 12 mmHg. Slit-lamp 
examination showed a clear and centered IoL (Fig. 2).
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Figure 1. (Case 1) Corneal topography image before the Artisan toric aphakic intraocular 
lens implantation, demonstrating the large variability (approximately 23 to 38 diopters) in 
corneal powers in the 3-mm zone.
Figure 2. (Case 1) A slit-lamp photograph taken one month after the implantation of 
an Artisan toric aphakic intraocular lens for the correction of progressive hyperopia and 
astigmatism after cataract surgery in an eye that was previously treated with radial kera-
totomy. The lens was enclaved along the 10-degree axis (the perforated line marks the 
90-degree meridian axis of the toric lens).
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Figure 4. (Case 2, left eye) A slit-lamp photograph taken four months after the implanta-
tion of an Artisan toric phakic intraocular lens for the correction of residual myopia in an 
eye previously treated with radial keratotomy (RK) (the arrows indicate RK incisions). 
The lens was enclaved along the 40-degree axis (the perforated line marks the 90-degree 
meridian axis of the toric lens).
Figure 3. (Case 2, left eye) Corneal topography image before Artisan toric phakic 
intraocular lens implantation for the correction of residual myopia in an eye that was 
previously treated with 12 radial keratotomy incisions. The image shows a well-centered 
optical zone and a regular astigmatism.
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Case 2
A 43-year-old female visited our university clinic in April 2005 for bilateral 
visual complaints. In 1995 she had undergone a bilateral RK procedure for the 
correction of a high myopia in both eyes. The pre-RK refraction was -10.5 -2.0 
x 142º on the right and -11.25 -2.0 x 1º on the left. The procedure included 12 
RK incisions in both eyes. Ten years after the RK procedure, the refraction was 
-6.0 -3.5 x 135º on the right and -6.0 -3.0 x 45º on the left. Due to contact lens 
intolerance, we scheduled her for a surgical correction of the residual myopia and 
astigmatism through the implantation of an Artisan toric phakic IoL implanta-
tion in both eyes. 
The preoperative BCVA in the right eye was 20/30 with a refraction of -6.0 -3.5 
x 130º on the right and 20/30 with a refraction of -6.5 -3.0 x 40º on the left. 
Topographic keratometry values were 40.0 x 50º and 37.4 x 140º on the right and 
39.7 x 120º and 37.4 x 30º on the left (Fig. 3). The endothelial cell densities were 
2117 cells/mm2 and 1971 cells/mm2, respectively. The ACDs were 3.28 mm and 
3.25 mm, respectively. The intraocular pressures were 14 mmHg. 
IoL power calculations for postoperative emmetropia were performed using the 
corneal curvature, adjusted ACD, and manifest SE of the patient’s subjective 
refractive error (van der Heijde formula)11 and resulted in an IoL power of -6.47 
-3.23 x 130º for the right eye and -6.93 -2.75 x 40º for the left eye. As mentioned 
above, it is usually preferred to position an Artisan IoL in a horizontal or an 
oblique angle, which resulted in an IoL with a dioptric power of -6.5 -3.0 x 
90º which was fixated in the 40-degree axis in the right eye and an IoL with a 
dioptric power of -7.0 -2.5 x 0º which was fixated in the 40-degree axis in the 
left eye.
We performed an implantation of an Artisan toric phakic IoL in the right eye, 
and two weeks later in the left eye. The surgical technique and postoperative 
medications were as described in the first case. 
Four months after the IoL implantation, the patient reported that her visual 
complaints had disappeared and that she was very satisfied. The uncorrected 
visual acuity was 20/25 and 20/30, respectively. The BCVA was 20/25 with a 
refraction of +0.25 -1.0 x 135º and 20/20 with a refraction of -1.0 x 40º, respec-
tively. Topographic keratometry values were 40.6 x 57º and 37.4 x 147º on the 
right and 39.4 x 130º and 37.1 x 40º on the left (Fig. 4). The ECDs were 2120 
cells/mm2 and 1946 cells/mm2, respectively. Endothelial cell loss as compared to 
the preoperative ECD was -0.14% and 1.27% for the right and left eye, respec-
tively. The intraocular pressures were 16 mmHg. Slit-lamp examination showed 
clear and centered IoLs (Fig. 4).
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DISCUSSIoN
Although RK procedures initially achieve satisfactory refractive outcome results, 
side effects are known to occur. Clinical studies show that the development of a 
hyperopic shift after RK is a common side effect that occurs with a frequency of 
17% to 43% with an additional incidence of 1% to 2% each year.1, 3, 4, 12-16 This is 
due to the long-term instability of the refraction which is related to the ongoing 
effect of the procedure and a possible insufficient corneal stability.12, 17 The devel-
opment of irregular astigmatism after RK can be induced by the intersection of 
the incisions with the visual axis or by the eccentricity of the optical zone.5 
We have no adequate explanation why the topographical K-values for the 
calculation of the IoL powers led to such a favorable outcome in our first case. 
one explanation could be that among the variable corneal powers in the 3-mm 
zone (Fig. 1), the selected K-value by chance was the most appropriate one. In 
the second case, it is probable that the K-values regressed toward the corneal 
curvature parameters prior to the RK, since it is unlikely that the K-values after 
RK (mean value 38.7 and 38.6 D, right and left eye) were comparable with the 
pre-RK refractions of -11.5 and -12.50 D, right and left eye. Following this 
hypothesis, the topographically measured error might have been smaller.
Various techniques can be used to treat residual refractive error following RK. 
The correction of myopic astigmatism after RK by a contact lens may be useful, 
but may be complicated by intolerance.18 The lasso-string suture serves only as 
an immediate solution for symptomatic overcorrected hyperopic eyes after radial 
keratotomy, but seems to have a diminishing effect over time.19, 20 Photorefrac-
tive keratectomy and laser in situ keratomileusis did not appear to be reasonable 
options because of the magnitude of the refractive error in both cases and the 
possible consequences for development of haze and flap complications.21-25 Clear 
lens extraction could be considered in our second case, but would not sufficiently 
treat her astigmatism and also has a higher risk for postoperative retinal detach-
ment.26, 27 The implantation of a (phakic) toric posterior chamber IoL could have 
been a suitable option in the second case.28, 29 Since the spectacle BCVA after 
RK was ≥ 20/25 in all eyes, indicating no significant visual loss from irregular 
astigmatism, penetrating keratoplasty (PK) was no valuable option. The implan-
tation of toric iris-fixated IoLs in normal virgin and post-PK eyes appears to be 
a safe and predictable method for the correction of high levels of astigmatism, 
with 63% to 73% of treated eyes within ±0.50 D of the predicted correction 
and a BCVA improvement in 65.7% to 70% of eyes.7-9, 30 To our knowledge, the 
implantation of an Artisan toric lens in RK-eyes has not been described before 
and therefore the long-term visual stability and safety data are unknown. During 
the procedure we aimed to avoid wound dehiscence of the RK incisions by 
making a corneoscleral tunnel at a distance of 1.5 mm from the limbus.
The amount of endothelial cell loss after Artisan lens implantation in normal 
virgin eyes has been shown to vary and can be as high as 12%.31-34 However, studies 
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on endothelial cell loss in eyes that underwent Artisan toric lens implantation 
after PK showed a loss close to 30% after 24 months, which suggests that corneal 
grafts are more susceptible to endothelial cell loss. As far as we know, there are no 
data in the literature of the long-term effects of the Artisan aphakic lens on the 
corneal endothelium.9, 35 our first case of implantation of the Artisan toric lens 
in an aphakic eye demonstrated an endothelial cell loss close to 14%. We believe 
that this is an acceptable loss in this patient, considering her limited treatment 
options and her significant visual complaints. The second case of implantations of 
the Artisan toric lens in phakic eyes showed a low endothelial cell loss of -0.14% 
and 1.27%, respectively, which is in accordance with the literature.
In summary, our first case was successfully treated by the implantation of an 
Artisan toric aphakic IoL and the second case had a similar satisfactory outcome 
after the implantation of an Artisan toric PIoL. In RK-eyes, the removability 
option of the Artisan lens can be an important advantage, especially when 
dealing with potentially progressive refractive error changes after corneal refrac-
tive surgery. 
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ABSTRACT
We describe a 54-year old man who developed a severe cell deposition one week after the 
implantation of a foldable Artiflex phakic intraocular lens (PIoL) with a silicone optic 
and polymethyl methacrylate (PMMA) haptics in the left eye for the correction of high 
myopia. Nine months after the lens implantation, many cell deposits remained visible on 
the posterior surface of the lens, causing him to suffer from severe glare, especially during 
daylight conditions. We explanted the Artiflex PIoL and exchanged it for a PMMA 
Artisan PIoL. 
one month after the lens exchange, the uncorrected visual acuity was 20/20 and the 
patients’ glare complaints had disappeared. Slit-lamp examination showed no signs of 
inflammation in the anterior segment or any cell deposits on the PMMA Artisan PIoL. 
Scanning electron microscopy demonstrated multiple cell deposits on the explanted 
Artiflex PIoL.
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INTRoDUCTIoN
The Artiflex lens is an iris-fixated phakic intraocular lens (PIoL) for the correc-
tion of myopia and has not been described before. The Artiflex PIoL has a 
convex-concave silicone optic with a 6-mm flexible optical zone (for intraocular 
lens powers from –2.0 up to –14.50 D) with polymethyl methacrylate (PMMA) 
rigid haptics and is available in 0.50 D steps (ophtec B.V., Groningen, the Neth-
erlands). The Artiflex design differs from the PMMA Artisan design in that the 
vault between the haptic-optic junction and the iris plane is 0.13 mm in the Arti-
flex PIoL as compared to 0.20 mm in the PMMA Artisan PIoL. The foldable 
Artiflex PIoL may offer an advantage compared to the PMMA Artisan PIoL 
by its insertion through a 3.4 mm incision as compared to a 6.3 mm incision for 
the PMMA Artisan PIoL. The smaller incision may decrease surgically induced 
astigmatism and postoperative inflammation. 
We report a case of severe adhesion of cell deposits to the posterior surface of 
an Artiflex lens and the lens haptics, which was treated by the exchange of the 
Artiflex PIoL for an Artisan PIoL, nine months after the initial implantation.
Case report
A 54-year old male was scheduled for Artiflex PIoL implantation in both eyes 
for the correction of high myopia. The preoperative best corrected visual acuity 
(BCVA) in the right and left eye was 25/20 and 20/20 with a refraction of –9.25 
D and -9.5 D -0.5 x 0º, respectively. The intraocular pressures were 16 mmHg 
in both eyes. The anterior chamber depths (IoL Master, Carl Zeiss Meditec, 
Germany) were 3.30 mm and 3.22 mm in the right and left eye. The endothelial 
cell counts were 2697 cells/mm2 and 2842 cells/mm2, respectively. The scotopic 
pupil diameter measured with the Colvard pupillometer (oasis Medical, Glen-
dora, CA) under dim light conditions was 6.0 mm in both eyes. 
The surgical procedure consisted of a two-plane 3.4 mm limbal incision centered 
at 12-o’clock. Two stab incisions were performed at 2- and 10 o’clock and directed 
towards the enclavation sites. After an intracameral injection of acetylcholine, the 
lens was introduced beneath an ophthalmic viscoelastic device (Healon GV®, 
Pharmacia, Uppsala, Sweden) and fixated with custom-designed instruments 
(ophtec B.V., Groningen, the Netherlands). A slit iridotomy was performed at 
12 o’clock to avoid pupillary block glaucoma. The wound was sutured with one 
10-0 nylon suture (Alcon, Fort Worth, Texas). At the end of the surgical proce-
dure, a 1.0 cc subconjunctival steroid injection (Celestone®, Schering-Plough, 
Kenilworth, New Jersey) was given. Postoperatively, topical tobramycin 0.3% 
combined with dexamethasone 0.1% (Tobradex®, Alcon, Couvreur, Belgium) 
and ketorolactrometamol 0.5% (Acular®, Westport Co., Mayo, Ireland) were 
used four times daily for 3 weeks in a tapered regimen and three times daily for 
1 week, respectively. 
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The procedure in the right eye whereby an Artiflex PIoL with a power of -9.5 
D was implanted, was uneventful and 1 month postoperatively the uncorrected 
visual acuity (UCVA) and BCVA were 20/20 and 25/20 with a refraction of 
plano –0.5 x 145º. Three months postoperatively, the UCVA was 20/20 with 
a 1+ cell reaction in the anterior chamber and cell and pigment deposits on the 
posterior surface of the PIoL. The intraocular pressure was 20 mmHg. A short 
course of prednisolone acetate (Predforte®, Allergan, Co. Mayo, Ireland) q.i.d. 
and timolol 0.5% 2 times daily eye drops was initiated and the inflammatory reac-
tion subsequently subsided. Twelve months postoperatively, UCVA and BCVA 
in the right eye were 20/20 and 25/20 with a refraction of +0.25 D. There were 
no inflammatory signs in the anterior chamber or any visible cell deposits on the 
PIoL. The endothelial cell density was 2746 cells/mm2.
Six weeks after the uncomplicated surgical procedure in the right eye, the left 
eye underwent an uneventful implantation of an Artiflex PIoL with a power of 
–10.0 D. There was no difference in the surgical technique or in the degree of 
iris manipulation between the procedures on the right and left eye. one week 
after the procedure, the patient complained of starbursts which he experienced in 
bright daylight conditions. Slit-lamp examination of the left eye demonstrated a 
severe cell deposition (>15 clusters of cells) and pigment on the posterior surface 
of the PIoL. The intraocular pressure was 24 mmHg. Prednisolone acetate 
(Predforte®, Allergan, Co. Mayo, Ireland) eye drops were given at a dose of 6 
times daily and eye-pressure lowering eye drops were applied once a day. Six 
months postoperatively, after slow tapering of the steroid drops, a recurrence 
of large cell deposits was seen on the posterior surface of the PIoL and on the 
lens haptics. Increasing the dosage of topical steroids resulted in a subsequent 
decrease of the cell deposits on the PIoL. Nine months after surgery however, 
after renewed tapering of the steroid eye drop regimen, slit-lamp examination 
again demonstrated many large cell and pigment deposits on the posterior surface 
of the PIoL (Figure 1). The BCVA decreased to 20/25 with a refraction of +0.5 
-1.0 x 170º. The patient reported persistent and severe glare complaints during 
daylight conditions. The endothelial cell count was 2457 cells/mm2. 
An uneventful explantation of the left Artiflex PIoL with a subsequent exchange 
for a PMMA Artisan PIoL was performed. During surgery, aqueous humor was 
obtained for inflammatory cell analysis and the explanted Artiflex lens was fixed 
for scanning electron microscopy. 
Three months after the lens exchange, the UCVA of the left eye was 20/20 and 
the intraocular pressure was 16 mmHg. Slit-lamp examination did not show any 
cell deposits on the PMMA Artisan PIoL and the patient no longer complained 
of glare.
Scanning electron microscopy demonstrated multiple cell deposits with a pseu-
dopodia-like pattern on the posterior surface of the PIoL and on the haptics 
(Figure 2). Inflammatory cell analysis with a CD45 and a stem-cell marker did 
not demonstrate specific staining for lymphocytes or granulocytes. Analysis with 
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a CD68 marker did not demonstrate the presence of macrophages, however since 
only one marker was used for analysis, it is not sure whether macrophages were 
present or not.
Figure 1. A slit-lamp photograph taken nine months after the implantation of the iris-fixated 
silicone Artiflex phakic intraocular lens. The photograph demonstrates the many large cell 
and pigment deposits, which are mainly dispersed in the central zone on the posterior surface 
of the lens.
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Figure 2. Scanning electron microscopy images illustrating an overview of the multiple 
large cell deposits on the posterior surface of the lens (a), demonstrating the finding of a very 
large accumulation of cell deposits at the junction of the silicone optic with the polymethyl 
methacrylate haptics (b), and demonstrating the pseudopodia-like pattern of the cells (c and 
d).
c
d
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DISCUSSIoN
The advantages of a phakic intraocular lens (PIoL) for the correction of moderate 
to high myopia are the potential reversibility, safety, predictability and stability 
of the correction. Clinical studies have demonstrated that the implantation of 
the recently FDA approved polymethyl methacrylate (PMMA) Artisan PIoL 
for the correction of myopia is a safe, effective and predictable procedure.1-6 The 
foldable Artiflex iris-fixated PIoL is a new development in the area of lenticular 
refractive surgery techniques for the correction of myopia and is currently being 
evaluated in a European multicenter study. one of the major advantages of the 
foldable Artiflex lens over the PMMA Artisan lens is the insertion through a 
smaller incision of 3.4 mm, which may reduce the surgically induced astigmatism 
and may shorten the visual recovery period after surgery. No reports on the 
safety or efficacy of the recently introduced Artiflex foldable PIoL are currently 
available in the literature, except for a case report on the correction of aphakia 
after penetrating ocular injury.7 
our case report demonstrates recurrent anterior segment inflammation with 
subsequent cell and pigment deposits on the posterior surface of the Artiflex 
PIoL. The pathogenesis of this reaction is currently unknown, but we hypo-
thesize that the decreased vault between the haptic-optic junction of the lens and 
the iris plane may result in mechanical irritation of iris tissue during pupillary 
constriction and dilation. This may trigger a foreign-body respons and lead to 
breakdown of the blood-aqueous barrier with subsequent cell adhesions to the 
lens. our hypothesis is supported by the finding that the largest accumulation of 
cell deposits occurred at the junction of the optic with the haptics. It is unclear 
whether the biocompatibility of the silicone material which has been used for 
the manufacturing of foldable posterior chamber lenses throughout many years 
by the same company without any adverse sequelae, plays a role in addition to 
Figure 3. This drawing with cross-sections of the old and the new design of the Artiflex 
phakic intraocular lens illustrates that the new lens design is made up of an increased vault 
of 0.20 mm (compared to 0.13 mm in the old design) between the optic-haptic junction and 
the iris plane. 
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the mechanical hypothesis. Various reports have described a decreased capsular 
or uveal biocompatibility of silicone lenses after cataract surgery in patients with 
uveitis or diabetes who are at risk for increased wound healing and inflammatory 
reactions after surgery.8, 9 Two recent studies have suggested that pigment disper-
sion and subsequent inflammatory reaction after the implantion of Artisan PIoLs 
may be caused by abnormal pressure on the iris, which can become sandwiched 
between the crystalline lens and the PIoL, especially in hyperopic eyes.10, 11 After 
the exchange of the Artiflex PIoL for the Artisan PIoL, which has a larger vault 
between the optic-haptic junction and the iris plane, the inflammatory reaction 
disappeared and no further cell adhesion was noted. 
In conclusion, we believe that further improvements in the design of the Artiflex 
PIoL are needed to achieve the similar safety profile of its precursor, the PMMA 
Artisan PIoL, which has been used for many years with excellent safety and effi-
cacy results. Recently, the company redesigned the Artiflex PIoL and increased 
the vault between the optic-haptic junction and the iris plane to 0.20 mm (Figure 
3). Further study is needed to evaluate whether this will prevent accumulation of 
cell and pigment deposits on the Artiflex PIoL.
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ABSTRACT
Purpose: To evaluate higher order aberrations (HoA) after implantation of a foldable 
Artiflex phakic intraocular lens (PIoL).
Design: Retrospective comparative case-series.
Methods: Twenty-seven eyes of 14 patients who underwent Artiflex PIoL implantation 
were analyzed and compared to 22 eyes of 13 patients after Artisan PIoL implantation. 
Refractive data, pupil size, lens decentration and HoA values were recorded. Laboratory 
analysis was performed on both lenses. Follow-up was 1 year.
Results: In the Artiflex group, the mean spherical equivalent (SE) changed from -9.95 ± 
1.43 diopters (D) (-6.75 to -12.13 D) to -0.30 ± 0.53 D (-1.94 to 0.56 D). Postoperatively, 
trefoil-y increased (increase factor 1.73) and spherical aberration decreased (increase 
factor 0.55). The mean decentration value was 0.24 ± 0.12 mm, with 96.3% demon-
strating a decentration value <0.5 mm. There was a significant correlation between lens 
decentration and postoperative spherical aberration and coma-y. In the Artisan group, 
the mean SE changed from -9.90 ± 2.74 D (-4.0 to -14.50 D) to -0.20 ± 0.42 D (-0.75 
to 0.50 D). Postoperatively, trefoil-y and spherical aberration both increased (increase 
factors 3.32 and 6.84, respectively). Laboratory analysis confirmed the negative spherical 
aberration profile of the Artiflex PIoL and the positive spherical aberration profile of the 
Artisan PIoL.
Conclusion: Artiflex implantation induced a decrease in spherical aberration, while 
Artisan implantation induced an increase in spherical aberration. Trefoil-y increased in 
both groups. These changes might be explained by incision size differences in relation to 
trefoil, and differences in optic design in relation to spherical aberration.
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INTRoDUCTIoN
Refractive surgery techniques have the goal of correcting the spherical and cylin-
drical refractive error in patients with visual complaints and who have the desire 
to be independent of spectacles and contact lenses.
We now know that naturally-occurring and surgically-induced optical abnor-
malities exist, which are also referred to as optical aberrations. optical aberra-
tions include lower and higher order aberrations (HoA). HoA (also referred to 
as irregular astigmatism) may influence postoperative visual outcome and patient 
satisfaction and need to be included in the preoperative evaluation and selection 
of refractive surgery candidates.1-3 The literature contains several clinical reports 
that have studied changes in HoA after refractive surgery for the correction 
of myopia, particularly after myopic laser in situ keratomileusis (LASIK) and 
photorefractive keratectomy (PRK).4-13 one study reported that the amount of 
achieved correction correlated with changes in ocular HoA.4 Another report 
demonstrated that total HoA increased by factor 1.53 and that spherical aberra-
tion increased by factor 1.6.6
The excellent levels of efficacy, predictability, and safety of the Artisan phakic 
intraocular lens (PIoL) for the correction of moderate to high myopia, have been 
confirmed by several clinical reports.14-24 The recently designed Artiflex lens is 
an iris-fixated PIoL which can be implanted for the correction of myopia25; 
the lens is currently under clinical investigation in Europe. To our knowledge, 
only a few case reports26, 27 and two clinical studies have so far evaluated the 
clinical and refractive results of this new iris-fixated PIoL model for the correc-
tion of myopia.28, 29 The Artiflex lens has a convex-concave silicone optic with a 
6-mm flexible optical zone (for intraocular lens powers from –2.0 up to –14.50 
D) with polymethyl methacrylate (PMMA) rigid haptics. In its early design, the 
vault between the haptic-optic junction and the iris plane of the Artiflex PIoL 
design was 0.13 mm as compared to 0.20 mm in the PMMA Artisan PIoL 
was. Recently, the company redesigned the Artiflex lens and increased the vault 
between the optic-haptic junction and the iris plane to 0.20 mm. The foldable 
Artiflex PIoL may offer an advantage compared to the PMMA Artisan PIoL 
by its insertion through a 3.4 mm incision as compared to a 6.3 mm incision for 
the PMMA Artisan PIoL. The smaller incision has advantages in that it leads to 
quicker rehabilitation and less trauma and postoperative inflammation.
The purpose of this study was to evaluate changes in HoA after Artiflex PIoL 
implantation and to compare these to a matched group of patients who had 
undergone Artisan PIoL implantation for the correction of a similar level of 
myopia.
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METHoDS
Patient population and study design
The Artiflex patient group consisted of 27 eyes of 14 patients who had undergone 
Artiflex PIoL implantation for the correction of myopia. The Artisan group 
consisted of 22 eyes of 13 patients who had undergone Artisan PIoL implanta-
tion for the correction of myopia.
Comparisons of pre- and postoperative clinical data were made for all eyes. 
Investigational review board approval was obtained from the Academic Hospital 
Maastricht.
Inclusion criteria
Inclusion criteria were identical for both patient groups and were: a stable refrac-
tion during the previous 2 years, a preoperative spectacle corrected visual acuity 
≥ 20/50; an anterior chamber depth of 3.0 mm or more (IoL Master, Carl Zeiss 
AG, Germany); an endothelial cell density (ECD) count of 2000 cells/mm2 or 
more (Noncon RoBo Pachy SP-9000, Konan Medical Inc, Tokyo, Japan), a 
normal pupil and iris configuration; no history of glaucoma, no pre-existent 
corneal, lenticular or retinal pathology likely to alter vision and no history of 
chronic or recurrent uveitis.
Clinical evaluation
Pre- and postoperatively, subjective and objective refraction was determined by 
measurement of the Snellen uncorrected (UCVA) and best-corrected (BCVA) 
visual acuity. Slit-lamp microscopy, corneal topography (Alcon Eyemap EH-290, 
Alcon, Fort Worth, TX), and intraocular pressure measurement with Goldmann 
applanation tonometry and dilated fundus examinations were performed.
Pupil size and PIOL decentration
The mesopic-low (with an illumination level of 0.4 lux) pupil size was meas-
ured with a digital infrared pupillometer (P2000 SA pupillometer, Procyon 
Instruments Ltd., London, UK). This device has been described before.14, 30 The 
amount of PIoL decentration was determined by measuring the deviation of the 
center of the PIoL from the center of the pupil using the digital photography 
mode within the pupillometer.
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Wavefront measurements
Wavefront measurements were performed with a Hartmann-Shack wavefront 
sensor (Zywave aberrometer, software version 3.21, Bausch & Lomb-Technolas, 
Munich, Germany) with an analysis pupil diameter of 6 mm. The aberrations 
analyzed in this comparative study are classified in terms of HoA, trefoil-x (Z
3
3), 
trefoil-y (Z
3
-3), coma-x (Z
3
1), vertical coma-y (Z
3
-1), and spherical aberration (Z
4
0). 
All values are in oSA order and sign convention. The Zywave aberrometer and 
technique of Zywave measurements have been described before.14, 31-33
Laboratory HOA analysis
To study the changes in HoA for each lens type, a laboratory investigation was 
performed at the Center for Visual Science at the University of Rochester. For 
this purpose, two Artiflex and two Artisan myopic lenses with a lens power 
of –9 D and two Artiflex and two Artisan myopic lenses with a lens power of 
-12 D were mounted vertically in a wet cell and measured with a high resolu-
tion Shack-Hartmann type wavefront sensor developed at the Center for Visual 
Science at the University of Rochester, to measure the aberration profile of these 
ophthalmic lenses. Collimated light (632.8 nm) was directed at the lens and 
aberrations to the 10
th order were collected. The spacing between the lenslets was 
133.33 μm with a focal length of 3.75 mm. There are 745 wavefront sensing spots 
in a 6 mm pupil which are sufficient to reliably calculate up to 10th order Zernike 
aberrations. HoA were measured over a 6 mm pupil size, and were renormalized 
to 5 mm and 4 mm diameters (with decentrations up to 200 μm). Spherical aber-
ration corresponds with Zernike mode number 12 (Z
4
0).
Surgical procedure
All treatments were performed by a single surgeon (R.N.) at the Academic 
Center for Refractive Surgery, University Eye Clinic of Maastricht.
The Artiflex lens is an iris-fixated PIoL for the correction of myopia. It is a three-
piece lens consisting of a 6-mm flexible optic made from ultraviolet absorbing 
polysiloxane and rigid haptics made from compression molded Perspex CQ UV 
PMMA (for intraocular lens powers from –2.0 up to –14.50 D) and is available 
in 0.50 D steps (ophtec B.V., Groningen, the Netherlands). The Artisan iris 
claw-fixated PIoL has a convex-concave PMMA optic with either a 6-mm (for 
intraocular lens powers up to –15.5 D) or a 5-mm (for intraocular lens powers 
from –16.0 D up to –24.0 D) and is available in 0.50 D steps (ophtec B.V., 
Groningen, the Netherlands) (Fig. 1).
The Artiflex design that was analysed in this study differed from the Artisan 
design in that the vault between the haptic-optic junction and the iris plane was 
0.13 mm in the Artiflex PIoL as compared to 0.20 mm in the PMMA Artisan 
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PIoL. The incision used for the foldable Artiflex PIoL is 3.4 mm as compared 
to the 6.3 mm incision required for the PMMA Artisan PIoL. Recently, the 
company redesigned the Artiflex PIoL and increased the vault between the 
optic-haptic junction and the iris plane to 0.20 mm, thereby aiming to prevent 
accumulation of cell and pigment deposits on the Artiflex PIoL.27
The dioptric power of the lens was calculated with the use of the refractive error, 
refractive cylinder power, anterior chamber depth, and topographically derived 
keratometric dioptric values (EyeMap EH-290, Alcon, Forth Worth, Tx), which 
were inserted into the Van der Heijde formula.17 The power of the lens was 
chosen to obtain emmetropia. When the emmetropic lens was not available, the 
power of the lens was estimated for a slight residual myopia.
Surgery was performed under general anaesthesia. Important differences between 
the Artiflex and Artisan surgical procedures are the incision size, which is 3.4 
mm for the Artiflex lens and 6.3 mm for the Artisan lens. Also, after the Artiflex 
implantation, the wound is sutured with one 10-0 nylon suture (Alcon, Fort 
Worth, Texas) and after the Artisan procedure with 5 interrupted 10-0 nylon 
Figure 1. Schematic photograph of the Artiflex 
(above) and Artisan (below) Phakic Intraocular 
Lens design
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sutures. At the end of the Artiflex procedure, a 1.0 cc subconjunctival steroid 
injection (Celestone®, Schering-Plough, Kenilworth, New Jersey) is adminis-
tered. The surgical technique for the enclavation of the lens and postoperative 
medication is basically the same as that used with standard Artisan PIoLs and has 
been described before.14, 20-22
Included patients showed a stable postoperative refraction and were examined 
preoperatively and at day 1, week 1, month 1, 3 and 6, and from then at 6-month 
intervals.
Data analysis
For statistical analysis and comparisons between preoperative and postoperative 
data, a parametric paired Student’s t-tests was used (P < 0.05 being significant). 
We compared absolute values, since a shift to more negative aberration values 
does not automatically mean a reduction of the wavefront error if preoperative 
values are negative. To maintain an overall level of less than 0.01 for multiple 
tests, a Bonferroni correction was performed. (SPSS for Windows, SPSS Inc., 
Chicago, IL). Increase factors were used to reflect the wavefront change in rela-
tion to the preoperative value (absolute values were used).
Snellen visual acuities were transformed to LogMAR values for statistical 
comparison.
Wavefront analysis was performed for pupil diameters of 6.0 mm. Results from 
the wavefront examinations were transformed into absolute values for statistical 
analysis. Zernike coefficients up to the 4th order are currently included in the 
measurements. Calculations were performed using HoA, trefoil-x, trefoil-y, 
coma-x, coma-y and spherical aberration.
Correlations between clinical parameters such as visual acuity and refractive 
outcome were performed for data obtained at the 12 month follow-up exami-
nation and assessed with the Pearson r coefficient of correlation. Intergroup 
comparisons were made using an independent samples Student’s t-test. All values 
in the text are mean ± standard deviation (SD).
RESULTS
Patient population
In the Artiflex group, 8 patients were female and 6 were male (Table 1). The 
mean preoperative patient age was 41 ± 8 years (26 to 51 years). The mean 
anterior chamber depth was 3.66 ± 0.33 mm (range, 3.20 to 4.72 mm) and the 
mean intraocular pressure was 14.77 ± 2.63 mmHg (range, 10.0 to 19.0 mmHg). 
The mean power of the implanted PIoL was -9.57 ± 4.23 D (range, -8.0 to 
-12.50 D).
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In the Artisan group, 9 patients were female and 4 were male. The mean preop-
erative patient age was 40 ± 12 years (18 to 52 years). The mean anterior chamber 
depth was 3.71 ± 0.29 mm (range, 3.0 to 4.0 mm) and the mean intraocular 
pressure was 14.19 ± 3.04 mmHg (range, 10.0 to 20.0 mmHg). The mean power 
of the implanted PIoL was -10.82 ± 2.69 D (range, -5.0 to -15.0 D).
Clinical outcome
For the Artiflex group, the mean preoperative spherical equivalent (SE) changed 
from -9.95 ± 1.43 D (range, -6.75 to -12.13 D) to -0.23 ± 0.40 D (range, -1.25 
to 0.75 D), postoperatively (Table 2). After 1 year, 85.7% of eyes were within ± 
0.5 D of the desired refraction. The mean refractive cylinder changed from -0.77 
± 0.53 preoperatively to -0.57 ± 0.54 D at 1 week, -0.49 ± 0.49 D at 1 month, 
-0.54 ± 0.47 D at 3 months and -0.51 ± 0.52 D at 1 year follow-up. The mean 
preoperative logMAR BCVA changed from 0.0 ± 0.07 (range, -0.08 to 0.15) to 
Table 1. Summary of population characteristics and preoperative data for the Artiflex and 
Artisan Phakic Intraocular Lens groups for the correction of myopia.
Artiflex group Artisan group
Variable Mean ± SD Range Mean ± SD Range
Mean patient age (yrs) 41.0 ± 7.8 26 to 51 40.0 ± 12.0 18 to 52
Number of eyes 27 22
Number of females 8 9
ACD (mm) 3.66 ± 0.33 3.20 to 4.72 3.71 ± 0.29 3.0 to 4.0
IoP (mmHg) 14.77 ± 2.63 10.0 to 19.0 14.19 ± 3.04 10.0 to 20.0
Implanted lens power (D) -9.57 ± 1.11 -8.0 to -12.50 -10.82 ± 2.69 -5.0 to -15.0
Mesopic-low pupil size (mm) 4.95 ± 1.11 3.34 to 6.69 3.84 ± 0.79 2.64 to 5.32
SD = standard deviation; ACD = anterior chamber depth; IoP = intraocular pressure; 
D = diopters.
Table 2. Summary of the visual and refractive data for the Artiflex and Artisan Phakic 
Intraocular Lens groups.
Artiflex group (n=27) Artisan group (n=22)
Variable Pre-op Post-op Pre-op Post-op
Sphere (D)* -9.57 ± 1.43 0.02 ± 0.46 -9.33 ± 2.72 0.02 ± 0.45
Cylinder (D)* -0.77 ± 0.53 -0.51 ± 0.52 -1.14 ± 0.65 - 0.48 ± 0.53
SE (D)* -9.95 ± 1.43 -0.23 ± 0.40 -9.90 ± 2.74 -0.21 ± 0.45
LogMAR BCVA* 0.0 ± 0.07 -0.11 ± 0.07 0.05 ± 0.10 -0.01 ± 0.08
Snellen BCVA of ≥ 20/20 100% 77.0 %
Loss of ≥ 1 Snellen BCVA lines 0% 4.8%
* Values are mean ± standard deviation. D = diopters; SE = spherical equivalent; BCVA = 
best-corrected visual acuity; PIoL = phakic intraocular lens.
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-0.09 ± 0.07 (range, -0.18 to 0.0) (P = 0.001). A Snellen BCVA of ≥ 20/20 was 
found in 100% of eyes and no eyes lost any Snellen lines of BCVA.
For the Artisan group, the mean preoperative SE changed from -9.90 ± 2.74 
D (-4.0 to -14.50 D) to -0.21 ± 0.45 D (-1.0 to 0.75 D), postoperatively. After 
1 year, 76.2% of eyes were within ± 0.5 D of the desired refraction. The mean 
refractive cylinder changed from -1.14 ± 0.65 preoperatively to –2.35 ± 1.39 D 
at 1 week, -0,79 ± 0.76 D at 1 month, -0.63 ± 0.58 D at 3 months and -0.48 ± 
0.53 D at 1 year follow-up. A comparison between the 2 lens groups showed that 
there was a significant difference between the refractive cylinder value at 1 week 
follow-up (P = 0.001), and from month 1 there was no significant difference 
between the groups.
The mean preoperative logMAR BCVA changed from 0.05 ± 0.10 (range, -0.10 
to 0.22) to -0.01 ± 0.08 (range, -0.10 to 0.10) (P = 0.003), postoperatively. A 
Snellen BCVA of ≥ 20/20 was found in 77.0% (n=17) of eyes and 4.8% (n=1) lost 
1 or more Snellen lines of BCVA. 
In the Artiflex and Artisan groups, the mean postoperative IoP were 16.76 ± 
3.36 mmHg (range, 10 to 24 mmHg) and 15.5 ± 2.71 mmHg (range, 10 to 19 
mmHg), respectively (P = 0.23).
Clinical HOA changes
For both the Artiflex and Artisan groups, the mean numerical changes and 
comparisons before and after surgery are displayed in Table 3 and Figs. 2 to 7.
In the Artiflex group, there was a statistically significant difference in trefoil-y 
(increase factor 1.73) and spherical aberration (increase factor 0.55).
In the Artisan group, there was a statistically significant difference in HoA 
(increase factor 1.68), trefoil-y (increase factor 3.32) and spherical aberration 
(increase factor 6.84).
The difference between the increase factors for SA were statistically significant 
(P = 0.04).
Laboratory HOA evaluation
Laboratory analysis of the 2 PIoLs showed the Artiflex PIoL to have nega-
tive primary spherical aberration and the Artisan PIoL to have positive primary 
spherical aberration. Spherical aberration corresponds with Zernike mode number 
12. An analysis overview of the spherical aberration profiles for the Artiflex and 
Artisan groups is displayed in Fig. 8.
Spherical aberration changed negligibly with 100 and 200 micron decentrations 
with a 4 and 5 mm pupil diameter.
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Figure 4. Changes in trefoil-y before and 
after Artiflex versus Artisan Phakic Intra-
ocular Lens implantation for the correction 
of myopia.
Figure 2. Changes in total higher order 
aberrations (HoA) before and after Arti-
flex versus Artisan Phakic Intraocular Lens 
implantation for the correction of myopia.
Figure 3. Changes in trefoil-x before and 
after Artiflex versus Artisan Phakic Intra-
ocular Lens implantation for the correction 
of myopia.
Figure 5. Changes in coma-x before and 
after Artiflex versus Artisan Phakic Intra-
ocular Lens implantation for the correction 
of myopia.
Figure 6. Changes in coma-y before and 
after Artiflex versus Artisan Phakic Intra-
ocular Lens implantation for the correction 
of myopia.
Figure 7. Changes in spherical aberration 
before and after Artiflex versus Artisan 
Phakic Intraocular Lens implantation for the 
correction of myopia.
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Pupil sizes and PIOL decentration
For the Artiflex group, the mean mesopic-low pupil size was 4.95 ± 1.11 mm 
(range, 3.34 to 6.69 mm). The mean amount of PIoL decentration was 0.24 ± 
0.12 mm (range, 0.06 to 0.54 mm). A decentration of more than 0.5 mm was 
found in 3.7% of eyes (n=1). There was a significant correlation between PIoL 
decentration and post-operative SA (r = -0.42, P = 0.03) and coma-y (r = 0.44, 
P = 0.02).
For the Artisan group, the mean mesopic-low pupil size was 3.84 ± 0.79 mm 
(range, 2.64 to 5.32 mm). The mean amount of PIoL decentration was 0.25 ± 
0.12 mm (range, 0.10 to 0.46 mm). A decentration of more than 0.5 mm was 
found in none of the eyes. No significant correlations with postoperative aber-
rations were found.
DISCUSSIoN
The aim of this study was to evaluate changes in total and individual HoA after 
Artiflex PIoL implantation for the correction of myopia and make a comparison 
to a matched patient group after Artisan PIoL implantation.
By now it has been well established that the recently FDA approved PMMA 
Artisan PIoL is a safe, effective and predictable device for the surgical correction 
of moderate to high myopia.14, 22, 24, 29, 34-36 The foldable Artiflex iris-fixated PIoL, 
on the other hand, is a relatively new development in the area of lenticular refrac-
Figure 8. Artiflex and Artisan Phakic Intraocular Lens laboratory higher order aberration 
measurements over a 6 mm pupil diameter.
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tive surgery for the correction of myopia25, 28, 29 and is currently being evaluated 
in a European multicenter study.
The Artiflex lens design is based on the Artisan lens design, with haptics compa-
rable to the Artisan myopia lens. In the Artiflex lens the haptics are also made of 
PMMA, while the foldable optical zone is made of silicone and has the advantage 
of an insertion of the PIoL through a smaller 3.4-mm incision. The Artiflex 
lens theoretically represents an improvement of the iris-supported PIoL concept 
leading to a lower level of induced surgical astigmatism.
Recently, a randomized, paired-eye study compared the Artiflex and the Artisan 
lenses and found that one year after surgery, the percent of eyes with UCVA > 
20/40 was statistically better for Artiflex with a higher efficacy index and a faster 
and better visual recovery time for Artiflex-treated eyes during the early post-
operative period.29 Another report on the Artiflex lens reported that 6-months 
after surgery, there was no loss of Snellen BCVA, with 91% of eyes within ± 0.5 
D of the targeted refraction and 82% of eyes reaching a Snellen UCVA of 20/25 
or better.28
The evaluation of changes in HoA in the field of refractive surgery is not a new 
occurrence. Several studies have shown that laser refractive surgery techniques 
such as PRK and LASIK can lead to a significant increase in postoperative total 
and individual HoA.4-6, 37-40 There are also several reports that have studied 
changes in HoA after PIoL implantations, mostly after Artisan PIoL implan-
tation in myopic eyes.3, 41 Among these, there was a study that demonstrated 
higher postoperative trefoil, which the authors attributed to the incision size and 
also higher postoperative spherical aberration, according to them lens-related. 
A recent study that changes in HoA after Artiflex lens implantation found no 
significant tendency toward increasing HoA (e.g. coma and spherical aberration) 
which they attributed to preservation of the corneal asphericity.42
Evaluation of the changes in aberration profiles in both lens groups showed that 
postoperative spherical aberration decreased significantly in the Artiflex group 
and increased significantly in the Artisan group. This reduction in postoperative 
spherical aberration in the Artiflex group may be attributed to the negative spher-
ical aberration noted in bench testing which was performed on the Artiflex lens. 
This finding of negative spherical aberration may help compensate for the posi-
tive spherical aberration present in the normal preoperative population.43 Thus, 
the total amount of positive spherical aberration may be reduced after Artiflex 
PIoL surgery. In contrast, we measured a modest amount of positive spherical 
aberration in the Artisan group, which may have added to the positive spherical 
aberration which is present in the normal preoperative eye, which increased the 
amount of positive spherical aberration postoperatively in the Artisan group. In 
addition, differences in spherical aberration profiles between both lens groups 
may be induced by differences in incision size and wound healing. Differences 
in the spherical aberration profile between the Artiflex and the Artisan lens with 
a 6-mm analysis pupil diameter may be due to differences in lens rim design 
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(see also Fig. 1). Currently, the exact cause and relation to lens design factors is 
unknown and needs further investigation. Another finding was that in both lens 
groups, trefoil-y increased significantly. These changes might be the result of the 
smaller incision size in the Artiflex group. Some previous studies that analyzed 
HoA changes in cataract surgery have also suggested that trefoil changes may 
be related to the surgical procedure, e.g. the incision size and position.44 Further 
studies seem warranted to observe our observations, since they cannot be fully 
explained by the present small study.
The refractive results at 1 year were similar for the Artiflex and Artisan groups. 
Both lenses lead to a postoperative SE close to zero and about 80% of eyes within 
± 0.5 D of the desired refraction. Refractive astigmatism was significantly 
different only at 1 week follow-up, demonstrating that thereafter the amount of 
refractive astigmatism was comparable for the 2 lens groups, despite differences 
in incision size. The finding of comparable astigmatism values in Artiflex and 
Artisan eyes has been recently demonstrated by Coullet who also did not find a 
significant difference in postoperative astigmatism beyond 3 months follow-up.29 
The resulting decrease in corneal astigmatism for the Artisan group was attrib-
uted to the suture removal after this time point.
In conclusion, our study demonstrated a decrease in spherical aberration after 
implantation of a foldable Artiflex PIoL in myopic eyes, which may be related 
to the lens compensating for the positive spherical aberration preoperatively, and 
showed an increase in postoperative spherical aberration after rigid Artisan PIoL 
implantation. The aberration differences may also be related to other factors such 
as incision size and deserve further investigation.
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Visual problems can often arise in persons with moderate to high refractive errors 
and lead to contact lens and/or spectacle intolerance, creating severe problems in 
the daily activities. For persons seeking contact lens or spectacle independence, 
corneal and/or refractive surgery can offer promising alternatives. In this thesis, 
the subjective and clinical outcome of several refractive surgery techniques are 
evaluated in virgin eyes and eyes that have previously undergone keratoplasty.
During the evaluation and selection process of potential refractive surgery candi-
dates, it is standard practice to measure the patients’ pupil size. The pupil size is 
an important parameter to take into account since it has been long-time postu-
lated that pupil size could be an important predictor of night vision complaints 
after refractive surgery procedures such as laser in situ keratomileusis (LASIK) 
and phakic intraocular lens (pIoL) implantations. However, this issue is still in 
debate since a few recent studies found no direct correlations between large pupil 
sizes and night vision disturbances or visual funcation.1-3 
In our study on patient satisfaction after LASIK for the treatment of myopia we 
found no significant correlation between the scotopic pupil size or the pupil–
optical zone disparity and patient satisfaction (specifically glare and night vision), 
leading to our belief that eyes with larger pupils can be considered for laser refrac-
tive surgery, considering that patients are thoroughly informed on the possibility 
of short-term postoperative glare and halo’s. 
As for preoperative pupil size and pIoL implantations, our studies show that 
the horizontal pupil diameter decreases after Artisan pIoL implantation with an 
increase in the vertical/horizontal ratio. In addition, we showed that the scotopic, 
but not the mesopic-low, pupil-optical zone disparity is related to night vision 
complaints in patients. This is important, since mesopic-low conditions are a 
better representation of “real-life” situations. Therefore, we believe that eyes 
with larger pupil sizes can be still considered for treatment with pIoLs.
Pupil size measurements should reflect real-time situations as much as possible 
and we believe that objective digital binocular infrared pupillometry in mesopic-
low conditions is most appropriate for standardized measurements, since it is 
more reproducible and approximates “real life” conditions more closely than the 
subjective measurements with a monocular pupillometer. The role of pupil size 
in the process of selecting suitable refractive surgery candidates will continue 
to need further scientific investigation. The objective quantification of pupil 
size will assist in the evaluation of the exact relationship between night vision 
complaints and pupil size under various light conditions.
The assessment and improvement of patient satisfaction will continue to play an 
important role in the field of refractive surgery. With the increasing variety of 
available refractive surgery techniques and the many choices which the refractive 
surgery candidate faces, it is increasingly important that the patient is thoroughly 
analyzed and advised before the procedure he or she is seeking. 
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The importance of evaluating patient satisfaction in the patient group is 
re-emphasized by the recent announcement of the American Society of Cata-
ract and Refractive Surgery (ASCRS) that it will participate in a post-LASIK 
quality of life study with the Joint LASIK Study Task Force, which includes 
the U.S. Food and Drug Administration, the National Eye Institute, ASCRS 
and the American Academy of ophthalmology. In addition, results of a very 
recent meta-analysis review by Kerry Solomon, MD (which was presented at the 
annual Symposium and Congress of the ASCRS, April 4-9 in 2008, in Chicago), 
showed that 95.4% of LASIK patients worldwide report satisfaction with the 
outcome of their procedure with a total range of satisfaction rates in individual 
studies from 87.2% to 100%. This review examined nearly 3,000 peer-reviewed 
articles published over the past 10 years in clinical journals from North America, 
South America, Europe, Asia, Africa and Australia. 
We recommend that patients be thoroughly counseled on the potential side effects 
of the planned procedure and offer alternative surgical techniques. It is also impor-
tant to determine the patients’ motivations and expectations before surgery, since 
the relationship between patient expectations, the medical outcome, and patient 
satisfaction is complex and the clinical outcome does not always directly correlate 
with the subjective outcome. When studying patient satisfaction, we recom-
mend to use standardized methods, such as validated patient questionnaires, and 
offer them to patients before and after the surgical procedure. We believe that 
self-administered tests, rather than physician-administered tests, enable a more 
objective view of patient satisfaction and quality of vision.
As to the outcomes of the various corneal and refractive surgery techniques 
which we discussed in this thesis, it seems that patient satisfaction after both 
LASIK and Artisan pIoL implantation is comparable. We propose that this 
comparable finding is related to the precise selection of suitable candidates before 
the individual procedure. This means that when refractive surgery candidates are 
carefully examined, counseled and selected, patient satisfaction is generally high 
after most refractive surgery techniques. 
For the past decade, LASIK has been the preferred refractive surgical procedure 
for patients seeking contact lens or spectacle independence. Although it is gener-
ally known that the medical outcome of LASIK is excellent4-8, in order to draw 
more complete and final conclusions on this refractive surgery procedure, further 
studies are needed with larger amounts of patients, longer follow-up, and evalu-
ation of the modern generation equipment and instruments. As for wavefront 
and aspheric laser treatments, it is still not very clear whether the excellent results 
with these procedures are related to better postoperative asphericity profiles or 
due to treatment of preexistent higher order aberrations (HoA). only a few 
randomized controlled trials have compared wavefront/aspheric to conventional 
treatments and show that customized aspheric treatments might induce less aber-
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rations, namely spherical aberration and better maintain the physiology of the 
corneal surface.9, 10
Although the medical outcome of LASIK for the correction of moderate degrees 
of ametropia has been shown to be excellent, it is generally agreed that LASIK 
be not performed in patients with high degrees of ametropia or astigmatism. 
For these eyes with higher degrees of myopia, laser ablative procedures such 
as LASIK are a less desirable procedure, which is related to the higher risk of 
reduced postoperative quality of vision and a trend toward myopic regression.8, 11, 
12 Another rare, but dramatic complication that can occur after LASIK is corneal 
ectasia, that develops due to biomechanical corneal changes after the procedure. 
Post-LASIK ectasia has been shown to occur with an incidence between 0.12% 
and 0.66%. The risk of post-LASIK ectasia seems to be higher in eyes with preop-
erative irregular topography, thin corneas, thin remaining corneal beds, forme 
fruste keratoconus, thick corneal flaps, large optical zones, and high myopia.13-19
The implantation of an iris-fixated pIoL in virgin and highly aberrated eyes 
(e.g. after keratoplasty) represents a promising development for vision correc-
tion in patients with high degrees of ametropia or astigmatism and has been 
studied for several years now.20-24 The meticulous selection of suitable pIoL 
patients will become increasingly important, and we expect the inclusion criteria 
to be expanded, with the advent of newer imaging systems that can accurately 
determine the sizing issues involved with the placement of pIoLs in the ante-
rior chamber. Further research should be aimed at consistently evaluating larger 
number of patients who have undergone pIoL implantation. For the evaluation 
of the outcome of pIoL implantation, we suggest that surgeons continue to pay 
special attention to the clinical follow-up of these patients. Particularly, regular 
and adequate endothelial cell density measurements on a yearly basis should be 
performed and the implementation of the newer anterior imaging devices is 
necessary to detect a change in the morphometric relationship between pIoL 
and endothelium in the anterior chamber. The recall in 2007 ordered by the 
French government of 3 models of angle-supported, anterior chamber pIoLs due 
to excessive endothelial cell loss in the immediate postoperative years, once again 
point out the importance of remaining cautious and meticulous in our clinical 
judgement and postoperative evaluation of eyes treated with pIoL implanta-
tions.
Next to the correction of the degree of ametropia by the implantation of pIoLs, 
leading to the independence of spectacles or contact lens, the prevention and/
or correction of HoAs in this patient group will continue to play an important 
role. This is especially important in patients with higher degrees of refractive 
error, since refractive surgical techniques in these patients can lead to excessive 
HoAs and reduce quality of vision.25-27 A few studies have analyzed aberration 
changes after pIoL implantations. Among others, they suggested that higher 
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postoperative trefoil was related to the incision size and higher postoperative 
spherical aberration to the lens itself.27, 28 Questions that remain are: what is the 
exact cause and mechanism for aberration changes in pIoL implantations, and 
how do they relate to patient satisfaction? And finally, what is the exact role of 
the implanted lens type, e.g. rigid Artisan pIoL and foldable Artiflex pIoL? A 
recent study that compared both lens types showed that the Artiflex lens provided 
faster visual recovery and a better UCVA than the Artisan lens, but this study did 
not evaluate wavefront changes.22 It is currently unclear how HoAs and a change 
in their profile after pIoL implantation relate to better medical outcome and/
or improved patient satisfaction. The next years will undoubtedly demonstrate 
clinical studies that discuss ways to more effectively prevent and correct excessive 
HoAs.
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SUMMARY
In this thesis we set out to describe the indications for and the outcome of several 
corneal and refractive surgery techniques for the correction of refractive error in 
virgin and post-keratoplasty eyes.
Chapter 1 is a general introduction and describes the aim and outline of the thesis. 
Chapters 2 and 3 relate to the importance of standardized pupil size measurements 
under defined light conditions with good repeatability in relation to screening 
eligible refractive surgery candidates. This is particularly important for patients 
with large pupils, who do not necessarily need to be excluded from refractive 
surgery procedures. Also, no real long-term relationship between preoperative 
pupil size and postoperative glare or halos have been found. In chapter 2 we 
show that Procyon measurements under mesopic-low conditions compared most 
favourably to Colvard measurements in a group of refractive surgery screening 
candidates, as well as the Artisan phakic intraocular lens (pIoL) implantation 
group. We also stated that digital binocular infrared pupillometry might be a 
better technique for standardized pupil size measurements, since it approximates 
“real life” conditions more closely than the monocular Colvard measurements. 
In chapter 3 pupil size measurements using 2 different pupillometers (the more 
subjective handheld Colvard device and the digital Procyon device) under 
defined illumination levels were compared in a population of 121 eyes selected 
randomly out of refractive surgery screening candidates and a population of 83 
eyes who underwent Artisan pIoL implantation. The mean differences in pupil 
diameters for both devices were comparable. The chapter also studied pupil 
shape after Artisan pIoL implantation. We found that after the procedure, the 
mean horizontal pupil diameter decreased by 13.8%. An increase in the vertical/
horizontal ratio was found under all light conditions, probably attributed to a 
mechanical restriction of the iris in the horizontal meridian, implicating an oval-
ization of pupil shape in the vertical direction. The postoperative constriction 
in the horizontal axis and subsequent smaller pupil diameter under mesopic-low 
light conditions may implicate that eyes with larger pupil sizes can be treated by 
Artisan pIoL implantation.
In chapter 4 we report on patient satisfaction and self-perceived quality of vision 
after laser in situ keratomileusis surgery in 142 patients with a mean preoperative 
spherical equivalent (SE) of -4.96 ± 2.15 diopters (D) (range, -9.13 to -0.50 D). 
The quality of vision was assessed using a validated questionnaire.The predict-
ability was excellent, with 86.8% of eyes within ± 0.5 D and 97.0% within ± 
1.0 D from emmetropia. Patient satisfaction was very good, the mean score was 
4.10 ± 0.71 on a scale of 0 to 5 (a score of 5 meaning that the patient was totally 
satisfied). In this patient group glare complaints occurred after surgery in 47.2%, 
however, 92.3% of the treated patients reported that they would choose the same 
type of surgery again if they had to make their choice again.
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In chapters 5 and 6 the application of the Artisan pIoL for the correction of 
myopia is discussed. In chapter 5 the Artisan pIoL is discussed by looking at 
patient satisfaction and visual outcome 1 year after treatment in 120 virgin eyes 
with a mean preoperative SE of -12.09 ± 4.09 D. After surgery, the mean SE was 
-0.60 ± 0.78 D. The predictability was good, with 62.4% within ± 0.5 D, and 
81.5% within ± 1.0 D from emmetropia. Lens centration was excellent, with 
86.4% of pIoLs placed within 0.5 mm of the center of the pupil, and 100% 
within 0.75 mm from the center. There was a loss of 1 Snellen line of best-
corrected visual acuity (BCVA) in 5.0% of eyes and a loss of 2 Snellen lines of 
BCVA in 0.8% of eyes. Mean scotopic pupil size was 6.2 ± 0.79 mm. Patient 
satisfaction (assessed using the same questionnaire as mentioned above) was high 
with the mean score being 4.22 ± 0.56. Night vision complaints occurred, but 
did not affect overall patient satisfaction. Quality of night vision was related 
to the scotopic pupil size, individual higher order aberrations (such as spherical 
aberration (SA) and coma) and the residual refractive error. Chapter 6 discusses 
the results of a long-term study, demonstrating the 10-year results of myopic 
Artisan pIoL implantation in a group of 89 eyes with a preoperative SE of -10.36 
± 4.69 D (range, -3.75 to -25.25 D). It showed that the mean SE remained stable 
after 10 years being -0.70 ± 1.00 D (range, -4.00 to 2.00 D). 43.8% (n=39) of 
eyes were within ± 0.5 D of the desired refraction and 68.8% (n=61) of eyes were 
within ± 1.0 D of the desired refraction. The efficacy index was 0.80 after 10 
years, a decrease probably relating to the development of age- and high myopia 
related changes. The majority (93.3%) of patients maintained a BCVA of 20/40 
or better. We looked at the changes in endothelial cell density (ECD) and found 
no significant endothelial cell loss 10 years after surgery. We know that the physi-
ologic rate of endothelial cell loss is 0.6% per year after age 18. Glare complaints 
were few after 10 years time.
Chapters 7 and 8 discuss the application of the Artisan toric IoL in patients 
with aberrations in the corneal shape after corneal transplantation surgery and 
corneal refractive surgery. Chapter 7 discusses the 3-year results of Artisan toric 
IoL implantation for correction of post-keratoplasty ametropia and astigma-
tism in 36 eyes. These eyes could not be corrected by spectacle wear because 
of anisometropia. The technique was shown to be effective for reduction of 
refractive astigmatism and ametropia. Patient satisfaction increased greatly and 
all patients were suitable for spectacle correction after implantation. There was 
a continuing endothelial cell loss from 6 months to 3 years postoperatively. In 
3 cases corneal graft failure developed. Chapter 8 describes two case reports of 
Artisan toric aphakic IoL implantation for the correction of severe astigmatism 
after myopic radial keratotomy (RK). The first patient developed a postopera-
tive hyperopic shift and cataract, for which she underwent intracapsular cataract 
extraction and implantation of an Artisan aphakic IoL. Later, hyperopia and 
astigmatism progressed, and the Artisan aphakic IoL was exchanged for an 
Artisan toric aphakic IoL. The other patient had residual myopic astigmatism 
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and contact lens intolerance after bilateral RK. We treated her by implanting an 
Artisan toric pIoL in both eyes. Both cases resulted in a satisfactory outcome.
In chapter 9 a complication and the consequences for the individual patient of 
implantation of a foldable pIoL are described. The patients’ eye suffered from 
recurrent intraocular inflammation after myopic Artiflex pIoL implantation. 
The patient developed a severe cell deposition one week after the procedure. 
Nine months later, many cell deposits remained visible on the posterior lens 
surface, leading to severe glare complaints. Despite initial medical treatment, 
the Artiflex lens had to eventually be exchanged for a polymethyl methacrylate 
(PMMA) Artisan pIoL. The lens exchange resulted in a postoperative UCVA of 
20/20 and a disappearance of the glare complaints. of particular concern with 
pIoLs is the long-term tolerance of the lens. The long-term results of the fold-
able Artiflex lens have yet to be demonstrated.
Finally, chapter 10 discusses differences between 2 iris-fixated pIoL models: a 
non-foldable PMMA Artisan pIoL and a recently developed foldable Artiflex 
pIoL. The chapter analyses changes in optical aberrations for the correction of 
myopia, which is important in order to obtain a more complete understanding 
of the eye’s refractive error, especially in regards to eyes with higher levels of 
myopia and/or astigmatism. In the Artiflex group of 27 eyes, trefoil–x increased 
significantly and trefoil-y and SA decreased significantly. In the Artisan group 
of 22 eyes, trefoil-x, trefoil-y and SA increased significantly. Laboratory analysis 
of both lens groups showed that the Artisan lens has positive SA and the Artiflex 
lens has negative SA, which supports the clinical finding that the Artiflex lens 
induces less SA postoperatively. This difference in SA profile might be explained 
by differences in optic material and/or lens design.
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SAMENVATTING
Dit proefschrift had als doel het beschrijven van de indicaties voor en de uitkom-
sten van diverse corneale en refractiechirurgie technieken voor de correctie van 
refractieafwijkingen in normale en post-keratoplastiek ogen.
Hoofdstuk 1 is een algemene introductie en beschrijft het doel en de opzet van dit 
proefschrift. Hoofdstukken 2 en 3 beschrijven het belang van gestandaardiseerde 
pupilgrootte metingen onder gedefinieerde lichtomstandigheden met goede 
reproduceerbaarheid, in relatie tot het screenen van refractiechirurgie kandidaten. 
Dit is vooral van belang voor patiënten met grote pupillen, die niet zonder meer 
uitgesloten hoeven te worden van refractiechirurgie technieken. ook is er nog 
geen echte lange termijn relatie gevonden tussen de preoperatieve pupilgrootte 
en postoperatieve glare of halo’s. In hoofdstuk 2 tonen we dat Procyon metingen 
onder laag-mesopische lichtomstandigheden het beste vergelijkbaar waren met de 
Colvard metingen in een groep van zowel refractiechirurgie kandidaten als een 
Artisan phake intraoculaire lens (pIoL) implantatie groep. We stelden tevens dat 
digitale binoculaire infrarood pupillometrie waarschijnlijk een betere techniek 
is voor gestandaardiseerde pupilgrootte metingen, aangezien het de ”real life” 
condities beter imiteert dan de monoculaire Colvard metingen. In hoofdstuk 3 
worden pupilgrootte metingen vergeleken die werden verricht met behulp van 
2 verschillende pupillometers (het meer subjectieve handheld Colvard apparaat 
en het digitale Procyon apparaat) onder gedefinieerde lichtomstandigheden in 
een populatie van 121 ogen, die willekeurig geselecteerd waren uit refractiechi-
rurgie kandidaten en een populatie van 83 ogen die Artisan pIoL implantatie 
ondergingen. Het gemiddelde verschil in pupildiameters voor beide apparaten 
was vergelijkbaar. Het hoofdstuk bestudeerde ook de pupilvorm na Artisan pIoL 
implantatie. Er werd aangetoond dat na de ingreep, de gemiddelde horizontale 
pupildiameter verminderde met 13.8%. Een toename in de verticale/horizontale 
ratio werd gevonden onder alle lichtomstandigheden, wat mogelijk te maken 
heeft met een mechanische restrictie van de iris in de horizontale meridiaan, 
welke een pupil ovalizatie in de verticale richting impliceert. De postoperatieve 
constrictie in de horizontale as en de daardoor kleinere pupildiameter onder laag-
mesopische lichtomstandigheden kan betekenen dat ogen met grotere pupillen 
toch een Artisan pIoL implantatie kunnen ondergaan. 
In hoofdstuk 4 rapporteren we over patiënttevredenheid en subjectieve kwali-
teit van zien na laser in situ keratomileusis in 142 patiënten met een gemiddeld 
preoperatief spherisch equivalent (SE) van -4.96 ± 2.15 dioptrie (D) (range, -9.13 
tot –0.50 D). Het kwaliteit van zien werd geëvalueerd met behulp van een geva-
lideerde vragenlijst. De voorspelbaarheid was zeer goed, met 86.8% van de ogen 
binnen ± 0.5 D en 97.0% binnen ± 1.0 D van emmetropie. Patiënttevredenheid 
was erg goed met een gemiddelde score van 4.10 ± 0.71 op een schaal van 0 
tot 5 (een score van 5 betekent dat de patiënt geheel tevreden was). In deze 
patiëntengroep traden postoperatieve glare klachten op in 47.2%, echter 92.3% 
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van de behandelde patiënten rapporteerden dat ze dezelfde behandelingstechniek 
zouden kiezen als ze hun keuze nogmaals moesten maken.
In hoofdstuk 5 en 6 wordt de toepassing van de Artisan pIoL voor de correctie 
van myopie besproken. In hoofdstuk 5 werd de Artisan pIoL besproken door het 
evalueren van patiënttevredenheid en visuele resultaten 1 jaar na de behande-
ling in 120 ogen met een gemiddeld preoperatief SE van -12.09 ± 4.09 D. Na 
behandeling was het gemiddelde SE -0.60 ± 0.78 D. De voorspelbaarheid was 
goed, met 62.4% binnen ± 0.5 D, en 81.5% binnen ± 1.0 D van emmetropie. 
Lens centratie was zeer goed, met 86.4% van de pIoLs geplaatst binnen 0.5 mm 
van het centrum van de pupil, en 100% binnen 0.75 mm van het centrum. Er 
trad een verlies van 1 Snellen best-corrected visual acuity (BCVA) lijn op in 
5.0% van de ogen en een verlies van 2 Snellen BCVA lijnen in 0.8% van de ogen. 
De gemiddelde scotopische pupilgrootte was 6.2 ± 0.79 mm. Patiënttevreden-
heid (geëvalueerd met dezelfde vragenlijst als hierboven genoemd) was hoog met 
een gemiddelde score van 4.22 ± 0.56. Problemen met het zien ’s nachts traden 
op, maar beïnvloedden de algehele patiënttevredenheid niet. Kwaliteit van zien 
‘s nachts was gerelateerd aan de scotopische pupilgrootte, individuele hogere orde 
aberraties (zoals spherische aberratie (SA) en coma) en de resterende refractieaf-
wijking. Hoofdstuk 6 bespreekt de resultaten van een lange termijn studie, die 
de 10-jaar resultaten toont van myope Artisan pIoL implantatie in een groep van 
89 ogen met een preoperatief SE van -10.36 ± 4.69 D (range, -3.75 tot -25.25 D). 
De studie laat zien dat het gemiddelde SE stabiel bleef met een waarde van -0.70 
± 1.00 D (range, -4.00 tot 2.00 D) na 10 jaar. 43.8% (n=39) van de ogen bereikte 
een refractie binnen ± 0.5 D van de gewenste refractie en 68.8% (n=61) van de 
ogen binnen ± 1.0 D van de gewenste refractie. De efficacy index was 0.80 na 
10 jaar, een vermindering welke mogelijk te wijten is aan de ontwikkeling van 
leeftijdsgebonden en hoge myopie gerelateerde veranderingen. De meerderheid 
(93.3%) van patiënten behield een BCVA van 0.5 of meer. We bestudeerden 
veranderingen in endotheelceldensiteit (ECD) en vonden geen significant endo-
theelcelverlies 10 jaar na de ingreep. We weten dat het fysiologisch ECD verlies 
0.6% per jaar is na de leeftijd van 18 jaar. Glare klachten waren zeldzaam na 10 
jaar tijd.
Hoofdstuk 7 en 8 bespreken de toepassing van de Artisan torische IoL in pati-
enten met corneale aberraties na keratoplastiek en na corneale refractiechirurgie. 
Hoofdstuk 7 bespreekt de 3-jaar resultaten van Artisan torische IoL implantatie 
voor de correctie van post-keratoplastiek ametropie en astigmatisme in 36 ogen. 
Deze ogen konden niet worden gecorrigeerd met behulp van brillenglazen door 
de grootte van de anisometropie. De Artisan torische IoL implantatie techniek 
toonde effectief te zijn in de vermindering van het refractie astigmatisme en 
ametropie. Patiënttevredenheid nam aanzienlijk toe en alle patiënten waren 
geschikt voor brilaanpassing na de ingreep. Er was een continu endotheelcel-
verlies tussen 6 maanden tot 3 jaar na de ingreep. In 3 gevallen trad een afsto-
ting op. Hoofdstuk 8 beschrijft 2 gevallen waarbij Artisan torische aphake IoL 
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implantatie werd uitgevoerd voor de correctie van fors astigmatisme na myope 
radiaire keratotomie (RK). De eerste patiënt ontwikkelde een postoperatieve 
hypermetrope shift en cataract, waarvoor zij een intracapsulaire cataractextractie 
en implantatie van een Artisan afake IoL onderging. De hypermetropie en astig-
matisme toonde later progressie, en werd de Artisan afake IoL uitgewisseld voor 
een Artisan torische afake IoL. De andere patiënt leed aan een resterend myoop 
astigmatisme en contactlensintolerantie na bilaterale RK. Wij behandelden haar 
door het implanteren van een Artisan torische pIoL in beide ogen. Beide gevallen 
resulteerden in een goede uitkomst.
In hoofdstuk 9 wordt een complicatie na en de gevolgen van een implantatie 
van een opvouwbare pIoL beschreven in een individuele patiënt. Het oog van 
deze patiënt leed aan recidiverende intraoculaire ontstekingen na myope Artiflex 
pIoL implantatie. De patiënt ontwikkelde ernstige celdeposities 1 week na de 
ingreep. Negen maanden later waren er nog vele celdeposities zichtbaar op de 
achterzijde van de lens, die leidden tot invaliderende glare klachten. ondanks 
medische behandeling, moest de Artiflex lens uiteindelijk worden uitgewisseld 
voor een polymethyl methacrylaat (PMMA) Artisan pIoL. De lenswissel resul-
teerde in een postoperatieve ongecorrigeerde visus van 1.0 en het verdwijnen van 
de glare klachten. Het belang bij pIoLs ligt voornamelijk bij de lange termijn 
tolerantie van de lens. Deze moet voor de opvouwbare Artiflex lens nog worden 
aangetoond.
Tenslotte, beschrijft hoofdstuk 10 de verschillen tussen 2 iris-gefixeerde pIoL 
modellen: een niet-opvouwbare PMMA Artisan pIoL en een recentelijk 
ontworpen opvouwbare Artiflex pIoL. Het hoofdstuk analyseerde de veran-
deringen in optische aberraties voor de correctie van myopie, wat van belang 
is bij het volledige begrip van refractieafwijkingen, vooral in relatie tot ogen 
met hogere myopie en/of astigmatisme waarden. In de Artiflex groep van 27 
ogen, daalden trefoil-y en SA significant. In de Artisan groep van 22 ogen, 
namen trefoil-y en SA significant toe. Laboratorisch onderzoek van de beide 
lenzen toonde dat de Artisan lens positieve SA heeft en de Artiflex lens negatieve 
SA, hetgeen de klinische bevindingen ondersteunt dat de Artiflex lens minder 
SA induceerde na de ingreep. Dit verschil in SA profiel kan mogelijk worden 
verklaard door verschillen in lens materiaal en/of lens ontwerp. 
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Allereerst wil ik mijn promotor Prof. Hendrikse bedanken, die dit alles mogelijk 
heeft gemaakt. U heeft vanaf het eerste moment vertrouwen in mij gehad, iets 
wat begon met mijn tijd in San Antonio. De opleidingstijd onder uw begeleiding 
was zeer leerzaam en al snel merkte u mijn interesse in cornea en refractie-
chirurgie op. Ik ben u en Astrid Hacking zeer dankbaar voor alles wat u voor mij 
mogelijk heeft gemaakt, de afgelopen jaren. 
Mijn co-promotor, Rudy Nuijts: het begon allemaal toen jij tijdens een druk 
arts-assistenten spreekuur in 2003 “even tussendoor” vroeg of ik interesse had 
om te promoveren. Ik wil je bedanken voor de bijzondere begeleiding die ik van 
je heb mogen ontvangen, ondanks je zeer drukke schema, en de mogelijkheden 
die je voor me hebt gecreëerd. Ik ben nog vaak verbaasd over wat je me hebt 
helpen bereiken. ook wil ik je bedanken voor je vertrouwen door me te willen 
opleiden als cornea specialist.
De leden van de leescommissie, Prof. van de Borne, Dr. Budo, Prof. Luyten, 
Prof. van Rij en Dr. Webers wil ik bedanken voor het lezen en beoordelen van 
mijn proefschrift.
Heel veel dank en waardering wil ik uiten aan alle stafleden, arts-assistenten, 
paramedici, polikliniek medewerkers, secretaresses, operatiekamer medewerkers 
en onderzoekers van de afdeling oogheelkunde in het academisch ziekenhuis 
Maastricht, Medisch Centrum Maastricht Annadal, Atrium Medisch Centrum 
Heerlen en Brunssum. Met name veel dank aan Sara Schneider, Fleur Goezinne 
en Niels de Vries. Fred Eggink en Sander Bootsma wil ik bedanken voor hun 
mede-auteurschap. Albert Liem, bedankt voor je mental coaching. Ellen Vrancken 
en Marian Jansen wil ik bedanken voor hun administratieve ondersteuning. Tos 
Berendschot en Jan Schouten ben ik dankbaar voor hun statistische hulp.
Veel dank aan mijn studievriendinnen Marianne, Monique, Suzanne, Zita en met 
name Marijke, die dit proces jarenlang hebben gevolgd. Samantha en Anneke, 
mijn trouwe vriendinnen sinds onze eerste middelbare schooldag: bedankt! Anke, 
thank you for our great friendship since our Texas time. 007, bedankt voor de 
gesprekken die me door de laatste fase van mijn promotie hebben geholpen.
Mijn paranimfen Anneke en Yanny wil ik bedanken voor hun goede hulp en 
ideeën bij de eindfase.
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En dan het belangrijkste, mijn familie. Mijn zussen en broer Bahia, Muni, Sharon, 
Abbas en hun partners en kinderen wil ik bedanken voor hun jarenlange steun. 
ook dank aan mijn tante en oom.
This book is for my mother and father, whom I love dearly. The completion of 
this book would have been impossible without your constant encouragement, 
guidance and love. Dad, I miss you… 
This book is dedicated to my nephew Max, who has been a great source of 
inspiration and a true example of perseverance.
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CURRICULUM VITAE
De auteur van dit proefschrift werd geboren op 31 oktober 
1974 te Utrecht als Nayyirih Grace Tahzib. Na het behalen 
van het examen Atheneum-B aan de Rijksscholengemeen-
schap Schoonoord te Zeist in 1993, ging zij geneeskunde 
studeren aan de Universiteit Utrecht. In 2000 behaalde zij 
haar artsendiploma, waarna zij naar San Antonio, Texas 
in de Verenigde Staten verhuisde om, in samenwerking 
met de afdeling oogheelkunde van het academisch zieken-
huis Maastricht, wetenschappelijk onderzoek te verrichtten 
gedurende 2 jaar. Hierna startte zij aan met haar opleiding 
tot oogarts (onder leiding van Prof. Hendrikse), welke zij in 2007 
afrondde. Begin 2004 begon zij met haar promotie-onderzoek. 
Sinds het afronden van haar oogartsen opleiding werkt zij als 
oogarts en cornea fellow in Maastricht, Heerlen en Brunssum, 
onder leiding van Prof. Hendrikse en Dr. Nuijts.
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